CA1330993C - Cyclic amine derivatives, pharmaceutical compositions containing these compounds and processes for their preparation - Google Patents

Cyclic amine derivatives, pharmaceutical compositions containing these compounds and processes for their preparation

Info

Publication number
CA1330993C
CA1330993C CA000567464A CA567464A CA1330993C CA 1330993 C CA1330993 C CA 1330993C CA 000567464 A CA000567464 A CA 000567464A CA 567464 A CA567464 A CA 567464A CA 1330993 C CA1330993 C CA 1330993C
Authority
CA
Canada
Prior art keywords
methyl
oxo
tetrahydro
group
dimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000567464A
Other languages
French (fr)
Inventor
Joachim Heider
Manfred Psiorz
Andreas Bomhard
Norbert Hauel
Berthold Narr
Klaus Noll
Christian Lillie
Walter Kobinger
Jurgen Dammgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of CA1330993C publication Critical patent/CA1330993C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Gears, Cams (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Abstract Cyclic Amine Derivatives This invention relates to compounds of formula I

Description

Cyclic amine derivotlve~ ;

This inventlon relates to certa:ln novel cyclic amlne derivatlve~, to pharmaceutical compos1tion~
con~alning them and to proce~se~s for .their preparation. -:~

Canadian Patent Nb. n ,086,726 describes, inter alia~ ;the c~mpound of formula ~ :

~ ~ ~CH2CH2CH2- N - CH2CH2 ~ 0CH3 and the physiologic~lly ~ccept~ble acid aadition :~
salts thereof, which has valuable pharmacological propertie~, namely a mild hypotensive activlty and, more particuIarly, a selective heart rate ''` '~
lowering aotlvlty.

Surpri~ingly, it has now:been found that certain ; ~
new cycllc ~mine d~rivatives have even more valuable ; ~ ~;
pharmacological propertie~, particularly a hypo~ensive ef~ect ~nd ~ long-l~sting heart rate lowering actlvlty ...
and the effect of reduclng ~he 2 requlrement of ~he heart.

Thus in one n~pect the present lnventlon provlde~
a compound o~ formula tIl ~.

~ ~ A \ ~CH2 ~
R2 - _ ¦ N - E - CH ~ - G - R ~ .
~3 / (C )n *

~, ' ~'~ "

`

(wherein 1330~93 A represents a -CH2-, -CH2-CH2- or -CH=CH- group;

B represents a -CH2-, -CH2-CH2-, or -CO- group or a -CH2CO- group of which the carbonyl carbon is attached :~.
to the nitrogen atom;

E represents a straight-chained Cl_3 alkylene group optionally substituted by a C1 3 alkyl group;

G represents straight-chained Cl 6 alkylene group optionally substituted by a Cl_3 alkyl group, or a group -G'-G"- (where G' represents a straight .
chained C2 5 alkylene group optionally substituted by a Cl 3 alkyl group and G" is attached to an :
aromatic or heteromatic group R and represents an oxa, thia, sulphinyl or sulphonyl group or an ~ :
imino group optionally substituted by a Cl 3 alkyl .
group);

Rl represents a hydrogen or halogen atom or a trifluoro-methyl, nitro, amino, Cl 3 alkylamino, di(Cl 3 alkyl)amino, ~ :
Cl 3 alkyl, hydroxy, Cl 3 alkoxy or phenyl(Cl 3 alkoxy) ;~ ~ ;
group and R2 represents a hydrogen or halogen atom or a hydroxy, Cl 3 alkoxy, phenyl(Cl 3 alkoxy) or Cl 3 alkyl group,~ .
or Rl and R2 together represent a Cl 2 alkylenedioxy group;

m is any one of the integers from 1 to 6 and n is any one of the integers from O to 3, and the sum of n and m is 3, 4, 5 or 6; and ' :~
R represents ' ~

1 3 3 ~3 r9 9 3 a ring carbon- or ring nitrogen-attached cyclic group comprising a 5- or 6-membered heteroaromatic ~ :
ring optionally carrying a fused benzene ring, .
wherein said heteroaromatic ring contains one oxygen, sulphur or n~trogen atom, two nitro~en atoms or one nitrogen atom and one oxygen or sulphur atom, wherein the carbon structure of said cyclic ~:
group optionally is mono- or disubstituted by substituents :
selected from halogen atoms and Cl_3 alkyl, hydroxy, Cl_3 alkoxy, phenyl(Cl_3alkoxy), phenyl, dimethoxyphenyl, nitro, amino, acetylamino, carbamoylamino, N-(Cl_3 :: :
alkyl)-carbamoylamino, hydroxymethyl, mercapto, ::~
Cl_3 alkylmercapto, Cl 3 alkylsulphinyl, Cl 3 alkylsulphonyl, Cl 3 alkylsulphonyloxy, Cl 3 alkylsulphonylamino, ;~
(Cl 3 alkoxy)carbonylmethoxy, carboxymethoxy and (Cl 3 alkoxy)methyl groups or optionally is substituted ;~
by a methylenedioxy or ethylenedioxy group, wherein any imino group in said heteroaromatic ring optionally is substituted by a Cl 3 alkyl, phenyl(Cl 3 alkyl) or phenyl group, wherein where said cyclic ~roup comprises an indolyl group it additionally optionally is substituted by a methylamino, dimethylamino, methoxy, aoetoxy, trifluoromethyl, trichloromethyl, carboxy, `~
methoxycarbonyl, ethoxycarbonyl, cyano, cyclohexyl, trimethoxyphenyl, trifluorophenyl, trichlorophenyl, tribromophenyl or dihaloaminophenyl group or by ~ ::
a benzyl, benzyloxy or benzylamino group optionally :~
mono-, di- or trisubstituted in the phenyl ring of the benzyl nucleus by methoxy or methyl groups, ,~

or a naphthyl group optionally substituted by a Cl 2 alkylenedioxy group or optionally mono- or :.
disubstituted by ~ubstituents selected from halogen atoms and Cl_3 alkyl, hydroxy, Cl_3 alkoxy, Cl_3 alkylsulphonyloxy, nitro, amino and Cl_3 alkanoylamino ~: :
groups, :;

or a benzyloxy or 4,5,6,7-tetrahydro-benzo[b]thienyl group, -? . 1 3 3 0 .~ 9 3 , ................................................................... .

or, if B represents a -CH2- or -Co- group, R may also represent a phenyl qroup optionally substituted by a Cl 2 alkylenedioxy group or by a halogen atom or by a Cl 3 alkyl, hydroxy, Cl 3 alkoxy, phenyl(C1 3 alkoxy), nitro, amino, Cl_3 allcanoylamino, Cl_3 alkylsulphonylamino, bis(Cl_3 alkylsulphonyl)amino, ~ -Cl 3 alkylsulphonyloxy, trifluoromethyl, trifluoromethoxy or trifluoromethylsulphonyloxy group, or disubstituted by substituents selected from halogen atoms and Cl 3 alkyl and Cl 3 alkoxy groups, or a tri(Cl 3alkoxy)~
phenyl group, a tetra(Cl_3 alkyl)phenyl group or a ~-dihaloaminophenyl group) or an enantiomer, diastereomer, N-oxide or acid ~-addition salt thereof.

The compounds of the invention may be in salt form, e.g. in the form of the physiologically acceptable salts of the compounds of formula I with organic or inorganic acids. Suitable acids for reaction include, for example, hydrochloric, hydrobromic, sulphuric, phosphoric, tartaric, acetic, lactic, `
furmaric, citric, maleic and succinic acids.

Where moieties in the structure of formula I may carry two or more optional substituents then unless otherwise stated these may of course be identical .
or different. m :~
Examples of the definitions of the groups given hereinbefore include:

for Rl: hydrogen, fluorine, chlorine and bromine atoms, and mèthyl, ethyl, n-propyl, isopropyl, trifluoromethyl, hydroxy, methoxy, ethoxy, n-propoxy, isopropoxy, nitro, amino, methylamino, ethylamino, n-propylamino, isopropylamino, dimethylamino, diethylamino, di-n-propylamino, diisopropylamino, N-methyl-ethylamino, N-methyl-n-propylamino, N-methyl-isopropylamino, N-ethyl-n-propylamino, benzyloxy, l-phenylethoxY~ ~ -133~3 l-phenylpropoxy, 2-phenylethoxy and 3-phenylpropoxy groups, for R2: hydrogen, chlorine and bromine atoms, and methyl, ethyl, n-propyl, isopropyl, hydroxy, methoxy, ethoxy, n-propoxy, isopropoxy, benzyloxy, l-phenylethoxy, -2-phenylethoxy, 2-phenylpropoxy and 3-phenylpropoxy groups, for Rl together with R2: methylenedioxy and ethylene-dioxy groups, for E: methylene, ethylene, n-propylene, ethylidene, n-propylidene, n-butylidene, 2-methyl-n-propylidene, l-methyl-ethylene, l-ethyl-ethylene, 2-methyl-ethylene, 2-ethyl-ethylene, l-n-propyl-ethylene, l-methyl- `~
n-propylene, 2-methyl-n-propylene, 3-methyl-n-propylene, l-ethyl-n-propylene, 2-n-propyl-n-propylene and 3-ethyl-n-propylene groups (n.b. the alkylene group is attached at its l-position to the nitrogen), for G: methylene, ethylidene, n-propylidene, n- `
butylidene, 2-methyl-propylidene, ethylene, l-methyl-ethylene, l-ethyl-ethylene, l-propyl-ethylene, 2-methyl-ethylene, 2-ethyl-ethylene, n-propylene, n-butylene, n-pentylene, n-hexylene, l-methyl-n-propylene, l-methyl-n-butylene, l-methyl-n-pentylene, l-ethyl-n-propylene, 2-ethyl-n-propylene, l-ethvl-n-butylene, ethyleneoxy, n-propyleneoxy, n-butyleneoxy, ethylenethio, n-propylenethio, n-butylenethio, ~`
ethylenesulphinyl, ethylenesulphonyl, n-propylene- ~ `
sulphinyl, n-propylenesulphonyl, n-butylenesulphinyl, ethyleneamino, n-propyleneamino, n-butyleneamino, N-methyl-ethyleneamino, N-methyl-n-propyleneamino, N-ethyl-n-propyleneamino, N-isopropyl-n-propyleneamino and N-methyl-n-butyleneamino groups (n.b. the alkylene `
groups are attached at their l-positions to the `
nitrogen atom of the saturated ring), ~ . .

3 3 ~

for R: pyrrol-2-yl, pyrrol-3~yl, N-methyl-pyrrol-2-yl, N-methyl-pyrrol-3-yl, ll2-aimethyl-pyrr 3-yl, 2,5-dimethyl-pyrrol-3-yl, fur-2-yl, fur-3- ~ :
yl, 5-methyl-fur-2-yl, 2-methyl-fur-3-yl, 5-nitro-fur-2-yl, 5-methoxymethyl-fur-2-yl, benzorb]fur-2-yl, benzolb]fur-3-yl, 7-methylbenzo[b]fur-3-yl, :
2-methoxy-benzo[b]fur-3-yl, 3-methoxy-benzo[b]fur-2-yl, 4-methoxy-benzo r b]fur-3-yl, 5-methoxy-benzo[b]fur-3-yl, 6-methoxy-benzo[b]fur-3-yl, 7-methoxy-benzo[b]fur- ~ :
3-yl, 5-methoxy-3-phenyl-benzo[b]fur-2-yl, 3-methyl- ~:
5-methoxy-benzo[b]fur-2-yl, thien-2-yl, thien-3-yl, 5-methyl-thien-2-yl, 2~methyl-thien-3-yl, 3- ~ -~
methyl-thien-2-yl, 2,5-dimethyl-thien-3-yl, 4,5,6,7-tetrahydro-benzo[b]thien-3-yl, 4,5,6,7-tetrahydro- ~: ~
benzo[b]thien-2-yl, 5-chloro-thien-2-yl, 5-bromo- ~; . `
thien-2-yl, 5-phenyl-thien-2-yl, 2-phenyI-thien- ~:
3-yl, benzo[b]thien-2-yl, benzo[b]thien-3-yl, 2,5-dimethyl-benzo[b]thien-3-yl, 5-methyl-benzo[b]thien- ~ :
3-yl, 6-methyl-benzo[b]thien-3-yl, 5-chloro benzo[b]thien-2-yl, 5-bromo-benzotb]thien-3-yl, 6-hydroxy-benzo[b]thien-3-yl, 7-hydroxy-benzorb]thien-3-yl, 5-hydroxy-benzorb]thien-2-yl, 6-hydroxy-benzo~b]thien-2-yl, 7-hydroxy-benzo[b]thien~
2-yl, 6-methanesulphonyloxy-benzo[b~thien-3-yl, 3-methoxy-benzo[b]thien-2-yl, 4-methoxy-benzo[b]thien- ~:
2-yl, 5-methoxy-benzo[b]thien-2-yl, 6-methoxy-benzo[b]thien-2-yl, 7-methoxy-benzo[b]thien-2-yl, 2~-methoxy-benzo[b]thien-3-yl, benzo~b]thien-4-yl, benzo[b]thien-5-yl, benzo[b]thien-6-yl, benzo[b]thien-7-yl, 4-methoxy-benzo[b]thien-3-yl, 5-methoxy-benzo[b]thien-3-yl, 6-methoxy-benzo[b]thien-3-yl, 7-methoxy-benzo[b]thien 3-yl, 5,6-dimethoxy~
benzolb]thien-3-yl, 5,6-methyienedioxy-benzo[b]thien-3-yl, 6-ethoxy-benzorb]thien-3-yl, 6-propoxy-benzo[b]thien- :~
3-yl, 6-isopropoxy-benzo[b]thien-3-yl, 6-mercapto-benzo[b]thien-3-yl, 6-methylmercapto-benzo[b]thien-3-yl, 6-methylsulphinyl-benzo[b]thien-3-yl, 6-methylsulphonyl-benzo[b]thien-3-yl, 6-methylsulphonyloxy-benzo[b]thien-3-yl, 6-methoxycarbonylmethoxy-benzo[b]thien-3-. ~:, .

~33~3 _ 7 --yl, 6-ethoxycarbonylmethoxy-benzo[b]thien-3-yl, 6-carboxymethoxy-benzo[bJthien-3-yl, 6-amino-benzo[b]thien-3-yl, 6-methylamino-benzo[b]thien-3-yl, 6-dimethylamino~
benzo[b]thien-3-yl, 6-diethylamino-benzorb]thien-3-yl, 6-acetamino-benzo[b]thien-3-yl, 6-methylsulphonylamino-benzo[b]thien-3-yl, pyrazol-l--yl, pyrazol-3-yl, 3,5-dimethyl-pyrazol-1-yl, 1,5-dimethyl-pyrazol-3-yl, imidazol-l-yl, imidazol 2-yl, imidazol-4~5)- ;~:
yl, l-methyl-imidazol-4-yl, l~benzyl-imidazol-4-yl, 5-nitro-2-methyl-imidazol~-1-yl, 2-(3,4-dim~thoxy- :~
phenyl)-imidazol-4(5)-yl, benzo[d]imidazol-l-yl, 2-benæyl-benzo[d]imidazol-1-yl, benzo[d]imidazol-2-yL, imidazo[l,2-a]pyrid-3-yl, oxazol-4-yl, oxazol-S-yl, isoxazol-3-yl, 3-methyl-isoxazol-5-yl, 5- ~ :
methyl-isoxazol-3-yl, 3,5-dimethyl-isoxazol-4-yl, 4-methyl-thiazol-5-yl, benzo[d]oxazol-2-yl, benzotd]isoxazol-3-yl, benzo[d]thiazol-2-yl, 5-ethoxy-benzo[d]thiazol-2-yl, benzo[d]isothiazol-3-yl, benzo[d]pyrazol-l-yl! benzo[d]pyrazol-3-yl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, pyrid-3-yl-N-oxide, 6-methyl-pyrid-2-yl, 4-nitro-pyrid-2-yl, 4-amino-pyrid-2-yl, 4-acetylamino-pyrid-2-yl, 4-carbamoylamino-pyrid-2-yl, 4-N-methyl-carbamoylamino-pyrid-2-yl, 2-chloro- ~ .
pyrid-3-yl, 2-chloro-pyrid-4-yl, 6-chloro-pyrid- : :
2-yl, 6-hydroxymethyl-pyrid-2-yl, quinol-2-yl, isoquinol-l-yl, 2-methyl-quinol-4-yl, 7-methyl-quinol-2-yl, 4-chloro-quinol-2-yl, 6,7-dimethoxy-quinol-4-yl, 6,7-dimethoxy-isoquinol-4-yl, 6,7-dimethoxy-isoquinol-4-yl-N-oxide, indol-~-yl, indol- .
3-yl, 5,7-dibromo-6-cyano-indol-3-yl, 5,7-dichloro- .
6-aminocarbonyl-indol-3-yl, 4,6-dibromo-5-aminocarbonyl- .
indol-3-yl, 5,7-dibromo-6-methoxy-indol-3-yl, 5,6- ~ ~ -dihydroxy-indol-3-yl, 4-dimethylamino-indol-3-yl, ~ ~.
4-methoxy-6-dimethylamino-indol-3-yl, 4-methyl-6-dimethylamino-indol-3-yl, 5-acetoxy-6-dimethylamino-indol-3-yl, 5-acetamido-7-dimethylamino-indol-3-yl, 5-dimethylaminocarbonyl-indol-3-yl, 5-carboxy- :~

~` ~330~9~ ~

indol-3-yl, 5-acetamido-indol-3-yl, 4-nitro-5-acetamido-indol-3-yl, 5-acetamido-6-nitro-indol-3-yl, 5-nitro-6-acetamido-indol-3-yl, 6-acetamido-7-nitro-indol~
3-yl, 4-chloro-5 acetamido-indol-3-yl, 5-acetamido-6-chloro-indol-3-yl, 5-chloro-6-acetamido-indol~
3-yl, 6-acetamido-7-chloro-indol-3-yl, 5-dimethylamino-indol-3-yl, 6-dimethylamino-indol-3-yl, 7-dimethylamino-indol-3-yl, 5-dimethylamino-6-chloro-indol-3-yl, 5-chloro-6-dimethylamino-indol-3-yl, 7-benzyl-indol~ -3-yl, 4-(3,4,5-trimethoxy-benzyl)-indol-3-yl, 5-(3,4,5-trimethoxy-benzyl)-indol-3-yl, 6-(3,4,5-trimethoxy-benzyl)-indol-3-yl, 7-(3,4,5-trimethoxy-benzyl)-indol-3-yl, 4-trifluoromethyl-indol-3-yl, :
4-trichloromethyl-indol-3-yl, 4,5-methylenedioxy- -~
indol-3-yl, 4,5-dimethoxy-indol-3-yl, 4,5-dimethyl-indol-3-yl, 5-methyl-6-methoxy-indol-3-yl, 4-methyl-5-methoxy-indol-3-yl, 5-trifluorot"ethyl-indol-3-yl, 5-methoxy-7-bromo-indol-3-yl, 5-bromo-7-methoxy-indol-3-yl, 5-bromo-indol-3-yl, 5-chloro-indol- ~:
3-yl, 5-(3,4,5-trimethoxy-benzyloxy)-indol-3-yl, 6-(3,4,5-trimethoxy-benzyloxy)-indol-3-yl, 5-(3,4,5-trimethoxy-benzylamino)-indol-3-yl, 6-(3,4,5-trimethoxy- ~;
benzylamino)-indol-3-yl, 5-(3,5-dichloro-4-amino-benzyloxy)-indol-3-yl, 6-(3,5-dibromo-4-amino-benzyloxy)-indol-3-yl, 5-(3,5-dichloro-4-amino-benzylamino)-indol-3-yl, 6-(3,5-dibromo-4-amino-benzylamino)- :~
indol-3-yl, 5-benzyl-indol-3-yl, 4-benzyl-indol- ~:
3-yl, 6-benzyl-indol-3-yl, 5,6,7-trimethoxy-indol-3-yl, 5,6,7-trimethyl-indol-3-yl, 5-nitro-indol- ~:
3-yl, 4,6-dichloro-5-amino-indol-3-yl, 4,6-dichloro-5-nitro-indol-3-yl, 5,7-dibromo-6-amino-indol-3- .
yl, 5,7-dibromo~6-nitro-indol-3-yl, 4,6-dichloro-5-methoxy-indol-3-yl, 5,6-dimethoxy-indol-3-yl, 5,7-dimethoxy-indol-3-yl, 6,7-dimethoxy-indol-3-yl, 4,7-dimethoxy-indol-3-yl, 5,6-methylenedioxy- : -indol-3-yl, 6,7-methylenedioxy-indol-3-yl, 5,6-dimethyl-indol-3-yl, 5,7-dimethyl-indol-3-yl, 6,7-` ` 1330~93 g dimethyl-indol-3-yl, 4,7-dimethyl-indol-3-yl, 6 methoxy-7-methyl-indol-3-yl, 4,6-dibromo-5-carboxy-inaol-3-yl~ 5,7-dichloro-6-carboxy-indol-3-yl, 5-ethoxycarbonyl-indol-3-yl, 6-ethoxycarbonyl-indol- ~ ~ -3-yl, 4,6-dibromo-5-ethoxycarbonyl-indol-3-yl, 5,7-dichloro-6-ethoxycarbonyl-indol-3-yl, 5-cyano- ~
indol-3-yl, 6-cyano-indol-3-yl, 4-cyano-indol-3- :
yl, 4-hydroxy-indol-3-yl, 7-hydroxy-indol-3-yl, 5-phenyl-indol-3-yl, 6-phenyl-indol-3-yl, 5-(3,4,5-tribromo-phenyl)-indol-3-yl, 6-(3,4,5-trimethoxy-phenyl)-indol-3-yl, 5-(4-trifluoromethyl-phenyl)-indol-3-yl, 6-(3,5-difluoro-4-amino-phenyl)-indol- .
3-yl, 4-phenyl-indol-3-yl, 5-cyclohexyl-indol-3- . .
yl, 5-(2-methoxy-benzyl)-indol-3-yl, 6-(2-methoxy-phenyl)-indol-3-yl, 6-(2,4-dimethyl-benzyl) indol-3-yl, 5-(2,4-dimethoxy-benzyl)-indol-3-yl, 7-(2-methoxy-benzyloxy)-indol-3-yl, 4-(2,4-dimethyl-benzyloxy)-indol-3-yl, 5-(2,4-dimethoxy-benzyloxy)-indol-3-yl, 6-(2-methoxy-benzylamino)-indolyl-3, 5-(2-methoxy-4-methyl-benzylamino)-indol-3-yl, 4-(2,4-dimethoxy-benzylamino)-indol-3-yl, 5,7-dibromo-6-cyano-indol-2-yl, 5,7-dichloro-6-aminocarbonyl-indol-2-yl, 4,6-dibromo-5-aminocarbonyl-indol-2- .
yl, 5,7-dibromo-6-methoxy-indol-2-yl, 5,6-dihydroxy- `.
indol-2-yl, 4-dimethylamino-indol-2-yl, 4-methoxy- ~ :
6-dimethylamino-indol-2-yl, 4-methyl-6-dimethylamino-indol-2-yl, 5-acetoxy-6-dimethylamino-indol-2-yl, 5-acetamido-7-dimethylamino-indol-2-yl, 5-dimethylamino- -~
carbonyl-indol-2-yl, 5-carboxy-indol-2-yl, 5-acetamido-indol-2-yl, 4-nitro-5-acetamido-indol-2-yl, 5-acetamido-6-nitro-indol-2-yl, 5-nitro-6-acetamido-indol-2 yl, 6-acetamido-7-nitro-indol-2-yl, 4-chloro-5~
acetamido-indol-2-yl, 5-acetamido-6-chloro-indol-2-yl, 5-chloro-6-acetamido-indol-2-yl, 6-acetamido~
7-chloro-indol-2-yl, 5-dimethylamino-indol-2-yl, 6-dimethylamino-indol-2-yl, 7-dimethylamino-indol- :~
2-yl, 5-dimethylamino-6-chloro-indol-2-yl, 5-chloro- ~.

~3309~ -~ 10 -- , 6-dimethylamino-indol-2 yl, 7-benzyl-indol-2-yl, 4-~3,4,5-trimethoxy-benzyl)-indol-2-yl, 5-(3,4,5-trimethoxy-benzyl~ indol-2-yl, 6-(3,4,5-trimethoxy-benzyl)-indol-2-yl, 7-(3,4,5-trimethoxy-benzyl)-indol-2-yl, 4-trifluoromethyl-indol-2 yl, 4-trichloromethyl-indol-2-yl, 4,5-methylenedioxy-indol-2-yl, 4,5-dimethoxy-indol-2-yl, 4,5-dimethyl-indol-2-yl, ~ :
5-methyl-6-methoxy-indol-2-yl, 4-methyl-5-methoxy-indol-2-yl, 5-trifluoromethyl-~indol-2-yl, 5-methoxy-7-bromo-indol-2-yl, 5-bromo-7~-methoxy-indol-2-yl, 5-bromo-indol-2-yl, 5-chloro-indol-2-yl, 5-(3~4,5-trimethoxy-benzyloxy~-indol-2--yl, 6-(3,4,5-trimethoxy-benzyloxy)-indol-2-yl, 5-(3,4,5-trimethoxy-benzylamino)-indol-2-yl, 6-~3,4,5-trimethoxy-benzylamino)-indol-2-yl, 5-(3,5-dichloro-4-aminobenzyloxy)-indol-2-yl, 6-(3,5-dibromo-4-amino-benzyloxy)-indol-2-yl, 5-(3,5-dichloro-4-amino-benzylamino)-indol-2-yl, 6-(3,5-dibromo-4-amino-benzylamino)-indol-2-yl, 5-benzyl-indol-2-yl, 4-benzyl-indol-2-yl, 6-benzyl- ~ ~.
indol-2-yl, 5,6,7-trimethoxy-indol-2-yl, 5,6,7- .
trimethyl-indol-2-yl, 5-nitro-indol-2-yl, 4,6-dichloro-5-amino-indol-2-yl, 4,6-dichloro-5-nitro-indol-2-yl, 5,7-dibromo-6-amino-indol-2-yl, 5,7-dibromo- - ~ :
6-nitro-indol-2-yl, 4,6-dichloro-5-methoxy-indol- .
2-yl, 5,6-dimethoxy-indol-2-yl, 5,7-dimethoxy-indol-2-yl, 6,7-dimethoxy-indol-2-yl, 4,7-dimethoxy-indol-2-yl, 5,6-methylenedioxy-indol-2-yl, 6,7-methylenedioxy-indol-2-yl, 5,6-dimethyl-indol-2-yl, 5,7-dimethyl- .
indol-2-yl, 6,7-dimethyl-indol-2-yl, 4,7-dimethyl-indol-2-yl, 6-methoxy-7-methyl-indol-2-yl, 4,6-dibromo-5-carboxy-indol-2-yl, 5,7-dichloro-6-carboxy-indol-2-yl, 5-ethoxycarbonyl-indol-2-yl, 6-ethoxycarbonyl-indol-2-yl, 4,6-dibromo-5-ethoxycarbonyl-indol-2-yl, 5,7-dichloro-6-ethoxycarbonyl-indol-2-yl, 5-cyano-indolyl-2, 6-cyano-indol-2-yl, 4-cyano- . ~. :
indol-2-yl, 4-hydroxy-indol-2-yl, 7-hydroxy-indol-2-yl, 5-phenyl-indol-2-yl, 6-phenyl-indol-2-yl, '~

`' ' ~330993 5-(3,4,5-trlbromo-phenyl)~indol-2-yl, 6-(3,4,5-trimethoxy-phenyl)-indol-2-yl, 5-(4~trifluoromethyl-phenyl)-indol-2-yl, 6-(3,5-difluoro-4-amino-phenyl)-indol-2-yl, 4-phenyl-indol-2-yl, 5-cyclohexyl-indol- :
2~yl, 5-(2-methoxy-benzyl)-indol-2-yl, 6-(2-methoxy-phenyl)-indol-2-yl, 6-(2,4-dimethyl-benzyl)-indol-2-yl, 5-(2,4-dimethoxy-benzyl)-indol-2-yl, 7-(2-methoxy-benzyloxy)-indol-2-yl, 4-(2,4-dimethyl-benzyloxy)-indol-2-yl, 5-(2,4-dimethoxy-benzyloxy-indol-2-yl, 6-(2-methoxy-benzylamino)-inaol-2 5-(2-methoxy-4-methyl-benzylamino)-indol-2-yl, 4-(2,4-dimethoxy-benzyIamino)-indol-2-yl, phenyl, 4-methyl-phenyl, 3-methyl-phenyl, 2-methyl-phenyl, 4-ethyl-phenyl, 4-isopropyl-phenyl, 4-cyano-phenyl, 4-trifluoromethyl-phenyl, 2-methoxy-phenyl, 3-methoxy- ~
phenyl, 4-methoxy-phenyl, 2-ethoxy-phenyl, 4-nitro- ..
phenyl, 2-nitro-phenyl, 4-methylamino-phenyl, 4-ethylamino-phenyl, 4-n-propylaminophenyl, 4-dimethylamino-phenyl, 4-diethylamino-phenyl, 4-di-n-propylamino-phenyl, 4-N-ethyl-methylamino-phenyl, 4-formylamino- .~ :
phenyl, 4-acetamido-phenyli 4-propionyl-amino-phenyl, .
3,4-methylenedioxy-phenyl, 3,4-ethylenedioxy-phenyl, 3,4-dimethoxy~phenyl, 3,5-dimethoxy-phenyl, 2,6-dimethoxy-phenyl, 2,4-dimethoxy-phenyl, 3,4-diethoxyphenyl, 3,4-dimethyl-phenyl, 3,5-dimethyl-phenyl, 2,6-dimethyl- :~:h~
phenyl, 2,4-dimethyl-phenyl, 3,4-diethyl-phenyl, 2,4-dichloro-phenyl, 2,4-dibromo-phenyl, 3-methyl-4-methoxy-phenyl, 3-methoxy-4-methyl-phenyl, 3-chloro-4-methyl-phenyl, 3-bromo-4-methyl-phenyl, 3-chloro-4-methoxy-phenyl, 3-bromo-4-methoxy-phenyl, 3-methyl-4-chloro-phenyl, 3-methyl-4-bromo-phenyl, 3-methoxy-4-chloro-phenyl, 3-methoxy-4-bromo-phenyl, benzyloxy, naphth-l-yl, naphth-2-yl, 2-methyl-naphth- ~::
l-yl, 6-methoxy-naphth-2-yl, 7-methoxy-naphth-2- ~ :
yl, 5-methyl-6-methoxy-naphth-2-yl, 5,6-dimethoxy- ~
naphth-2-yl, 5,6-dichloro-naphth-2-yl, 5,6-dimethoxy- -~ ~ :
naphth-l-yl, 5,6-dichloro-naphth-1-yl, 6-methoxy- ;

~` ~33a~t~

naphth-l-yl, 5-methyl-6-methoxy-naphth-1-yl, 6-nitro-naphth-l-yl, 6 nitro~naphth-2-yl, 6-methoxy-5-nitro-naphth-1-yl, 6-methoxy-5-nitro-naphth-2- ~ :
yl, 6-amino-naphth-2-yl, 4-methoxy-naphth-1-yl, 5,6-diethoxy-naphth-2-yl, 5,6-di-n-propoxy-naphth-2-yl, 6-chloro-naphth-1-yl, 6-chloro-naphth-2-yl, 6-~hloro-7-nitro-naphth-2-yl, 6-chloro-7-amino-naphth-2-yl, 6-chloro-7-acetamido-naphth-2-yl, 5,6-methylenedioxy-naphth-2-yl, 5-chloro-6-methoxy-naphth-2-yl, 6-ethyl-naphth-2-yl, 6-methylmercapto-naphth-2-yl and 6-isopropyl-naphth-2-yl groups.

The following are compounds which fall within the :~
scope of the present invention and are listed by ;~
way of example~
.. ,..: ~ -2-[(N-(2-rnaphth-2-yl)-ethyl)-hexahydro-aæepin~
3-yl)-methyl~-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline, : - :
,. . :- .
2-[ (N-(2- (naphth-2-yl)-ethyl)-azacyclooct-3-yl)-methyl~-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline, ~- -2-[(N- (2-(naphth-1-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- ~ :
isoquinoline, 2-[(N-(2-(naphth-1-yl)-ethyl)-azacyclooct-3-yl)- ;
methyl~-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ''''~: ~':~
2-[(N-(2-methyl-naphth~l-yl)-methyl)-pyrrolid-3- :
yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ' :. .:::,:
2-[3- (N- ( 2-methyl-naphth-1-yl)-methyl)-piperid-3-yl)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinolinle, :

L 3 3 ~ ~ 9 3 2-[(N-t2-t5-methyl-6-methoxy-naphth-2-yl)-ethyl~-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-azacyclooct-3-yl)-methyl~-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-~6-methoxy-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimet:hoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-azacyclooct- :
3-yl)-methyl]-6,7-dimethoxy~l-oxo-1,2,3,4-tetrahydro-isoquinoline, ~ -~

2-[3-(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-pyrid-3-yl)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- .
isoquinoline, 2-[(N-(4-(naphthyl-2-oxy)-butyl)-azacyclooct-3-yl)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline, 2-[2-(N-(4-(naphthyl-2-oxy)-butyl)-piperid-2-yl)- :~
ethyl]~6,7-dimethoxy-1-oxo-1~2,3,4~tetrahydro-isoquinoline, -: ~, 2-[(N-(3-(naphthyl-2-oxy)-propyl)-azacyclooct-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(3-(naphth-2-yl)-propyl)-piperid-3-yl)-methyl]-6,7-dimethoxy~1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(3-(naphth-2-yl)-propyl)-azacyclooct-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinolin~e, ;

. ., 330~93 2-[~N-(2-(naphth-2-yl~-ethyl~-piperid-3-yl~-methyl]-6,7-methylenedioxy-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(naphth~2-yl~-ethyl)-azacyclooct-3-yl)-methyl~-6,7-methylenedioxy-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-methyl-naphth-1-yl)-methyl)-pyrrolid-3- ~ ``;
yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- ~,;
isoquinoline, 2-[(N-(2-methyl-naphth-1-yl~-methyl)-piperid-3- ~: ~
yl)-methyl]-6,7-methylenedioxy-1,2,3,4 tetrahydro- ~
isoquinoline, -- .

2-[(N-(2-methyl-naphth-1-yl)-methyl)-azacyclooct- . ... ..
3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~ ,: . . ~
2-[(N-(2-(5-methyl-6~methoxy-naphth-2-yl)-ethyl~
azacyclooct-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[2-(N-(2-(S-methyl-6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~.. .:.
2- r (N-~2-~6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl~-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(4-(naphthyl-2-oxy)-butyl)-pyrrolid-3-yl)-methyl~-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(4-(naphthyl-2-oxy)-butyI)-piperid-3-yl)- ~ :
methyl]-6,7-methylenedioxy-1-oxo~ ,3,4-tetrahydro-isoquinoline, '..", ~

133~3 2- [ ~N- ( 4-(naphthyl-2-oxy~-butyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1,2,3,4-tetrahydro- ~.:
isoquinoline, 2-[(N-(2-(naphth-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]- ~: .
6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~.
.
2-[ tN- (2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, - ~ .

2-[(N-(2-(naphth-2-yl)-e~hyl)-azacyclooct-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(naphth-2-yl)-ethyl)-azacyclooct-3-yl)~
methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(naphth-1-yl)-ethyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(naphth-1-yl)-ethyl)-hexahydro-azepin~
3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[3-~N-(2-(naphth-1-yl)-ethyl)-piperid 3-yl)-propyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ;~

2-[(N-(2-methyl-naphth-1-yl)-methyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-methyl-naphth-1-yl)-methyl)-piperid-3~
yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-methyl-naphth-1-yl)-methyl)-azacyclooct-3-yl)-methyl.]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~` 1 33~93 . . .

2-[2-(N-(2-methyl-naphth-1-yl)-methyl)-piperid- `
2-yl)-ethyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- :~:
isoquinoline, :~

2-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4- ~:
tetrahydro-isoquinoline, : :
. :..: , .::
2-[(N-(2-(5-methyl-6-methoxy-nlaphth-2-yl)-ethyl)- `
hexahydro-azepin-3-yl)-meth~1]-6,7-dimethyl-1-oxo~
1,2,3,4-tetrahydro-i~oquinolinle, 2-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-azacyclooct-3-yl)-methyl~-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl~
azacyclooct-3-yl)-methyl]-6,7-dimethyl- 1,2,3,4-tetrahydro-isoquinoline, , ~ ' '':
2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, ~ ~ .

2- r (N-(2-(6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoguinoline, .' ' :.' 2-r(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro- ~:~
azepin-3-yL)-methyl]-1,2,3,4-tetrahydro-isoquinoline, ~ ~ ;
' 2-t2-(N-(2-(6-methoxy-naphth-2 yl)-ethyl)-piperid-2-yl)-ethyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- ~ : :
isoquinoline, 2-[(N-(4-(naphthyl-2-oxy)-butyl)-piperid-3-yl)-methyl]-6~7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, : ' ~` ~3309~3 2-[(N-(4-(naphthyl-2-oxy)-butyl)-hexahydro-azepin-3-yl)-methyl~-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro~
isoquinoline, 2- [ (N- ( 4- ( naphthyl-2-oxy)-butyl~-azacyclooct-3- .
yl)-methyll-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(~-(3-(6-methoxy-naphthyl-2--oxy)-propyl)-hexahydro-azepin-3-yl~-methylJ-6,7-dimethyl-1-oxo-1,2,3,4- '~
tetrahydro-isoquinoline, 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-azaayclooct-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinol1ne, 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)~
azacyclooct-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-r(N-(3-(naph~h-2-yl)-propyl)-azacyclooct-3-yl)- ~:-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 3-[(N-(3-(pyrid-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-~etrahydro-2H- :~
3-benzazepine, ~ `

3-r(N-(pyrid-3 yl-methyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine, -""~
3-[(N-(3-(pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-dimethyl-1,3,4,5-tetrahydro-2H-3-benzazepine, :
.

2-[(N-(pyrid-3-yl-methyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(3-(pyrid-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-methylenedioxy-1-oxo-1,3-dihydro-isoindole, '~' ' , l3~a~3 2-[(N-~3-(pyrid-4-yl)-propyl)-pyrrolid~3-yl)-methyl]-5,6-methylenedioxy-1,3-dihydro-isoindole, -2-[ ~N-(2- (6-methyl-pyrid-2-yl)--ethyl)-pyrrolid-3-yl~-methyl]-5,6-methylenedio~y-1-oxo-1,3-dihydro-isoindole, 2-[(N-~ 2-(6-methyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl)-methyll-5,6-methylenedioKy-1,3-dihydro-isoindole, 2-[ (N- (pyrid-3-yl-methyl)-pyrrolid-3-yl)-methyl]-5,6-dimethyl-1,3-dihydro-isoindole, ~-: .' " ':
3-[(N- ( 3-(pyrid-3-yl)-propyl)-pyrrolid-3-yl)-methyl]- : .
7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine, ~
'"'~ '' "- ' :~
2-[(N-(3-(pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]- : . -5,6-dimethoxy-1,3-dihydro-isoindole, 2-[(N-(pyrid-3-yl-methyl)-pyrrolid-3-yl)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole, 2-r(N-(pyrid-3-yl-methyl)-pyrrolid-3-yl)-methyl]- ~ ~.
5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[(N-(2-(6-methyl-pyrid-2-yl~-ethyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline, ;~

2-[(N-(2-(6-methyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole, -;~

2-~(N-(2-(6-methyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- -~
isoquinolinle, :~

'' '';~''''~ ~:

-~ ~330~9~
- 19 - ,~
2-[(N-(2-(6-methyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethy~ 5 6,7-dimethoxy-1,2,3,4-tetrahydxo-isoquinoline, 2-~2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~ :
, :, 3-[(N-(2-(6,7-dimethoxy-i soqu i !nol- 4 -y 1 ) -ethyll-piperid-2-yl)-methylJ-7,8-dimethyl-2-oxo-1,3,4,5- .
tetrahydro-2H-3-benzazepine, :-2-[(N-(pyrid-4-yl-methyl)-piperid-3-yl)-methyl]- ::~
6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(6,7-dimethoxy-isoquinol-4-yl)-ethyl)-piperid-3-yl)-methyl]-5,6-methylenedioxy-1-oxo-1,3-dihydro-isoindole, 2-12-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-5,6-methylenedioxy-1,3-dihydro-isoindole, ~ .
2-[(N-(3~(pyrid-3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(3-(pyrid-3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(2-(6-methyl-pyrid-2-yl)-ethyl)-hexahydro~
azepin-3-yl)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole, 2-[(N-(2-~6-~methyl-pyrid-2-yl)-ethyl)-hexahydro- ;
azepin-3-yl~-methyl~-5,6-dimethoxy-1-oxo-1,3-dihydro- :
isoindole, .

~ . . ., ~ - , , . ~ . - ., `~ ~ 3 3 ~

3-r(N-(3-(5-hydroxy-indol-3-yl~-propyl)-pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 2-[ (N- (3-(5-hydroxy-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-methylenedioxy-1,2,3,4-tetrahydro-iso~uinoline, ~ .

3-1(N-(3-(5-methoxy-indol-3-yl)-propyl)-pyrrolid~
3-yl~-methyl]-7,8-dimethyl-1,3,4,5-tetrahydro-2H~
3-benzazepine, 2-[(N-(3-(5-methoxy-indol-3-yl)-propyl)-pyrrolid- ~ ~
3-yl)-methyl]-5,6-methylenedioxy-1,3-dihydro-isoindole, -2-[(N-(3-(5-benzyloxy-indol-3-yl)-propyl)-pyrrolid- ~-3-yl)-methyl~-6,7-methylenedioxy-1-oxo-1,2,3,4- ~: ;
tetrahydro-isoquinoline, -:...::
2-[(N-(3-(5-benzyloxy-indol-3-yl)-propyl)-pyrrolid- ;~
3-yl)-methyl]-5,6-methylenedioxy-1-oxo-1,3-dihydro-isoindole, ;

3-[(N-(3-(N-methyl-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine, 2-[(N-(3-(N-methyl-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-[(N-(3-(indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethyl-1,3-dihydro-isoindole, 3-r(N-(3-(indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, - . .

',~ `i' ~ ~330~93 2-[(N-(3-(5-hydroxy-indol-3-yl)-propyl~-pyrrolid-3-yl)-methyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole, 2-[(N-(3-(5-hydroxy-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro~
isoquinoline, 3-[(N-(3-(5-methoxy-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl~-7,8-dimethoxy-1,3,4,5-tetrahydro-2~-3-benzazepine, 2-[(N-(3-(5-methoxy-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[rN-(3-(5-benzyloxy-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoLine, .

2-[(N-(3-(5-benzyloxy-indol-3-yl)-propyl)-pyrrolid-: 3-yl~-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~:''-, 2-[(N-(3-(N-methyI-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole, .
2-[(N-(3-(N-methyl-indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole, 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ::
:
2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4- .
tetrahydro-:Lsoquinoline, '~

- ~233~3 2-[(N-(2-(4-trifluoromethoxy-phenyl)-ethyl~-piperid-3-yl)-methyl]-5,6-dime~hoxy-1-oxo-1,3-dihydro-isoindole, :

2-[(N-(2-(4-trifluoromethyl-phenyl)-ethyl~-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-t (N- (2- ( 3,4-dichloro-phenyl)-ethyl)-piperid-3-yl)-methyl]-5/6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[(N-(2-~3,4,5-trimethoxy-phenyl~-ethyl)-piperid- ~ ~
3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, ::

2-[(N-(2-(4-methoxy-phenyl~-ethyl)-piperid-3-yl)- . :
methyl~-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, : ~-2-[(N-~2-(3-methyl-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[(N-(2-(3,4-dimethyl-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-t(N-(2-(2,3,4,5-tetramethyl-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[~N-(2-(4-benzyloxy-phenyl)-ethyl)-piperid-3 yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, -`~

-r (N-(2-(4-hydroxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[( N- ( 2-(4-methanesulphonyloxy-phenyl)-ethyl)~
piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, :; ;.
-,-2-[ (N- ~2-~4--trifluoromethanesulphonyloxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo- ; -~
1,3-dihydro--isoindole, ' ` '.,. ," ~

:: ~

2- [ (N- ~ 2- ~ 4-methanesulphonylamino-phenyl)-ethyl~-piperid-3-yl)-methyl~-5,6-dimethoxy-1-oxo-1,3-dihydro-i soinaole, 2-[ (N- (2- (4-dimethanesulphonylamino-phenyl)-ethyl)-piperid-3-yl)-methyl~-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-~(N-(3-(4-bromo-phenyl)-propyl)-piperid-3-yl)~
methyl~-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-r(N-(3-(4-methoxy-phenyl)-propyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2- r (N- (3-(3-methoxy-phenyl)-propyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[(N-(3-(3,4-dimethoxy-phenyl)-propyl)-piperid- ~ -3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2-[(N-(4-(4-methoxy-phenyl)-butyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, 2- r (N-(3-(4-amino-3,5-dibromo-phenoxy)-propyl)~
piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole, -;

3-[(N-(2-(2,5-dimethyl-thien-3-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-t(N-(2-(5-methoxy-benzo[b]thienyl-3)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-te~rahydro-2H-3-benzazepine, 3-[(N-(2-(6--methoxy-benzo[b]thienyl-3)-ethyl)-piperid-3-yl)-methy]L]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- :
2H-3-benzaz~?pine, ~ ~330~

3-[(N-(2-(6-bromo-benzo[b]thienyl-3~-ethyl~-piperid-3-yl~-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~ ~

3-r tN- (2-(benzo[b]thienyl-2~-ethyl)-piperid-3-yl)- .:
methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- .
2H-3-benzazepine, .

3-[(N-(2-(benzo[b]furyi-3~-ethyl)-piperid-3-yl)- :
methyl]-7,8~dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~ :
': ~,.. :' 3-[(N-(2-(2,5-dimethyl-thien-3-yl)-ethyl)-piperid-3-yl)-me~hyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(5-methoxy-benzo[b]thienyl-3)-ethyl)-piperidy-3-yl)-methyl3-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro- :~
2H-3-benzazepine, 3-~(N-(2-(6-methoxy-benzorb]thienyl-3)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(6-bromo-benzo[b]thienyl-3)-ethyl)-piperid- :~
3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2~-3-benzazepine, 3-r(N-(2-(benzo[b]thienyl-2)-ethyl)-piperid-3-y~
methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H- : .
3-benzazepine, :~.

3-~(N-(2-(benzo[b3furyl-3)-ethyl)-piperid-3-yl)- ;
methyl~-7,8--dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~'~:' . ' ' . - 25~ -3 3 ~ ~ 9 3 3-[(N-~2-~2,5-dimethyl-thien-3-yl~-ethyl)-piperid-3-yl)-methyL]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(5-methoxy-benzo[b]thienyl-3)-ethyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(6-methoxy-benzo[b]thienyl-3)-ethyl~-piperid~
3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5- - :
tetrahydro-2H-3-benzazepine, 3-[(N-(2-(6-bromo-benzo[b]thienyl-3)ethyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(benzo[b]thienyl-2)-ethyl)-piperid-3-yl)- ~ ~ :
methyl[-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, .: "
3-[(N-(2-(benzo[b]furyl-3)-ethyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-~3 (2,5-dimethyl-thien-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(3-(5-methoxy-benzo[b]thienyl-3)-propyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5- ` :~
tetrahydro-2H-3-benzazepine, ;
` '',`
3-[(N-(3-(6-methoxy-benzo[b]thienyl-3)-propyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-~etrahydro-2H-3-benzazeplne, ~,.
:':

~33~9~3 ~
- 26 ~
3-[(N-(3-(6-bromo~benzo[b]thienyl-3)-propyl~-piperid-3-yl) methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-t3-(benzo[b]thienyl-2)-propyl)-piperid-3-yl) methyl~-7,8-aimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~ ~-3-t (N- (3-(benzo[b]furyl-3)-propyl)-piperid-3-yl) methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro~
2H-3-benzazepine, 3-[(N-(3-(2,5-dimethyl-thien-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, .
:.~-3-~tN-(3-(6-methoxy-benzo~b]thienyl-3)-propyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-~(N-~3-(benzorb]thienyl-2)-propyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, .-3-[(N-(3-(benzo[b]furyl-3)-propyl)-piperid-3-yl)-methyl~-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, - : ~
3-~(N-(3-(2,5-dimethyl-thien-3-yl)-propyl)-piperid- ;~
3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5- :
tetrahydro-2H-3-benzazepine, .: - ;
: 3-~(N-(3-(6-methoxy-benzo~b]thienyl-3)-propyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,S-tetrahydro-2H-3-benzazepine, ~.

:

-~233a9~3 3-[ (N- (3-(benzo[b]thienyl-2)-propyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro- : .
2H-3-benzazepine, 3-[(N-(3-(benzo~b]furyl-3)-propyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(~-(2-(thien-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(benzolb]thienyl-31-ethyl)-piperid-3-yl)-methyl~-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H- :-:
3-benzazepine, 3-[(N-(2-(benzo[b]furyl-2)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~ :
., 3-[(N-(2-(thien-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(benzorb]thienyl-3)-ethyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro- '~ `'t~Jy~, 2H-3-benzazepina, ::
:
: 3-[(N-(2-(benzo[b]furyl-2)-ethyl)-piperid-3-yl)- : -methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro- ~-~
2~-3-benzazepine, 3-[(N-(2-(thien-2-yl)-ethyl)-hexahydro-azepin-3-yl1 methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ;~

3-[(N-(2-(benzo[b]thienyl-3)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~:
~ ' , ~.33a~93 ::

3-(N-(2-(benzo[b]furyL-2~-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5 tetrahydro-2~-3-benzazepine, 3-[ (N- ~2-~thien-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(benzo[b]thienyl-3)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-~(N-(2-(benzo~b]furyl-2)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[ (N- (2-(thien-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(~-(2-(benzorb~thienyl-3)-ethyl)-pyrrolid-3 yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro- ::::
2H-3-benzazepine, 3-l(N-(2-(benzo~b]furyl-2)-athyl)-pyrrolid-3-yl)- ~ .
methyl]-7,8-dimethyl-2-oxo-1,3,4,5~tetrahydro-2H- -~
3-benzazepine, 3-[(N-(2-(thien-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-r(N-(2-(b~nzo[b]thienyl-3)-ethyl)-pyrrolid-3-yl)-methyl]--7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(~-(2-~bienzo[b]furyl-2)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzaz,epine, ,: .

~33~3 3-[ (N- (2-~thien-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]- ~
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ::

3-[ (N- (2-(benzo[b]thienyl-3)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(benzo[b]furyl-2)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(thien-2-yl~-ethyl)-hexahydro-azepin-3- - -yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- :
2H-3-benzazepine, 3-[(N-(2-(benzolb]thienyl-3)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~ ~r'~
3-r(N-(2-(benzo[b]furyl-2)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- ..
2H-3-benzazepine, 3-[(N-(4-(thien-2-yl)-butyl)-piperid-3-yl)-methyl]- ~.
7,:8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ~' 3-[(N-14-(benzo[b]thienyl-3)-butyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(4-(benzolb]furyl-2)-butyl)-piperid-3-yl)-methyl]-7,B-:dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, : :

3-[(N-(5-(thien-2-yl)-pentyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, . ':'.~;.' ' ''' .' ; ' :~.' ~33~9~

3-[(N-~5-tbenzorb]thienyl-3)-pentyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5 tetrahydro- ;~
2H-3-benzazepine, 3-[(N-(5-(benzo[b]~uryl-2)-pentyl)-piperid-3-yl)~
methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, .

3-[(N-(4-(thien-2-yl)-butyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(4-tbenzo[b]thienyl-3)-butyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-r (N-(4-(benzo[b]furyl-2)-butyl)-piper~d-3-y~
methyl]-7,8-methylenedioxy-2-oxo-1~3,4,5-tetrahydro-2H-3-benzazepine, , 3-[(N-(S-(thienyl-2)-pentyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H- ~:
3-benzazepine, 3-t(N-(5-(benzo[b]thienyl-3)-pentyL)-piperid-3- :~
yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5 tetrahydro-2H-3-benzazepine, 3-[(N-(5-(benzo~b]furyl-2)-pentyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-, . , :
2H-3-benzazepine, -~ .
3-[(N-(4-(benzo[b]thienyl-3)-butyl)-piperid-3-yl)- : :
methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- . .-2H-3-benzazepine, ..,, ~:

`'. ~"':"
' ~ .'~' ~ '.

~33~3 . - 31 -3-[ (N- (4-~benzo[b]furyl-2~-butyl~-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-r(N-(5-(benzo[b]thienyl-3)-pentyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(5-(benzo[b]furyl-2)-pentyl)-piperidyl-3)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2~-3-benzazepine, and : :~

the enantiomers, diastereomers, N-oxides and acid :
addition salts thereof, more particularly, for pharmaceutical use, the physiologically acceptable . -acid addition salts thereof.

Preferred compounds according to the invention include those of general formula I wherein A, B, m and n are as hereinbefore defined, E represents a straight-chained Cl_3 alkylene group, ~;

G represents a straiqht-chained Cl 6 alkylene group or a group -G'-G"- wherein G' represents :
a straight chained C2 5 alkylene group and G" represents an oxa, methylimino or ethylimino group, . ~ .
~:
Rl represents a methyl or methoxy group and R2 represents a methyl or methoxy group, or R
and R2 together represent a methylenedioxy group, .:~
and ..
'`''. "' -'~
R represents an optionally methyl-substituted furyl, thienyl, pyridyl, benzo[b]furyl or benzo[b]thienyl ` ~ ~33~3 .,~, qroup, a benzo[b]thienyl group substituted by a : : ::
halogen atom or by a methoxy or methanesuLphonyloxy group, an indolyl or N-methylindolyl group optionally substituted by a hydroxy, methoxy or benzyloxy -~
group, a dimethyl-thienyl or dimethoxy-isoquinolyl group, a naphthyl group optionally mono- or disubstituted by methyl or methoxy groups wherein the substituents ~ :
may be the same or different, or if B represents a -CH2- or -CO- group, R may also represent a phenyl group optionally substituted by a methylenedioxy ~ :~
group, a phenyl group mono- or disubstituted by chlorine or bromine atoms or methyl or methoxy groups ::
wherein the substituents may be the same or different, ~ :
a phenyl group substituted by a hydroxy, benzyloxy, methanesulphonyloxy, trifluoromethanesulphonyloxy, trifluoromethyl, trifluoromethoxy, nitro, am;no, acetamido, methanesulphonylamino or bis(methanesulphonyl~
amino group, or a trimethoxyphenyl, tetramethylphenyl ~ ~ :
or dihaloaminophenyl group, ~::
~ ' and the enantiomers, diastereomers, N-oxides and acid addition salts thereof.

Particularly preferred compounds of the invention include those of formula Ia : :
":' ' ':
R1 ~ A \ /(CH2)m\ ~ ;~

R2 B / \(CH ) /

.. .

wherein Rl~ R2, R, A, B, E, G, m and n are as hereinbefore defined, .,~.. :, .

~` ~33a9~

and the enantiomers, diastereomers, N-oxides and acid addition salts thereof, more particularly, for pharmaceutical use, the physiologically acceptable acid addition salts thereof. :

Especially preferred compounds of the invention include those of formula Ia above wherein A represents a -CH2CH2- group, -B represents a -CH2-, -CH2-CH2-, -CO- or -CH2CO- . ~ :~
group, .

E represents a methylene or ethylene group, G represents a straight-chained C2 4 alkylene group . ~:~
or a straight-chained C2 3 alkyleneoxy group, Rl represents a methoxy group and ~ .
R2 represents a methoxy group or Rl and R2 together represent a methylenedioxy group, m represents any one of the integers from 2 to 4, ::'. ~:' n represents the integer 1, and R represents a naphth-2-yl, 6-methoxy-naphth-2- .
yl, 5-methyl-6-methoxy-naphth-2-yl, thien-2-yl, benzo[b]furyl-2 or benzo~b]thienyl-3 group or, if B represents a -CH2- or -CO- group, a 4-methoxyphenyl or 3,4-dimethoxyphenyl group, ;.

and the enantiomers, diastereomers, N-oxides and physiologically acceptable acid addition salts thereof.

`-`i ` ~3~09~3 The following are particularly preferred compounds~

3-[(N-(2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl~
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)- :.
piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 3-~2-(N-(2-(6-methoxy-naphth-2-yl)-e~hyl~-piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro~
2H-3-benzazepine, -. :
:
2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-heXahydro- ~ `
azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ~:
2-r(~-(2-(naphth-2-yl)-ethyl)-hexahydro-azepin- .
3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4- . ~.
tetrahydro-isoquinoline, . :.
2-[(N-(2-(3,4-dimethoxy-phenyl)-e~hyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline, 2-r(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, ::, ~ , 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- -~
isoquinoline, 3-[(N-(4-(thien-2-yl)-butyl)-piperid-3-yl)-methyl]- ` - ~:
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazeplne, 3-[(N-(2-(benzo[b]furyl-2)-ethyl)-piperid-3-yl)-methyl]-7,B-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, ,~

~ 35 - ~33~3 3-[(~-~2-~benzo[b]thienyl-3)-ethyl)-piperid-3-yl~-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro- -2H-3-benzazepine, 2-[ (N- (3-(6-methoxy-naphthyl-oxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- :
isoquinoline, 2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro- ~:
azepin-3-yl)-methyl~-6,7-methylenedioxy-1-oxo-1,2,3,4- ~:
tetrahydro-i~oquinoline, 3-[(N-(2-(4-methoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, . -3-[(N-(2-(3~4-dimethoxy-phenyl)-ethyl)-hexahyaro-: azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, and the enantiomers, diastereomers and acid addition salts thereof.
'., ,.,"" '. -The following compounds are especially highly preferred: `` .;.;

3-[(N-(2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl~- . `
N : 7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, .

2-[(N-(3-~4-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline, : . ,., :.~,~ ~,, 3-[(N-(4-~thienyl-2)-butyl)-piperid-3-yl)-methyl~
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine, 2-[(N-t3-~6-methoxy-naphthyl-2-oxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- ~ .
isoquinoline, . . . .

: `' ~ 3~ o ~
2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro- :~
azepin-3-yl)-methyl]-6,7-methylenedioxy-l-oxo-l,2,3,4-tetrahydro-isoquinoline, 3-[(N-(2-(4-methoxy-phenyl)-ethyl)-hexahydro-azepin- :
3-yl~-methyl]-7,8-dimethoxy-2-oxo-l,3,4,5-tetrahydro-2H-3-benzazepine, : .

3-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-l,3,4,5-tetrahydro-2H-3-benzazepine, and .

the enantiomers, diastereomers and acid addition .
salts thereof.

In a further aspect ~he present invention provides a process for preparing the compounds of the invention, said process comprising a~ least one of the following :::
steps~

a) reacting a compound of formula II .

~1 \ / \ (II) R2 ~ l ~ / \(CH ) / `~

(wherein Rl, R2, A, B, E, m and n are as hereinbefore defined) -~
with a compound of formula III .~
..:
Zl ~ G~ - R

wherein R is as hereinbefore defined and f~
_ 37 _ ~330~3 Zl represents a nucleophilic leaving group such as a halogen atom or a sulphonyloxy group, e.g.
a chlorine, bromine or iodine atom, a methanesulphonyloxy, p-toluenesulphonyloxy or ethoxysulphonyloxy group, or a hydroxy group and G"' is a group G as hereinbefore defined or Zl represents an oxygen atom and G'l' represents a straight chained Cl 6 alkanylylidene group optionally substituted by a Cl 3 alkyl group or a group -G""G"- where G" i~; as hereinbefore defined and G"" represents a straight--chained C2 5 alkanylylidene ; ~ ~
group optionally substituted by a Cl_3 alkyl group; .
. ., -.:
b) reacting a compound of formula IV

R1 .' .. "- '. ':, R2 ~ ~ \ - H (IV) (wherein Rl, R2, A and B are as hereinbefore defined) with a compound of formula V

Z2 ~ E - CH N - G - R ~V) ~ :
(CH2 )n '': ,'~ . ' '~ ' ' wherein R, E, G, m and n are as hereinbefore defined and ~ :' .:
..

`~ ~330~

Z2 represent~ a nucleophlllc leaving group such as a halogen atom or a su~phonyloxy group, e.g.
a chlorine, bromine or 1odine atom or a methane~ulphonyl-oxy, p-toluene~ulphonyloxy or ethoxysulphonyloxy group;

c1 (to prepare compounas of formula I wherein B
repre~ent~ a -CH2- or -CH2CH2- group) ~.
redu~ing ~ compound o~ formulD VI

R

R2 ~ \ / \

wherein R, Rl, R2, E, G, m and n are as hereinbefore defined A' represents a -CH2-, -CH2CH2-, -CH=CH- or -cO-group, and Bl represent~ a -CO- group or a -C~2CO- group of :~
which the carbonyl carbon i8 attached to the nltrogen atom;

d~ ~to prepare compounds of formula I whereln A
represent~ a -CH2- group and B repre~ents a -CO-or -CH2CO- group) reducing a compound of formula VII

r.. t .
~ CO~ CH2)~

, ~

~33~993 39 ~ 27169-1~7 lwhereln R, Rl, R2, E, G, m and n are deflned a~ hereinbe~ore and ~. .
82 represents a -CO- group or a -C~2CO- group of which the carbonyl caebon is attached to the nitrogen ~-atom) w1th na~cent hydrogen e~ ~to prep~re compounds of formula I wherein G
is a group a3 de~lned for G hereinbefore, with the exceptlon o~ the group~ corlta~ning a sulphur atom or ~ sulphinyl or sulphonyl group, and wherein ;~
A represent~ a -CH2-CH2- group and ~ rePresents a methylene, carbonyl or -CH2-CO- group) hydrogenating a compound of ~ormula VI~I

R1 . ,~
2 ~ / CNz) wherein R, Rl, R2, a, E, m ~nd n are as hereinbe~ore de~ined, -~
Gl i~ a gro~p G a~ hereinbefore defined wlth the provl~o that it does not represent a group containing a sulphur atom or d sulphinyl or sulphonyl group, :~
and B3 represents a -CH2- , -CO- or -CH2-CO- group; . ~:

f~ reduclng a resulting compound of formula I wherein R contains a nitro group to yield a corre~ponding ~:
amino compound of formula Is ~:
g) acylating a resultlng compound of formula I wherein R contains sn amino group to yield a :.

~ ' . , .

_ 40 _ 1~ 3 corresponding alkanoylamino compound o~ ~ormula I;

h~ resolving a resulting compound of formula ~
I lnto its diastereomers or enantiomers; and ~ ~-i) converting a compound of formula I into an -~
acid addition salt thereof or a salt of a compound `~
of formula I into the free base. -~ -~
: .. :
In general, the process of the invention may conveniently be carried out in a solvent or solvent mixture.

In reaction step (a~, if Zl represents a nucleophilic leaving group, the reaction is convenientLy carried out in a solvent or mixture of solvents ~such as acetone, diethylether, methylformamide, dimethylformamide, dimethylsulfoxide, benzene, chlorobenzene, tetrahydrofuran, benzene/tetrahydrofuran and dioxan) or in an excess of the compounds of formulae II and/or III used and optionally in the presence of an acid binding agent (e.g. an alkoxide such as potassium tert.butoxide, ;
an alkali metal hydroxide such as sodium or potassium hydroxide, an alkali metal carbonate such as potassium carbonate, an alkali metal amide such as sodium amide, an alkali metal hydride such as sodium hydride, a tertiary organic base such as triethylamine or pyridine, twhich may simultaneousIy be used as ~;
solvent)) or a reaction accelerator such as potassium iodide, depending on the reactivity of the nucleophilically exchangeable group, conveniently at temperatures of between O and 150C, preferably at temperatures ~
of between 50 and 120C, e.g. at the boiling temperature of the solvent used. However the reaction may also be carried out without a solvent. It is, however, particularly advantageous to perform the ~
~"':

'::
:

~33~3 reaction in the presence of a tertiary organic ~ ~
base or an excess of the amine o formula II used. ~ ~-If Zl represents a hydroxy group, the reaction -of step (a) is preferably carried out in a solvent such as methanol, ethanol, tetrahydrofuran, dioxan, ethyl acetate or glacial acetic acid, with hydrogen in the presence of a hydrogenation catalyst such as platinum, palladium/charcoal or Raney nickel under a hydrogen pressure of from 2 to 10 bar, preferably 5 bar, and at temperatures of between 20 and 120C, preferably at temperatures between 50 and lOO~C.

If Zl represents an oxygen atom, the reaction of step (a) is preferably carried out in a solvent such as methanol, ethanol, tetrahydrofuran, dioxan, ethyl acetate or glacial acetic acid, with hydrogen ~
in the presence of a hydrogenation catalyst such -as platinum, palladium/charcoal or Raney nickel ~ -~
under a hydrogen pressure of from 2 to lO bar, ~ -preferably 5 bar, and at temperatures of between 20 and 120C, preferably at temperatures of between 50 and 100C, or in the presence of a complex metal -hydride such as sodium cyanoborohydride in a solvent such as methanol, ethanol, tetrahydrofuran, dioxan ~ ;
. . .
or acetonitrile at temperatures of between 0 and 50C, but preferably at ambient temperature.

The reaction of step (b) is preferably carried out in a solvent or mixture of solvents such as methylformamide, dimethylformamide, dimethylsulphoxide, benzene, chlorobenzene, tetrahydrofuran, benzene/tetra~
hydrofuran or dioxan in the presence of an acid-binding agent, e.g. an alkoxide such as potassium ;~ ~
tert.butoxide, an alkali metal hydroxide such as ;

i33~9~

sodium or potassium hydroxide, an alkali metal carbonate such as potassium carbonate an alkali metal amide such as sodium amide or an alkali metal hydride such as sodium hydride, conveniently at temperatures of between 0 and 150C, preferably at temperatures of between 0 and 50C.

The reduction of step (c) is preferably carried out with a metal hydride such as li~hium aluminium hydride or diborane or a complex of borane and a thioether, e.g. with borane--dimethylsulphide ~
complex, in a solvent such as diethylether or tetra- -hydrofuran, at temperatures of between 0 and 80C, but preferably at temperatures between 10 and 45C.

The reduction of step (d) is conveniently carried out in a suitable solvent such as glacial acetic -~
acid, glacial acetic acid/water or glacial acetic acid/ethanol with nascent hydrogen, e.g. in the presence of zinc/glacial ace~ic acid, tin/hydrochloric~ `
acid or tin dichloride/hydrochloric acid at temperatures between 20 and 150C, but preferably at the boiling temperature of the reaction mixture, e.g. at temperatures between 80 and 100C.
'~:
The hydrogenation of step (e) is conveniently carried out in a solvent or mixture of solven~s such as methanol, ethanol, ethyl acetate or glacial acetic acid with catalytically activated hydrogen, e.g.
with hydrogen in the presence of platinum or palladium/~
charcoal, under a hydrogen pressure of from 1 to 7 bar, but preferably from 3 to 5 bar, and at temperatures of between 0 and 75C, but preferably at temperatures between 20 and 50C.
~.

3 3 a ~ 9 ~
- 43 ~
In the reactions described above, any reactive groups present such as hydroxy, amino, alkylamino or imino groups may be protected during the reaction by means of conventional protecting groups which are cleaved off again after the reaction.

For example, suitable protecting groups for a hydroxy group include trimethylsilyl, acetyl, benzoyl, benzyl and tetrahydropyranyl groups and suitable protecting groups for an amino, alkylamino or imino group include acetyl, benzoyl, ethoxycarbonyl and benzyl groups. ;

The optional subsequent cleaving of a protecting group is preferably carried out hydrolytically in an aqueous solvent, e.g. in water, isopropanol/water, --tetrahydrofuran/water or dioxan/water, in the presence of an acid such as hydrochloric or sulphuric acid ~-or in the presence of an alkali metal base such as sodium hydroxide or potassium hydroxide at temperatures between 0 and 100C, preferably at the boiling temperature of the reaction mixture. However, ;; ;~
a benzyl group is preferably split off by hydrogenolysis, e.g. with hydrogen in the presence of a catalyst such as palladium/charcoal in a solvent such as methanol, ethanol, ethyl acetate or glacial acetic acid, optionally with the addition of an acid such as hydrochloric acid at temperatares between 0 and 50C, but preferably at ambient temperature, under a hydrogen pressure of from 1 to 7 bar, preferably from 3 to 5 bar.

The reductlon of ~he nitro compound in step (f) is preferab:Ly carried out in a solvent such as water, water/ethanol, methanol, glacial acetic acid, ethyl acetate or dimethylformamide, conveniently with hydrogen in the presence of a hydrogenation `

1 ~ 3 ~

catalyst such as Raney nickel, platinum or palladium/char-coal, with metals such as iron, tin or zinc in the presence of an acid, with salts such as iron(II)-sulphate, tin~II) chloride or sodium dithionite or with hydrazine in the presence of Raney nickel at temperatures of between 0 and 50C, but preferably at ambient temperature.

The acylation of step (g) is conveniently carried out in a solvent such as methylene chloride, chloroform, carbon tetrachloride, ether, tetrahydrofuran, dioxan, benzene, toluene, acetonitrile or dimethylformamide, preferably with a reactive derivative of the acid, for example with acetyl chloride, acetic anhydride or propionic anhydride, and optionally in the presence of an inorganic base such as sodium carbonate or a tertiary organic base such as triethylamine or pyridine, which may simultaneously serve as solvent, at temperatures of between -25C and 100C, but preferably at temperatures of between -10C and the boiling temperature of the solvent used.

Since they have at least one chiral centre, the -compounds of formula I obtained can be resolved by conventional methods into their diastereomers, for example by column chromatography, and into their enantiomers, for example by column chromatography on a chiral phase or by crystallisation with optically active acids, e.g. with D- or L-monomethyl tartaric acid, D- or L-diacetyl tartaric acid, D- or L-tartaric acid, D- or L-lactic acid or D- or L-camphoric acid.

The compounds of formula I obtained may also be converted into the acid addition salts thereof, and particularIy for pharmaceutical use into the physiologically acceptable acid addition salts ` ~ :
_ 45 _ ~33~93 :~
thereof with inorganic or organic acids. Suitable acids include, for example, hydrochloric, hydrobromic, sulphuric, phosphoric, acetic, lactic, citric, tartaric, succinic, maleic ancl fumaric acids.

The compounds of formulae Il to VIII used as starting materials are known from the literature in some cases or may be obtained using methods known Per se.
, .
Thus, for example, a starting compound of formula II may be obtained by alkylation of a corresponding ;
imino compound of formula IV with a cyclic amine protected at the N atom by a conventional prot~cting groupl said cyclic amine being substituted in the ;
carbon structure by an alkyl group which is in i`~
turn substituted in the terminal position by a nucleophilic leaving group, and subsequently cleaving the protecting group used. The cyclic amine required for this reaction may be obtained by converting a corresponding cyclic amine substituted by a hydroxyalkyl group into a suitable halogen- or sulphonic acid ester derivative thereofl and the imino compound of formula IV required for this reaction may be obtained by cyclising a corresponding compound, e.g. by cyclising a compound of formula IX

R1 ., ~ ~:

: R2 ~ N CH2CH \ (IX) ~

,',', ' "'', ''', '"''~''' ''' "' ,'';'~

- ~6 - ~ ~;3 or of formula X

R1 ~: :
R2 ~ 1l N~ - COCH2Cl (X) / ,,.

optionally followed by catalytic hydrogenation and/or reduction of the carbonyl group, for example with sodium borohydride/glacial acetic acid ~see EP-A-7070, ~P-A-65229 and EP-A-109639).

A compound of formula V used as starting material ~ ~-may be obtained by N-alkylation of a corresponding ~ , ~ :cyclic amine, substituted in the carbon~structure :~:: by a hydroxyalkyl group, with a corresponding compound:~
or with a corresponding l,h~-dihaloalkane and subsequent : reaction with a corresponding HO, SH or HN compound and if necessary subsequent ox;idation, a hydroxyalkyl , compound thus obtained then being:converted into ~:: its reactive halogen or sulphonic acid ester derivatives.

; : ,, :
~ A compound of formulae VIt VII:or:~VIII used as ~
..
: starting material may preferably be obtained by reacting a corresponding haIogen~compound with a corresponding amine; optionally followed by the : spli~tting off of protecting groups used to protect : amino groups.

: . ,;, ~:

.: -: ~ . ., ~.
~y~

- 47 _ 133~,~9~
As already mentioned hereinbefore, the new compounds :
of formula I and the physiologically acceptable acid addition salts thereof with inorganic or organic acids have valuable pharmacological properties, .
particularly a hypotensive effect and an especially long-lasting heart rate lowering effect and the :
effect of reducing the 2 reauirement of the heart, .~-with only minor side-effects on the central nervous system.

" ::
For example, the following compounds~

, .,: : .....
A = 3-[(N-(2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride, ~ ~:

B = 3-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5- -~
tetrahydro-2H-3-benzazepine-hydrochloride, C = 3-[2-(N-(2-(6-methoxy-naphth-2-yl)-ethyl~-piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride, ;~

,.: '..,.:, '.'~' : ~ . - : .
.: :~:, " ~

' ;' ~ ' ~

'~"'~ `' ' ~.
~ `, ' ~ 48 - L33~
D = 2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo- ~ .
1,2,3,4-tetrahydro-isoquinoline-hydrochloride, : ~ . .. .
E = 2-[(N-(2-(naphth-2-yl)-ethyl)-hexahydro-azepin~
3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrobromide, F = 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl] 6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride, .
~: G = 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid- :
~:~ 3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride, : H = 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperid~
3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoIine-hydrochloride, I = 3-[(N-(4-(thienyl-2)-butyl)-piperid-2-yl)-methyl]-: 7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride, ~ '""

- ~ 33~9~

K = 3-[(N-(2-(benzo[b~furyl-2)-ethyl~-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride and ~

L = 3-[(N-f~-(benzo[b]thienyl-3)-ethyl~-piperid- ~-:
3-yl)-methyl]-7~8-aimethoxy-2-oxo-l~3~4~5-tetrahydro- ~:
2H-3-benzazepine-hydrochloride were tested for their biological properties as follows:

Effect on heart rate in rats . ~, . .
The activity of the test substances on the heart rate was investigated, for each dosage, on 2 rats with an average weight of 250-300 g. The rats :~ ~d~-were anaesthetised with pentobarbital (50 mg/kg -~
i.p. and 20 mg/kg s.c.). The test substances were injected in aqueous solution into the jugular -~ :
vein (0.1 ml/100 9). . .

The blood pressure was measured using a cannula inserted in a carotid artery and the heart rate was recorded from an ECG (second or third derivation) derived with needle electrodes. The heart rate of the animals in the control period was between ;~
350 and 400 beats per minute (b/min). .

The results obtained are set forth in the following .
Table~

_ 50 - 133~3 Substance Dosage Lowering of heart Lowering of blood rate in b/m after pressure in mmHg after ~ -[mg/kg] 5 min. 20 min. 5 min. 20 min.
A 5.0 - 218 - 259 - 46 - 32 B 5.0 - 188 - 218 - 22 - 15 C 5.0 - 236 - 194 - 40 - 31 D 5.0 - 173 - 123 - 21 - 16 E 5.0 - 169 - 150 - 30 - 16 F 5.0 - 150 - 120 - 49 - 27 G 5.0 - 207 - 101 - 57 - 8 H 5.0 - 190 - 180 - 57 - 33 I 5.0 - 320 - 253 - 65 - 32 K 2.5 - 138 - 156 - 36 L 2.5 - 110 - 163 - 40 - 24 ~ ` ~
. `:

- 51 - 133~
When administered in therapeutic doses the compounds ~ -prepared according to the invention show no toxic side effects of any kind. Thus, for example when administered intravenously to mice, even in a high dosage of 20 mg/kq, substances A and L showed no toxic side effects apart from a slight sedation.
~ ~ ' In view of their pharmacological properties, the compounds according to the invlention are suitable for the treatment of sinus tachycardia of various origins and for the prevention and treatment of ;~
ischaemic heart disease.
, ~,: . , : : .
The dosage required to achieve this effect is conveniently from 0.01 to 0.2 mg/kg of body weight, preferably ; ~ Y
from 0.03 to 0.15 mg/kg of body weight, once or twice a day. The compounds of formula I and the :

: ~ .

' :, ' 2 - ~33~
physiologically acceptahle acid addition salts thereof with inorganic or organic acids may be incorporated, optionally combined with other active substances, with one or more inert conventional carriers and/or diluents, e.g. with corn starch, lactose, glucose, microcrystalline cellulose, magnesium stearate, ` ~-polyvinylpyrrolidone, citric acia, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, water/polyethyleneglycol, propyleneglycol, carboxymethyl~
cellulose or fatty substances such as hard at or suitable mixtures thereof, to produce conventional galenic preparations such as tablets, coated tablets, capsules, powders, suspensians, drops, ampoules, -syrups or suppositories.

Thus, in a further aspect the invention provides -~
a pharmaceutical composition comprising a compound of formula I, or a physiologically acceptable acid addition salt thereof, together with at least one pharmaceutical carrier or excipient.

In a still further aspect, the invention provides a method of treatment of the human or non-human body to combat sinus tachycardia or ischaemic heart disease, `
said method comprising administering to said body a compound of formula I or a physiologically acceptable salt thereof.

In a yet further aspect the present invention provides the use of a compound of formula I or a physiologically acceptable salt thereof, for the preparation of a therapeutic agent for use in the treatment of sinus tachycardla or ischaemic heart disease.

The following Examples are intended to illustrate the invention without restricting its scope in any way.
:-Unless otherwise stated, all ratios, parts and percentages given herein are by weight.
' :'. . ' '..'., ''.".:' ."~

~, '.~ : ~`,'', ",` ~, '.? !?`

- 53 L33~993 ExamPle A

2-~Piperid-3-yl)-meth~1]-6~7-dimethoxy-1-oxo-1~2~3~4-tetrahydro-isoquinoline ~ :
a) N-BenzYl-3-(hydrox~methyl~-piperidine A mixture of 40O3 g (0.35 mol) of 3-(hydroxymethyl~
piperidine, 97.4 ml ~0.70 mol) of triethylamine and 40.3 ml (0.35 mol) of benzyl chloride is heated to 95C within 30 minutes and kept at this temperature for 2 hours. The reaction mixture is cooled down and dissolved in a mixture of 2 molar sodium hydroxide solution and ethyl acetate. The organic phase ;~
is washed with water, separated off, dried over magnesium sulphate and evaporated down in vacuo. -~
Yield: 57.2 g (79.6% of theory~
Rf value: 0.45 (aluminium oxide, neutral, eluant:
3% ethanol in methylene chloride).

b) N-Benzyl-3-(benzenesulphonyloxYmethyl)-piperidine A mixture of 6.8 g ~0.033 mol) of N-benzyl-3-(hydroxy-methyl)-piperidine, 6.7 ml (0.~52 mol) of benzenesulphonic acid chloride, 50 ml of 20% aqueou~ sodium hydroxide solution, 100 ml of toluene and 1 spatula tip of tetrabutyl ammonium bromide is stirred for 3 hours at ambient temperature. The mixture is then diluted witn 250 ml of ethyl acetate and the organic phase is washed with water. The organic phase is separated off, dried over magnesium sulphate and evaporated to dryness in vacuo. The residue is purified over ~ :~
200 g of silica gel (0.063 - 0.2 mm) with methylene chloride and then with increasing amounts of ethanol (up to 5%).
Yield: 9.4 g (92% of theory), Rf value: 0.5 (silica gel, eluant: 5% ethanol in methylene chloride). ~ ;
. .

, .

133~93 c~ 2-[(N-Benzy~piperid-3-yl)-methyll-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoguinoline 5.2 g (0.025 mol) of 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline are di~;solved in 70 ml of dimethylsulphoxide and 3.1 cl ~0.025 mol) of potassium tert.butoxide are added with stirring.
After half an hour, 9.3 9 (0.0275 mol) of N-benzyl-3-(benzenesulphonyloxymethyl)-piperidine in 20 ml of dimethylsulphoxide are added to the resulting potassium salt suspension and the mixture is stirred for 2 hours at 40~C. It is then poured onto ice water and extracted three times, each time with 120 ml of ethyl acetate. The combined organic phases are washed with water, dried over magnesium ~;;r.
sulphate and evaporated down in vacuo. The residue obtained is purified over 200 g of silica gel (0.063 -0.2 mm) with methylene chloride and then with increasing amounts of ethanol (up to 2%). ;
Yield: 7.7 g (78.5% of theory), R value: 0.5 (silica gel, eluant: 5% ethanol in methylene chloride and 1 drop of ammonia).

d) 2-[tPiPerid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline 9.4 g (0.0238 mol) of 2-[(N-benzyl-piperid-3-yl)-methyl]-~,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline are hydrogenated in 200 ml of methanol in the presence of 2 g of 20% palladium hydroxide/charcoal for 3 hours at ambient temperature under 5 bar of hydrogen. The catalyst is then removed by suction filtering and the filtrate is evaporated to dryness ~;~
in vacuo.
Yield: 7.2 g (99~ of theory), Rf value: O.lS (silica gel, eluant: 10% ethanol in methylene chloride and 1 drop of ammonia).
- , , "- .

~' ': ., ".
'"'"'`''.."'.'"-" "

: : :
~ 55 1 3 ~ a.~ ~3 Example B
".
3-Chloromethyl-N-[3-(naphthyl-2-oxY)-propyl~-Piperidine a) 3-(HydroxYmethYl)-N-[3-(naphthY1-2-oxy)-propY~
piperidine ~ ;

A mixture of 11.5 g (0.2 mol) o~ 3-hydroxymethyl-piperidine and 11 g of 2-(3-chloropropoxy1-naphthalene is heated to 120C for 1 hour. The residue is ~ -~
purified over silica gel (0.063 - 0.2 mm) with -ethyl acetate/ethanol/ammonia = 90:10:1.
Yield: 11.5 g (76.6~ of theory~
Melting point: 99-101C.

b) 3-Chloromethyl-N-[3-(naPhthyl-2-oxy)-propyl]-~iperidine - .
A solution of 1.5 9 (5 mmol) of 3-(hydroxymethyl)-N-~3-(naphthyl-2-oxy)-propyl]-piperidine in 25 ml of chloroform is mixed with 1.5 ml of thionyl chloride and refluxed for 1~ hours. The mixture is evaporated ~ ~
to dryness ln vacuo. The residue is taken up in - -methylene chloride, washed with water, 2 molar sodium hydroxide solution and again with water.
After the methylene chloride phase has been dried over magnesium sulphate it is evaporated down in vacuo.
Yield: 1.4 g (87.5% of theory), Rf value: 0.8 (silica gel, eluant: ethyl acetate/ethanol/
ammonia = 90:40:2).
Example C

2-[(Hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline ;~
a) N-Benzyl--caprolactam ~ ~ -''''. ~, - 56 - i~3~3 33.9 g (0.3 mol) of caprolactam are dissolved in 250 ml of dimethylsulphoxide and 37 g (0.33 mol~
of potassium tert.butoxide are added with stirring.
The reaction temperature rises to 60C. It is -stirred for half an hour at 60C and then 35 ml (0.3 mol) of benzyl bromide are added dropwise. -After another 2~ hours at 60C it is poured onto 1 litre of ice water and extr~cted three times with ethyl acetate. The orgamic phases are combined, washed with water, dried over magnesium sulphate and evaporated down in vacuo.
Yield: 60.3 g (99% of theory), Rf value: 0.6 (silica gel, eluant: 5% ethanol in methylene chloride). -~
. .
b) l-Benzyl-caprolactam-3 carboxylic acid ::
180 ml of 2.6 molar butyllithium solution in n- -hexane are added at -60C, with stirring and under nitrogen, to 33.9 g = 47.1 ml (0.33 mol) of diisopropyl-amine in 450 ml of absolute ether. Tben, while cooling is continued, 48.8 g (0.24 mol) of N-benzyl-caprolactam dissolved in 150 ml of absolute ether are added dropwise. After stirring for 10 minutes, the cooling bath is removed and carbon dioxide is piped in for 15 minutes. The reaction mixture is poured onto ice, the ethereal phase is separated off and extracted twice with 2 molar sodium hydroxide solution. The aqueous-alcoholic phases are combined, -extracted with ether, acidified with concentrated ~
hydrochloric acid and extracted twice with methylene ~ `
chloride. The combined methylene chloride phases ~-are dried over magnesium sulphate and the solvent is distilled off in vacuo.
Yield: 15.7 g (26.5~ of theory), IR spectrum (methylene chloride): 1735 and 1600 cm ~CO).

~3~993 ~
~ ,, c) l-Benzyl-3-h5~droxYmethYl-hexahYdro-aZePine 14.8 g t0.06 mol) of 1-benzyl-caprolastam-3-carboxylic acid dissolved in 300 ml of absolute tetrahydrofuran are added drop~ise to 6.84 g (0.28 mol) of lithium aluminium hydride in 300 ml of absolute tetrahydrofuran.
Then the mixture is refluxed for 6 hours, then 6.8 ml of water, 6.8 ml of 2 molar sodium hydroxide solution and 21 ml of water are added whilst cooling with ice water. The precipitate is suction filtered, washed with tetrahydrofuran and the filtrate is evaporated down in vacuo. ~he residue is purified by column chromatography over aluminium oxide N
(activity II, eluant: methylene chloride~
Yield: 8.4 g (63.8% of theory), IR spectrum (methylene chloride): 3620 cm 1 ~OH~

d) l-BenzY1-3-(4-toluenesulphonYloxymeth~l)-hexahydro-azepine , ~
15 9 (0.0684 mol) of 1-benzyl-3-hydroxymethyl-hexahydro-azepine are dissolved in 150 ml of pyridine and 14.3 9 tn.o75 mol) of p-toluenesulphonic acid chloride are added with stirring and the resulting mixture is stirred for 1 hour at ambient temperature.
It is evaporated down in vacuo, taken up in methylene chloride and washed with 2 molar sodium hydroxide solution and water. After drying over magnesium sulphate the organic phase is evaporated down in vacuo Yield- 23.3 9 t91.3~ of theory), `;~
Rf value: 0.45 (silica gel, eluant: 5~ ethanol in methylene chloride).

e) 2-[(N-Benz~l-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2 L3,4-tetrahydro~
isoquinoline ~`

- 58 - 133~9~3 7.4 g ~0.0387 mol) of 6,7-methyl0nedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline are dissolved in i r ;~
100 ml of dimethylsulphoxide, 4.5 g tO.04 mol) of potassium tert.butoxide are added and the mixture is stirred for half an hour at ambient temperature.
Then 16.8 9 (0.044 mol) of 1-benzyl-3-~4-toluenesulphonyl-oxymethyl)-hexahydro-azepine are added and the mixture is stirred for 3 hours at ambient temperature.
The reaction mixture is dissolved in ethyl acetate and extracted twice with water. The organic phase is dried over magnesium sulphate and evaporated down in vacuo. The residue is purified over aluminium ~-oxide N (activity II, eluant: methylene chloride, methylene chloride + 2% ethanol).
Yield: 3.0 g (19.6~ of theory), Rf value: 0.6 (silica gel, eluant: 5% ethanol in methylene chloride~.

f) 2-[(HexahYdro-azepin-3~ methyl]-6,7-methylenedioxy- -l-oxo-1,2,3,4-tetrahYdro-isoquinoline 6.7 g (0.017 mol) of 2-r(N-benzyl-hexahydro-azepin-3-yl)-methyl]-6 r 7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline are hydrogenated in 250 ml of methanol in the presence of 2 g of 20~ palladium hydroxide/charcoal for 4 hours at ambient temperature under 5 bar of hydrogen. The catalyst is then removed by suction filtering and the filtrate is ~ `
evaporated down ~o dryness in vacuo. The residue is crystallised from acetone. ~ ~-Yield: 4.9 g (95% of theory), ;~
M.p.: 267-269C.

Example D
~ . . .
3-Chloromethyl-N-[3-(naphthyl-2-oxy)-propyl~-hexahydro-azepine ', ' ~.

' ~ "
'' ' ~'' ',-' ~ 1 3 ~

a) 3-Hydroxymethyl-hexahydro-azepine 16.6 g (0.0757 mol) of l-benzyl-3-hyaroxymeth hexahydro-azepine are hydrogenated in 500 ml of methanol in the presence of 16.6 g of 20~ palladium hydroxide/charcoal for 2 hours at ambient temperature under 5 bar of hydrogen. The catalyst is then removed by suction filtering and the filtrate is evaporated down _ vacuo.
Yield: 8 g (81.8~ of theory), Rf value: 0.5 (silica gel, eluant: methylene chloride/-ethanol/ammonia = 5:4:1).

b) 3-HYdrox~methYl-N-[3-rnaphthyl-2-oxy)-~ropyl]
hexahydro-azePine-hydrochloride A mixture of 7.8 g (0.06 mol) of 3-hydroxymethyl-hexahydro-azepine and 6.7 g (0.03 mol) of 2-(3-chloropropoxy)-naphtbalene is heated for 1 hour to 120~C. The reaction mixture is purified over silica gel 10.063 - 0.2 mm) with ethyl acetate/ethanol/
ammonia 90:10:1.
Yield: 2.3 g (24.3% of theory), Melting point: 127-129C. ;~

c) 3-Chloromethyl-N-[3-(naPh~ yl-2-oxy)-pr hexahydro-azepine - ..
2.4 g (6.86 mmol) of 3-hydroxymethyl-N-[3-(naphthyl-2-oxy)-propyl~-hexahydro-azepine hydrochloride dissolved in 30 ml of chloroform are mixed with 5 ml of thionyl chloride and refluxed for 1 hour.
The mixture is evaporated to dryness in vacuo. ~`~
The residue is dissolved in methylene chloride, and extracted with water, 2 molar sodium hydroxide solution ancl again with water. The methylene chloride ;`~
phase is dried over magnesium sulphate and evaporated down in vacuo.

- 60 - ~3~ 3 Yield: 1.1 g ~48.5~ o theory~, Rf value: 0.55 (silica gel, eluant: 5% ethanol in methylene chloride).

Example E

2-[(Pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,?,3,4-~etrahydro-isoquinoline -a) N-Benzyl-2-pyrroliaone ~ .
14.4 9 (0.33 mol) of 50% sodium hydride dispersion in oil is added in batches to 25.5 g (0.3 mol) ~ ;
of 2-pyrrolidone in 300 ml of absolute dimethylsulphoxide.
The mixture is then stirred for 5 hours at 40 to 50C and, at 25 to 30C, 56.4 g = 39.2 ml (0.33 mol) :
of benzyl bromide are added dropwise. After stirring for 10 hours at ambient temperature the reaction mixture is dissolved in S00 ml of ethyl acetate and extracted several times with water. The organic phase is separated off, dried over magnesium sulphate and the solvent is eliminated in vacuo. The residue -~ `
obtained is purified over 900 g of aluminium oxide ~-(neutral, activity II) with methylene chloride and 0.1% ethanol.
Yield: 35.6 g (67.7~ of theory), Rf value: 0.77 ~aluminium oxide, neutral, eluant:
5% ethanol in methylene chloride).
b) N-Benzyl-2-pyrrolidone-3-carboxylic acid lS0 ml of 1.6 molar butyllithium solution in n-hexane are added with stirring and under nitrogen at -60C to 28.3 g = 39.3 ml ~0.28 mol) of diisopropyl-amine in 400 ml of absolute ether. 35.1 g ~0.2 mol) of N-benzyl--2-pyrrolidone dissolved in lS0 ml of absolute ether are added dropwise thereto at -60C.
" ~

~33~3 The cooling bath is removed and dry carbon dioxide is introduced for 15 minutes. After stirring for 10 minutes, the mixture is poured onto ice, the organic phase is separated off and extracted twice with 2 molar sodium hydroxide solution. The combined aqueous phases are extracted once with ether and then acidified with concentrated hydrochloric acid whilst being cooled. The aqueous phase is extracted twice with methylene chloride and ater the organic phase has been dried over magnesium sulphate it is evapora~ed down in vacuo.
Yield: 35 g (79.8~ of theory), Rf value: 0.42 (silica gel, eluant: 5~ ethanol in methylene chloride).
c) N-Benzyl-3-hydroxymethyl-pyrrolidine 35 g (0.16 mol) of N-benzyl-2-pyrrolidone-3-carboxylic acid dissolved in 250 ml of absolute tetrahydrofuran are added dropwise, with stirring to 12.2 g (0.32 mol) of lithium aluminium hydride in 350 ml of absolute tetrahydrofuran. After refluxing for 6 hours, 18.2 ml of water, 12.2 ml of 15% aqueous sodium hydroxide solution and 36.6 ml of water are added whilst cooling with ice water. The precipitate formed is suction filtered and washed with tetrahydrofuran.
The combined filtrates are evaporated down i vacuo and the residue obtained is purified over 900 9 of aluminium oxide (neutral, activity II) with methylene chloride and then with increasing amounts of ethanol (up to 2~
Yield: 16 g (52.3% of theory), Rf value: 0.42 (aluminium oxide, neutral, eluant:
5% ethanol in methylene chloride).
d) 3-(Benzenesulphonyloxymethyl)-l-benzyl-pyrrolidine '~ ~
- 62 - 133~
40 ml of 20~ sodium hydroxide solution are added dropwise, for a period of 1 hour, to a mixture of 3.8 g (20 mmol) of N-benzyl-3-hydroxymethyl-pyrrolidine and 3.7 ml (24 mmol) of benzenesulphonic acid chloride. 150 ml of toluene are added, the organic phase is washed with water, dried over magnesium sulphate and evaporated to dryness in vacuo.
Yield: 5.9 g (89.4% of theory), ;~
Rf value: 0.4 (silica gel, eluant: 5% ethanol in methylene chloride).
. . .:. :--~ . . :. :.
e) 2-[N-(Benzyl-pyrrolid-3-yl)-methyl~-6,7-dimethoXV- -~
l-oxo-1,2,3,4-tetrahydro-isoquinoline - ~ ~
~...-, ~.. ..
3.3 g (15.9 mmol) of 6,7-dimethoxy-1-oxo-1,2,3,4 tetrahydro-isoquinoline are dissolved in 50 ml of dimethylsulphoxide and combined with 2 q (17.5 mmol) of potassium tert.butoxide with stirring at ambient temperature. After half an hour, 5.8 g (17.5 mmol) of 3-(benzenesulphonyloxymethyl)-1-benzyl-pyrrolidine in 10 ml of dimethylsulphoxide are added to the -resulting potassium salt suspension and the mixture is stirred for 3 hours at 60C. It is poured onto ice water and extracted with ethyl acetate. The combined organic phases are washed with water and -dried over magnesium sulphate. The organic phase ~ ;~
is evaporated down in vacuo and the residue obtained is purified over 350 9 of aluminium oxide N (activity II) `~
with methylene chloride and then wi~h increasing .
quantities of ethanol (up to 1%).
Yield: 3.3 g (54.4% of theory), Rf value: 0.74 raluminium oxide N, eluant: 5% ethanol in methylene chloride).

f) 2-~(Pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline 1 3 ~ r9 ~3 .

3.2 9 (8.4 mmol) of 2-[(N-benzyl-pyrrolid~3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline are dissolved in 250 ml of methanol and hydrogenated in the presence of 1 g of 20%
palladium hydroxide/charcoal for 3 hours at ambient temperature under 5 bar of hydrogen. The catalyst is then removed by suction filtering and the filtrate is evaporated to dryness in vacuo. The residue is purified over 150 g of silica gel (0.063 - 0.2 mm) with methylene chloride~ethanol/ammonia = 6:1:0.5.
Yield: 0.9 g (37.5~ of theory), Rf value: 0.6 (silica gel, eluant: methylene chloride/-ethanol/ammonia = 5:4:1).

Example F

3-(p-ToluenesulphonYloxymethyl)-N-[2-~6-methoxy- ;~
naphth-2-yl)-ethyl]-pyrrolidine .
a) 3-Hydroxymethyl-pyrrolidine ;~

14 g (0.073 mol) of N-benzyl-3-hydroxymethyl-pyrrolidine are hydrogenated for 7 hours at 50C and under 5 bar in 300 ml of methanol and in the presence of 1.5 g of 20% palladium hydroxide/activated charcoal.
The catalyst is then removed by suction filtering and the filtrate is evaporated down in vacuo.
Yield: 7.3 g (99% of theory3, Mass spectrum: molecular peak 101.

b) 3-HYdroxYmethyl-N-[2-(6-methoxy-naPhth-2-yl) ethyl]-pyrrolidine A mixture of 3.6 g (29.4 mmol) of 3-hydroxymethyl-pyrrolidine and 4.7 g (14.7 mmol) of 2-(2-bromoethyl3-6-methoxy-naphthalene is heated to 120C for 2 hours. The reaction mixture is purified over 200 g " ~ ~ . . . ; ,. . ~ .

of silica gel (0.063 - 0.2 mm) with methylene chloride and then with increasing amounts of ethanol (up ~ -to 5%).
Yield: 3.48 g (82.5% of theory), -~
Melting point: 121-123C.

.:
c) 3~ ToluenesulphonYloxymethyl)-N-[2-(6-methoxy- -~
naphth-2-yl)-eth~l]-pyrrolidine 0.8 g (2.8 mmol) of 3-hydroxymethyl-N-[2-(6-methoxy-naphth-2-yl)-ethyl]-pyrrolidine are dissolved in ~ -10 ml of pyridine and 1.2 g (6.3 mmol) of p-toluene-sulphonic acid chloride are added with stirring.
After 2 hours at ambient temperature the mixture is evaporated to dryness in vacuo. The residue is dissolved in methylene chloride, washed with 2 molar sodium hydroxide solution and water. The ~-organic phase is then dried over magnesium sulphate and evaporated down in vacuo. The residue is purified over 150 g of silica gel (0.063 - 0.2 mm) with ethyl acetate and then with increasing amounts ;
of ethanol. `
Yield: 0.6 g (48.8~ of theory), Rf value: 0.45 (~ilica gel, eluant: 5% ethanol in methylene chloride). ~ ~

, ~ . .

' ': . ' ~ . r~

Example G ~ 3 3 ~ 9 9 ~
~.
2-[(Azacyclooctyl-3)-methyl]-6!7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline a) l-Benzyl-2-oxo-azacyclooctane ~ ;

25 9 (0.196 mol) of 2-azacyclooctanone are dissolved in 150 ml of dimethylsulphoxide and combined, with stirring, with 24.2 g (0.216 mol3 of potassium tert.butoxide and stirred for half an hour at 40C.
Then 24 ml (0.2 mol) of benzylbromide are added dropwise over a period of a quarter of an hour, during which time the temperature rises to 80C.
The mixture is stirred for 2 hours, during which the reaction temperature falls back to ambient ~;
temperature. The reaction mixture is poured onto 1 litre of ice water and extracted 4 times, each time with 150 ml of ethyl acetate. The combined -organic phase is washed with water, dried over magnesium sulphate and evaporated down in vacuo.
Yield: 42.7 9 (100% of theory), Rf value: 0.55 (silica gel, eluant: 5% ethanol in methylene chloride).

~ .. . .
b) l-Benzyl-azacylooctane-2-oxo-3-carboxylic acid :: ~
147 ml of 1.6 molar butyl lithium solution in n- ~;-r .
hexane are added dropwise at -60C, with stirring and under nitrogen, to 26.7 9 = 38.4 ml (0.26 mol) of diisopropylamine in 250 ml of absolute ether.
Then at -60C, 42.7 g (0.196 mol) of 1-benzyl-2-oxo-azacyclooctane in 100 ml of ahsolute ether were added dropwise thereto. After 10 minutes, dry carbon dl~oxide was introduced for 20 minutes. ;
The reaction mixture is poured onto ice, the ethereal phase is separated off and extracted twice with 13~93 .. `~.`. . ;~

2 molar sodium hydroxide solution. The combined ;
aqueous phases are extracted once with ether and then acidified with concentrated hydrochloric acid, whilst being cooled. The mixture was extracted ~ -3 times with methylene chloride, and the methylene chloride phase is dried over magnesium sulphate ~
and evaporated down in vacuo. -Yield: 25.9 g ~50.6% of theory), Rf value: O.lS (aLuminium oxide, eluant: 5% ethanol in methylene chloride~

c) l-Benzyl-3-hydroxYmethyl-azacyclooctane , 53.6 g (0.205 mol) of 1-benzyl-2-oxo-azacyclooctane-3-carboxylic acid dissolved in 100 ml of absolute tetrahydrofuran is added dropwise with stirring to 22.7 g (0.6 mol) of lithium aluminium hydride `~
in 800 ml of absolute ether. After refluxing for half an hour, the mixture is combined with 28.4 ml of water, 19 ml of 15% sodium hydroxide solution and 57 ml of water, whilst cooling with ice water.
The precipitate formed is suction filtered and washed with tetrahydrofuran. The combined filtrates are evaporated down in vacuo and the residue obtained ~ ;
is purified over 700 g of aluminium oxide (neutral, activity II) with 1% ethanol in methylene chloride. -~
Yield: 9.3 g (19.6% of theory), Rf value: 0.5 (silica gel~ eluant: 5% ethanol in methylene chloride). ;- ~-d) l-Benzyl-3-chloromethvl-azacYclooctane 9.3 g (39.8 mmol) of l-benzyl-3-hydroxymethyl-azacyclo octane are combined in 30 ml of pyridine with 10 ml ~ ;
(79.6 mmol3 of benzenesulphonic acid chloride and stirred for 2~ hours at ambient temperature. The reaction mixture is evaporated down in vacuo.

~33~993 The residue remaining is dissolved in 150 ml of methylene chloride, then washed with 2N sodium hydroxide solution and water. ~he organic phase is dried over magnesium sulphate, evaporated to dryness and purified over 150 g of silica gel (0.063-0.2 mm) with methylene chloride.
Yield: 3.5 g (35~ of theory) Rf value: 0.75 (silica gel, eluant: 5% ethanol in methylene chloride).
. , e) 2-[~N-Benzyl-azacyclooct-3-~ methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline 2.3 g (11.1 mmol) of 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline are dissolved in 40 ml of dimethylsulphoxide and 1.33 g (12.2 mmol) of potassium tert.butoxide are added with stirring.
After half an hour, 3.5 g (9.4 mmol) of l-benzyl-3-chloromethyl-azacyclooctane in 40 ml of dimethylsulphoxide are added to the resulting potassium salt suspension and the mixture is stirred for 2~ hours at 120C. ;~
It is poured onto ice water and extracted 3 times, each time with 50 ml of ethyl acetate. The combined organic phases are washed with water, dried over magnesium sulphate and evaporated down in vacuo.
The residue obtained is purified over 150 g of silica gel (0.063-0.2 mm) with 1% ethanol in methylene chloride.
.::
Yield: 1 9 (25.1~ of theory), Rf value: 0.5 (silica gel, eluant: 2% ethanol in ~ -methylene chloride).
.
f) 2-~(Azacyclooct-3-yl)-methyl]-6,7-dimethoxy- ~ ~
l-oxo~1,2,3,4-tetrahydro-isoquinoline , 0.85 9 (2 mmol) of 2-[(N-benzyl-azacyclooctyl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- ~
.:

~ ~3~993 isoquinoline are hydrogenated in 50 ml o methanol in the presence of 0.85 g of 20~ palladium hydroxide/char~
coal for 4l hours at ambient temperature under 5 bar of hydrogen. The catalyst is then removed by suction filtering and the f;ltrate is evaporated to dryness.
Yield: 0.5g (74.6% of theory), Rf value: 0.45 (silica gel, eluant: 25~ ethanol in methylene chloride and 1 drop of ammonia) ExamPle H
l-Chloro-3-1N-(4-methoxy-phenyl)-methylamino]-propane :
10 g (0.073 mol) of N-methyl-4-methoxy-aniline are dissolved in 50 ml of dimethylsulphoxide and 9 g (0.08 mol) of potassium tert.butoxide are added with stirring. After haLf an hour, 10 ml of 1~
bromo-3-chloropropane are added and the mixture is stirred for 3 hours at ambient temperature. `
It is poured onto ice water, extracted with ethyl ~ ~
acetate, the organic phase is ~ashed with water, ~ ~ ;
dried over sodium sulphate and evaporated to dryness.
The residue is purified over silica gel (0.063 - 0.2 mm) with methylene chloride.
Yield: 9.1 g (58.3% of theory), Rf value: 0.55 (silica gel, eluant: methylethyl ketone/xylene = 1:6) Calculated: C 61.82H 7.55 N 6.55 Cl 16.59 Found: 61.71 7.88 6.69 16.24.
.. ::
Example I -~

2-[(N-(3-(Pyrid-3-yl)-propvl)-piperid-3-yl)-methYl]-5,6-methylenedloxy-phthalimide ~ ;
~';.'"'''.`''''`''~''''' ..~',': ' ' ',- "'.

13~0~93 2.1 g ~0.011 mol) of 5,6-methylenedioxy-phthalimide are dissolved in 100 ml of dimethylsulphoxide and 1.25 g (0.012 mol) of potassium tert.butoxide are added with stirring. The potassium salt is precipitated.
It is stirred for a further ~ hour at ambient temperature, ;-a solution of 2.5 g (0.01 mol) of 3-chloromethyl-N- (3-(pyrid-3 yl)-propyl)-piperidine in 20 ml of dimethylsulphoxide is added and the mixture is heated to 120C for 8 hours. It is poured onto ice water, extracted three times, each time with 150 ml of ethyl acetate, and after drying over magnesium sulphate, the organic phase is evaporated ;~
down in vacuo. The residue is purified over 200 g of silica gel (0.063 - 0.2 mm) with ethyl acetate/ethanol/
~ammonia = 80:10:0.5.
Yield: 3 g (74% of theory), Calc. (2 x HCl) C 55.42 H 5.86 N 8.43Cl 14.22 Found: 55.28 6.06 8.2614.64 Example K

2-[N-(3-Chloropropyl)-piperid-3-yl-methYl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoc~noline 3 g (Q.01 mol) of 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline are dissolved in 50 ml of dimethylsulphoxide and 1.3 g (0.011 mol) of potassium tert.butoxide are added with stirring. After half an hour, 3 mI
of l-bromo-3-chloro-propane are added and the mixture is stirred for 1 hour at ambient temperature.
It is pourecl into ice water, extracted with ethyl acetate, and the organic phase is washed with water, dried over sodium sulphate and evaporated to dryness in vacuo. ;
Yield: 2.7 g (71% of theory), Rf value: 0065 (silica gel, eluant: ethyl acetate/ethanol/
ammon~a = 50:45:5).

.' ,. ' '.'.

` ~ 13~ 3 Example 1 2-[(N-(3-(Naphth-2-vl)-proP~ piperid-3-yl)-meth 6,7-dimethoxv-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride ~-A mixture of 1 g (3.2 mmol) of 2-(piperid-3-yl-methyl)-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline, 5 ml of dimethylsulphoxide, 0.5 g (0.36 mmol) of potassium carbonate and 0.75 g (3.66 mmol) of 2-(3-chloropropyl)-naphthalene is heated to 120C for 3 hours. The reaction mixture is poured onto ice water and extracted three times, each time with 50 ml of ethyl acetate. The combined organic phases are washed with 2 molar sodium hydroxide solution and water, dried ~ver magnesium sulphate, evaporated down ln vacuo and the residue obtained is purified over silica gel (0.063 - 0.2 mm) with 1% ethanol in methylene chloride. The hydrochloride is precipitated from a solution in acetone with ethereal hydrochloric acid and recrystallised from acetone.
Yield: 0.74 g (44% of theory), Melting point: 179-181C
Calculated: C 70.77 H 7.37 N 5.50 Cl 6.96 Found: 70.47 7.40 5.47 7.06. ~-~

Example 2 2-[(N-(3-(NaphthY1-2-oxy) -pro~yl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahYdro-isoquinoline- ~ -..... ...
hydrochloride-monohydrate ;~

1.58 g (9 mmol) of 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline are dissolved in 30 ml of dimethylsulphoxide and 1.1 g (9.9 mmol) of potassium tert.butoxide are added with stirring. After 1 hour, a solution ~, ,~. ..:
' ' "' ' ' ' ~ ~

3 3 ~ 9 9 D j~

of 2.9 g (9.1 mmol) of 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-piperidine in 10 ml of dimethylsulphoxide is added and the reaction mixture is stirred for 16 hours at 80C. It is then poured onto ice water, extracted 3 times, each time with 50 ml of ethyl acetate, the organic phase is washed with water/
dried over magnesium sulphate and, after evaporation, purified on silica gel (0.63 - 0.2 mm~ with ethyl acetate/ethanol/ammonia = 95:5:0.5. The hydrochloride is obtained as a hydrate from a solution in acetone using ethereal hydrochloric acid.
Yield: 2 g ~45.1% of theory), Melting point: 152-154C
Calculated: C 70.50 H 7.69 N 5.49 Cl 6.93 Found: 70.31 7.52 5.49 7.10 Example 3 2-[(N-~3-~Naphth-2-yl)-propyl)-piperid-3-yl)-methYl]-6,7-dimethyl-1,2,3,4-tetrahYdro-isoquinoline-dihYdro-chloride 0.8 g (18 mmol) of 2-[~N-(3-(naphth-2-yl)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline are dissolved in 10 ml of absolute tetrahydrofuran and 20 ml of absolute ether, 70 mg (18 mmol) of lithium aluminium hydride are added and the mixture is refluxed for 1 hour.
The reaction mixture is decomposed by the addition of 5 ml of satura~ed aqueous sodium sulphate solution, filtered to remove the sodium sulphate precipitated and washed with tetrahydrofuran. The filtrate is dried over magnesium sulphate and after evaporation, purified over 150 g of silica gel (0.063 - 0.2 mm) with ethyl acetate/ethanol/ammonia = 90:10:0.05.
The hydrochloride is precipitated from a solution in acetone with ethereal hydrochloric acid.
i, :., .,<,~ t~jt~, ` ` 133~3 Yield: 0.49 9 ~54.4~ o~ theory), Melting point: 148-150C
Calculated: C 69.61 H 8.18 N 5.41 Cl 13.70 Found: 69.46 8.32 5.26 14.17 Example 4 ... ..
2-[(N-(3-(Pyrid-3-yl)-propyl)-piperid-3-yl)-meth_l]-5,6-methylenedioxy-1-oxo-1,3-dihydro-isoindole-dih~drochloride 2.4 9 (S.9 mmol) of 2-[(N-(3-(pyrid- 3-yl)-propyl)-piperid-3-yl)-methyl]-5,6-methylenedioxy-phthalimide are dissolved in S0 ml of glacial acetic acid and refluxed for 5 hours. At intervals of 1 hour, 1 9 batches of zinc powder are added. After the reaction time has ended, the mixture is suction filtered and evaporated with ethanol. The residue is dissolved in methylene chloride, extracted with concentrated ammonia, dried over magnesium sulphate and after evaporat;on in vacuo purified over 150 g of silica gel (0.063 - 0.2 mm) ethyl acetate/ethanol/-ammonia = 90:10:0.2. The hydrochloride is precipitated from a solu~ion in acetone. ;~
Yield: 2.05 9 (75~ of theory), Melting point: 165-167C
Calculated: C 59.22 H 6.27N 9.00Cl 15.20 -~
Found: 59.03 6.45 8.85 15.06 .:."". ",,. ,~
ExamPle 5 3-~(N-~3-~Pyrid-3-yl)-propyl)-pyrrolid-3-Yl)-methyl]-7,8-d~methoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzoazepine~
dihydrochloride 1.1 9 (2.6 mmol) of 3-[(N-(3-(pyrid-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-`~ ~3~93 dihydro-2H-3-benzazepine, dissolved in 50 ml of ethanol, are ~ ~
hydrogenated in the presence of 1 g oE 10~ palladium on activated ~ -charcoal at 80C and under 5 bar of hydrogen for 2 hours. Then the catalyst is removed by suction filtering and, after being evaporated down in vacuo, ~he filtratle is purified over 100 g of silica gel (0.063 - 0.2 mm) with ethyl acetate/ethanol/ammonla =
80:40:1. The hydrochloride is precipitated from a solution in acetone.
Yield: 0.37 g (33% of theory), Meltlng point: 96-98C
Calculated: C 60.42 H 7.11 N 8.46 C1 14.28 Found: 60.35 7.468. 4314 . 58 Example 6 3-l(N-( 3- ( Indol-3-Yl)-propyl) -hexahydro-azePin-3-vl)-methvll-7,8-dimethoxy-1,3,4,5-tetrahvdro-2H-3-benzazepine-dihvdrochloride-monohydrate Prepared from 3-[(N-(3-(indol-3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1, 3, 4, 5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran and diethylether analogously to Example 3.
Yield: 53% of theory, ' ~
Melting point: 158-160C
Calculated: C 63.58 H 8.00N 7.41 C1 12.51 Found: 63.41 8.18 7.36 12.23 ~,. ~. ~

:

~ ~L33~9~3 2 7 1 6 9 1 ~L 7 ~ 74 -' ~ ~

.

Example 7 .
2-t(N-~2-~4-Amino-phenyl)-ethyl)-piperld-3-yl)-methyl]-5,6-dlmethoxY-l-oxo-1,3-dihydro-isoindole- i dlhyarochloriae 2.1 g t4.78 mmol) of 2-[~N-~2-14-nitro-phenyl)-ethyl~-piperld-3-yl~-methyl]-5,6-dlmethoxy-1-oxo-1,3-dlhydro-l~oindole are dissolved in 50 ml of glaclal acetic acid and 0.4 ml ~8.22 mmol) of hydrazine hydrate and 1 spatula ~lp of Raney nickel are added with ~tirring. The addition of 0.2 ml of hydrazine ~ -hydrate ~nd 1 spatula tlp of Raney nickel i~ repeated 3 time~ ~t interval~ of 1 hour. The cat~lyst i8 .
removed by ~uction filtering, the residue is wa~hed `~
with methanol, the filtrate is dried with magne~ium ~ ~
~ulphate, evaporated down in vacuo and the re~idue ~ `
obtained i9 puriied over aluminium oxide ~neutral, - ~
actlvlty II~ with methylene chloride and then wlth ~ -inareasing quantitles of ethanol.
yield: 1.8 9 ~91. 8% of theory), 1 9 18 di~olved ln ac~tone and the dlhydrochloride precipltated with ethereal hydrochlorlc ~cid.
Yleld: 1.02 9 (86.4~ of theory based on the base), Melting point: 232-235DC
Calculated:C 59.72 H 6.89 N 8.71 Cl 14.69 Found:59.54 7.08 8 56 14.45 , ExamPle 8 ~
; ~ . .
2-ttN-~2-(4_Acetamino PhenYl)-ethyl)-plperid-3~
Yl)-methyll~5r6-dimethoxy-l-oxo-l~3-dihydro-lsoindole ~i '.:;

133~

819 mg (2 mmol) of 2-[(N-(2-~4-amino-phenyl~-ethyl)-piperid-3-yl)-methyll-5,6-dimethoxy-1-oxo-1,3-dihydro- ~ -isoindole are mixed with 10 ml of methylene chloride and after the addition of 0.3 ml ~2.2 mmol) of triethylamine, 0.16 ml ~2.2 mmol) of acetyl chloride are added dropwise. The reaction temperature rises to 30C. The mixture is stirred for half an hour at ambient temperature, extracted twice with water, the organic phase is dried over magnesium sulphate and evaporated down in vacuo. The residue is crystallised from acetone.
Yield: 660 mg (73.2% of theory), M.p.: 195-196C
Calculated: C 69.16 ~1 7.37 N 9.31 Found: 69.33 7.11 9.16 ExamPle 9 3-[(N-~3-(FurYl-2)-propyl~-piPerid-3-yl)-methYl~-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazepine~
hydrochloride 3.2 g (0.010 mol) of 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine are hydrogenated in 100 ml of absolute ethanol in the presence of 1.3 g (0.010 mol) of 3-(furyl-2)-propanal and 1 9 of Raney nickel at 80C for 2 days under 5 bar. The catalyst is removed by suction -filtering, the filtrate is evaporated down and purified over a silica gel column with methylene chloride/methanol as eluant. The hydrochloride is precipitated with e~hereal hydrochloric acid and crystallised from acetone.
Yield: 0.50 g (11% of theory~
Melting point: 204-206C
Calculated: C 64.85 H 7.62 N 6.05 Cl 7.66 Found: 64.88 7.76 5.93 7.55 -^; ~L330~3 Rf value: 0.69 (silica gel; methylene chloride/methanol =
10:1; ammonia/atmosphere~
::
Example 10 2-~(N-(3~(3-Methylphenoxy)-prop~l)-piperid-3-yl)- ~
methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline- ~ ~;
dihydrochloride -Prepared from 2-1(N-t3-(3-methylphenoxy~-propyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in diethylether and tetrahydrofuran analogously -~
to Example 3.
Yield 92.9% of theory, ;~
Melting point: 100-103C ~-Calculated: C 61.23 H 7.99 N 5.29 Cl 13.39 Found: 61.21 8.13 5.10 13.15 Example 11 2-[(N-(3-(NaPhthYl-2-oxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline~hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-pyrrolidine analogously to Example 2.
Yield: 22% of theory, ~
Melting point: 78-80C ~ -Calc. (x H2O): C 65.83 H 7.04 N 5.29 Cl 6.70 ~
Found: 65.79 7.00 5.03 6.99 ~;

~ ~33~3 Example 12 ~-2-[(N-(3-(NaPhthyl-2-oxY~eropYl)-pyrrolid-3-Yl)-methYl]-6~7-methYlenedioxy-l-oxo-l~2l3~4-tetrahydr isoquinoline-hydrochloride . :
Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-E3-(naphthyl-2-oxy)-propyl~-pyrrolidine analogously ~~
to Example 2 Yield: 53% of theory, Melting point: 78-80C
Calc. (x H2O): C 65.56H 6.48N 5.46 Cl 6.91 Found: 65.44 6.32 5.38 7.13 Example 13 -2-[(N-(2-(Naphth-2-yl)-ethYl)-p~rrolid-3-yl)-methyl]- It~
6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-hYdrochloride'~':

Prepared from 2-r(N-(2-(naphth-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydro-furan and ether analogously to Example 3.
Yield: 66.2% of theory, Melting point: 239-241C
Calc. (x H2O): C 64.48 H 7.44 N 5.37 Cl 13.91 Found: 64.30 7.34 5.52 13.69 ~: ;
Example 14 2-[(N-((2-~Methyl-naphth-l-yl)-methyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahYdro-isoquinoline-hydrochloride Prepared from 2-[(N-((2-(methyl-naphth-1-yl)-methyl)-hexahydro-a~epin-3-yl)-methyl]-6,7-dimethoxy-1-.. .. - ~..-:

,. :' ~, 133~993 oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran and ether analogously to Example 3.
Yield: 73.8~ of theory, Melting point: 182-184C
Calc. ~x H~O): C 65.56 H 7.70 N 5.09 Cl 12.90 Found: 65.52 7.57 5.32 12.72 Example 15 .. ~ ,:,. : .:
2-[(N-(4-(NaphthYl-2-oxy)-butyl)-pyrrolid-3-yl)-methYl]-6l7-dimethyl-l-oxo-l~2l3~4-tetrahydro-isoquinoline .
hYdrochloride Prepared from 2-(pyrrolid-3-yl-methyl)-6,7-dimethyl-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(4- ~ ~
bromo-butyloxy)-naphthalene analogously to Example 1 -Yield: 30% of theory, Melting point: 133-136C
Calculated: C 67.02 H 6.92 N 5.21 Cl 14.86 Found: 67.26 7.03 5.36 14.89 Example 16 ~. ...

2-[(N-(2-Methyl-naphth-l-yl)-methyl)-pyrrolid-3- :.
yl)-methYl]-6~7-dimethyl-l-oxo-l~2~3r4-tetrahydro-isoquinoline-hYdrochloride r Prepared from 2-(pyrrolid-3-yl-methyl)-6,7-dimethyl-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloromethyl-2-methyl-naphthalene analogously to Example 1.
Yield: 32.5~ of theory, Melting point: 142-144C
Calculated: C 69.34 H 7.69 N 5.77 Cl 7.37 Found: 69.59 7.63 5.72 7.89 Example 17 `

33~93 ,9 2-[(N-(2-t5-MethyL-6-methoxy-naphth-2-yl~-ethYl~-pyrrolid-3-yl)-methyl]-6~7-dimethyl-l-oxo-l~2~3~4 tetrahydro-isoquinoline-hydrobromide Prepared from 2-[N-(pyrrolid-3-yl-methyl)]-6,7-aimethyl-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-t2-bromoethyl)-5-methyl-6-methoxy-naphthalene -~
analogously to Example 1.
Yield: 19% of theory, Melting point: 230-232C
Calculated: C 67.02 H 6.93 N 5.21 Br 14.86 ;~
Found: 67.10 7.12 5.33 15.01 ExamPle 18 .
2-[~N-(2-(Naphth-2-Yl)-ethyl)-p ~rolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-(pyrrolid-3-yl-methyl)-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromoethyl)-naphthalene analogously to Example 1.
Yield: 7.8~ of theory, Melting point: 219-221C -Calc. (x H2O): C 67.39 H 7.07 N 5.61 Cl 7.10 Found: 67.21 7.23 5.57 7.63 Example 19 2-[(N-~2-(6-Methoxy-naphth-2-yl)-ethyl)-pYrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro- -isoquinoline-hydrochloride Prepared from 2-((pyrrolid-3-yl)-methyl)-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromoethyl)-6-methoxy-naphthalene analogously to Example 1.
'"'~;"..'' " ..
: ~ ... .. .

1 ~0~3 ~ Y

Yield: 39.2~ of theory, Melting point: 224-226c Calc. (x H2O): C 65.84 H 7.05N 5.29 Cl 7.05 Found: 66.08 7.1~ 5.39 6.77 :, Example 20 .
2-L(N-(3-~Naphth-2-yl)-propyl)-piperid-3-yl)-methyl~
6,7-dimethyl 1-oxo-1,2,3,4-tet.rahydro-isoquinoline-hydrochloride Prepared from 6,7-dimethyl-1-oxo~1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphth-2- -yl)-propyl]-piperidine analogously to Example 2.
Yield: 40.4~ of theory, Melting point: 185-187C
Calculated: C 75.52 H 7.82 N 5.87 Cl 7.43 Found: 75.39 7.85 5.82 7.52 Example 21 2-[2(N-t3-(Naphthyl-2-oxy~-propvl~-piperid-2-yl)-ethylJ-6~7-methylenedioxy-l-oxo-1~2~3~4-tetrahYdr isoquinoline-hydrochloride Prepared from 2-(2-(piperid-2-yl)-ethyl)-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-iso~uinoline and 2-t3-chloropropoxy)-naphthalene analogously to Example 1.
Yield: 21.2% of theory, Meltinq point: 85-87C
Calc. (x H2O): C 66.59 H 6.89N 5.17 Cl 6.53 Found: 66.77 6.98 4.95 6.74 Example 22 2-[(N-(3-(Naph~hyl-2-oxy)-propyl)-piperid-3-yl)- ~ ~-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride ` 1~3~3 Prepared from 2-[(N-(3-(naphthyl-2-oxy~-propyl~
piperid-3-yl~-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 53% of theory, Melting point: 133-135C i r Calc. (x HzO) C 68.30 H 6.87 N 5.31 Cl 13.44 Found: 68.05 6.85 5.23 13.03 Example 23 2-[(N-(3-(Naphthyl-2-ox~-propyl~-piperid-3-yl~-methyl]-6~7-methylenedioxy-1~2~3,4-tetrahYdro-iso~uinoline dihvdrochloride ~ ~.
Prepared from 2-[(N-(3-(naphthyl-2-oxy~-propyl~
piperid-3-yl~-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 44.7% of theory, Melting point: 130-132C
Calc. (x H2O): C 63.62 H 6.62 N 5.11 Cl 12.95 Found: 63.49 6.86 4.97 12.64 Exam~le 24 2-[(N-(~2-Methyl-naphth-l-yl)-methYl)-piperid-3- -Yl~-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride .... , ., ~., : ~
Prepared from 2-[(N-((2-methyl-naphth-1-yl)-methyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- ~ `
tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
~ield: 80.5% of theory, Melting point: 210-212C

~ -' ~.'.' ~' ~ ' 33a~

Calc. (x H2O): C 65~05 H 7.53 N 5.23 Found: 65.23 7.78 5.03 Example 25 2-[2-(N-(2-(6-Methoxy-naphth-2-yl)-ethyl)-piperid-2-yl)-ethyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hYdrochloride ~' `' Prepared from 2-[2-(piperid-2-yl)-ethyl]-6,7-methylene-dioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-~2-bromo-ethyl)-6-methoxy-naphthalene analogously to Example 1.
Yield: 27.6~ of theory, Melting point: 112-117C
Calc. (x ~ H2O): C 67.74 H 6.82 N 5.26 Cl 6.65 Found: 67.54 6.73 5.47 6.86 . . :
Example 26 2-[~N-(2-(Naphth-l-yl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoq~inoline-hYdrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-(2-benzene-sulphonyloxy-ethyl)-naphthalene analogously to Example 1.
Yield: 26.9~ of theory, -~ -Melting point: 220-225~C
Calculated: C 67.89 H 7.27 N 5.46 Cl 6.91 Found: 67.75 6.92 5.56 7.00 : :' : . ' 133~3 Y;~
-- ~3 --Example 27 2-~N- ( 2-(Naphth-2-yl)-ethyl)-piperid-3-yl)-methy~
6,7-methylenedioxy-1-oxo-1~2,3,4-tetrahydro-isoquinoline-hydrochloride .
Prepared from 2-[(piperid-3-yl)-methyll-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-benzene-sulphonyloxy-ethyl)-naphthalene analogously to Example 1.
Yield: 27.9% of theory, Melting point: 128-130C
Calc. (x H2O): C 67.66 H 6.69 N 5.63 Cl 7.13 Found: 67.64 6.70 5.76 7.35 Example 28 ;~
~. .
2-[ (N- (2-(5-MethYl-6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-6~7-methylenedi 1,2,3,4-tetrahydro-isoquinoline-hvdrochloride -Prepared from 2-[(piperid-3-yl)-methyl]-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromoethyl)-5-methyl-6-methoxy-naphthalene analogously to Example 1.
Yield: 51.2% of theory, -~
Melting point: 128-131C
Calculated: C 68.88 H 6.74 N 5.34 Cl 6.77 Found: 68.90 6.61 5.30 7.05 -Example 29 2-[(N-((2-Methyl-naphth-1-yl)-methyl)-piperid-3-Yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloromethyl- ~

: :
:. ~
- 8~ -2-methyl-naphthalene analogously to Example 1.
Yield: 57.9% of theory, Melting point: 212-214C
Calc. ~x 2 H20~: C 67.63H 7.63N 5.44 Cl 6.88 Found: 67.46 7.56 5.54 6.67 Example 30 2-[(N-(4-(Naphthyl-2~oxy)-butyl)-~iperid-3-yl)-methY-l]-6~7-dimethoxy-l-oxo-l r 2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(4-bromo-butoxy)-naphthalene analogously to Example 1. ~;-Yield: 46.3~ of theory, Melting point: 80-84C
Calc. (x H2O): C 66.83~ 7.41 N 5.03 Cl 6.36 Found: 66.79 7.22 4.90 6.64 ~ . ~.....
Example 31 -~
'"~` . .~' .' ~
2-[(N-(2-(6-MethoxY-naphth-2-yl)-ethYl)-piperid-3-Yl)-methYl]-6~7-dimethoxy-l-oxo-l~2~3r4-tetrahydr isoquinoline-hydrochloride Prepared from 2-1(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromo-ethyl)-6-methoxy-naphthalene analogously to Example 1.
Yield: 22.8~ of theory, Melting point: 80-85C -~
Calc.: (x H2O x HCl x CH3COCH3): C 64.01 H 7.65 N 4.52 Cl 5.72 Found: 64.26 7.70 4.62 5.49 ' '~ ` 133~3 - 85 -Example 32 2-[3-(N-(2-(6-Methoxy-naPhth-2-yl)-ethyl)-piperid 3-yl)-Propyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline Prepared from 2-[3-(piperid-3--yl)-propyl~-6,7-methylenedioxy-l-oxo-l~2~3~4-tetrahyaro-isoqllinoline and 2-t2-bromo-ethyl)-6-methoxy-naphthalene analogously to Example 1.
Yield: 36.8% of theory, Melting point~ 118-121C
Calculated: C 74.37 H 7.25 N 5.60 Found: 74.60 7.43 5.65 Example 33 . .... ~ ~ .:
2-[3-(N-(2-(Naphth-l-yl)-ethyl)-piperid-3-yl)-propyl]-6,7-methylenedioxy-1-oxo-1,2,3t4-tetrahydro-isoquinoline- ,~
hydrochloride Prepared from 2-[3-(piperid-3-yl)-propyl]-6,7-methylenedioxy-l-oxo-1~2,3,4-tetrahydro-isoquinoline and 1-(2 benzenesulphonyloxy-ethyl)-naphthalene analogou~ly to Example 1.
Yield: 20.8% of theory, Melting point: 195-197C
Calculated: C 71.07 H 6.95 N 5.53 Cl 6.99 Found: 71.30 6.95 5.65 6.80 Example 34 : . ~
2-[2-(N-(2-(5-Methvl-6-methoxy-naphth-2-ylt-ethyl)-piperid-2-yl)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[2-(piperid-2-yl)-ethyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-~ 1~3~3 bromo-ethyl)-5-methyl-6-methoxy-naphthalene analogously to Example 1.
Yield: 33.6% of theory, Melting point: 95-100C
Calc. (x 1 H2O~: C 68.38 H 7.52 N 4.98 Cl 6.30 Found: 68.14 7.43 4.92 6.77 '' .,.
ExamPle 35 2-[(N-(3-(Naphthy1-2-oxy)-Propyl)-piperid-3-Yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro~
isoquinoline-hydrochloride - ~ -Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-piperidine analogously to Example 2.
Yield: 27.3% of theory, Melting point: 104-106C
Calc. (x H2O): C 66.09 H 6.69 N 5.31 Cl 6.72 found: 66.19 6.34 5.24 7.22 Example 36 2-[rN-(3-(Naphth 1-2-oxy)-propyl)-piperid-3-yl)-methYl~-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(naphthyl-2-oxy)-propyl]-piperidine analogously to Example 2.
Yield: 28.6% of theory, Melting point: 191-193C
Calc. (x H2O): C 66.3~ H 7.23 N S.lS Cl 6.53 Found: 66.59 7.19 5.03 6.65 Example 37 ~
,, ~3~

2-[(N-(3-(Naphthyl-2-oxy~-propyl)-hexahydro-azepin-3-Yl)-methyl]-6,7-dimethox~ oxo-l,2,3,4-tetrahydro-isoquinoline-hy~rochloride '.. ".
Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-naphthalene analogously to Example 1.
Yield: 16.1~ of theory, Melting point: 86-88C
Calc. (x H20): C 66.83H 7.42 N 5.03 Cl 6.36 Found: 66.90 7.40 5.26 6.37 : .: . ' .: ':
Example 38 2-~(N-~3-(NaPhthyl2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hydrochloride Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoguinoline and 3-chloromethyl-N-E3-(naphthyl~
2-oxy)-propyl]-hexahydro-azepine analogously to Example 2.
.:.
Yield: 22.5% of theory, Melting point: 191-193C
Calculated: C 73.42 H 7.75N 5.52Cl 6.99 `~
Found: 73.37 7.67 5.52 7.12 Example 39 2-[(N-(2-(5-MethYl-6-methoxy-naphth-2-yl)-ethYl)- -hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride Prepared frc~m 2-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline ~ ~ ~3~9~3 ; - 88 -and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 77.6~ of theory, Melting point: 170-172C -~
Calc. (x H2O): C 64.96 H 7.49 N 4.73 Cl 11.98 Found: 65.11 7.62 4.95 11.84 Example 40 2-[(N-(2-(5-Methyl-6-methoxY-naphth-2-yl)-ethYl)-hexahydro-azepin-3-yl)-methYl~-6,7-dimethoxY-l-~:~ : :-oxo-1,2,3,4-tetrahydro-isoquinoline Prepared from 2-[(hexahydro-a2epin-3-yl)-methyl~
6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromoethyl)-5-methyl-6-methoxy-naphthalene analogously to Example 1.
Yield: 43.5% of theory, - ~-Melting point: 125-127C
Calculated: C 74.39 H 7.80 N 5.42 -~
Found: 74.31 7.82 5.3S

Example 41 ~' ~
2-[(N-(2-Methyl-naphth-l-yl)-methyl)-hexahydro- ~
azepin-3-yl)-methyll-6,7-dimethoxy-1-oxo-1,2,3,4- :-. .
tetrahydro-isoquinoline-hydrochloride ':
Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline ~ -and l-chloromethyl-2-methyl-naphthalene analogously to Example 1.
Yield: 67.5% of theory, Melting point: 128-130C
Calc. (x 2 H2O) C 66.10 H 7.58 N 5.13 Cl 6.50 Found: 66.24 7.44 5.23 6.85 133~99~

E x amp l e 4 2 2-[ tN- t4-~NaphthY1-2-oxY)-butyl)-hexahydro-azepin-3-Yl)-methyl]-6~7-dimethoxY-l-oxo-1,2,3,4-tetrahydro- ,'.
isoquinoline-hydrochloride Prepared from 2-[~hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline -and 2-(4~bromo-butyloxy)-naphthalene analogously to Example 1.
Yield: 26% of theory, -~
Melting point: 192-194C
Calculated: C 69.22H 7.80 N 5.04 Cl 6.38 : --: -Found:70.01 7.70 5.15 6.48 :~ :
Example 43 ~;
- ~ .
2-[(N-(2-t~aphth-1-yl)-ethyl)-hexahydro-azepin-3-Yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-1(hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-~2-benzenesulphonyloxy-ethyl)-naphthalene analogously to Example 1.
Yield: 15.4% of theory, Melting oint: 236-238~C
Calc. (x ~ H2O):C 69.40 H 6.82N 5.58 Cl 7.06 Found: 69.07 6.74 6.13 7.29 ,, .
Example 44 ~ ~ .
2-[(N-(2-(Naphth-2-yl)-ethyl3-hexahydro-azepin~
3-~1)-methyl]-6,7-methYlenedioxy-l-oxo-1,2,3,4- -tetrahydro-lsoquinoline-hydrobromide `

Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline ~ ' -~ ~33~33 - 9 0 -- ~ ~
and 2-(2-bromo-ethyl)-naphthalene analogously to ;
Example 1.
Melting point: 100-102C
Yield: 31.6~ of theory, Calculated: C 64.80 H 6.18 N 5.21 Br 14.86 Found: 65.02 6.07 5.39 14.78 Example 45 : ~:
2-[~N-(2-(6-MethoxY-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methYl~-6,7-methylenedioxY-l-oxo-1,2,3,4-tetrahYdro-lsoquinoline-hYdrochloride ,~ :~

Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromo-ethyl)-6-methoxy naphthalene analogously to Example 1.
Yield: 34.1% of theory, Melting point: 147-149C
Calc. (x H2O): C 68.62 H 7.10 N 5.33 Cl 6.75 Found: 68.88 6.98 5.41 6.78 Example 46 ~ ;

2-[(N-(2-~5-MethYl-6-methoxy-naphth-2-yl)-ethYl)- ~--hexahydro-azepin-3-yl)-methyl]~6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline-hYdrochloride :
Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(2-bromo-ethyl)-5-methyl-6-methoxy-naphthalene -analogously to Example 1.
Yield: 36~1~ of theory, ~ ;
Melting point: 112-114C
Calc- (x H2O): C 67.07 H 7.08 N 5.04 Cl 6.38 Found: 67.13 7.15 4.97 6.56 ' , 1 3 3 ~ 9 9 3 Example 47 2~(N-(3-(4-Methoxy-phenoxyj-propyl)-piperid-3-yl~-methYl]-6,7-dimethoxy-1,2,3,4-tetrahYdro-isoquinoline-dihydrochloride Prepared from 2-~(N-(3-(4-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 88.5% of theory, Melting point: 189-191C -Calculated: C 59.44 H 7.76 N 5.13 Cl 12.99 Found: 59.55 7.99 5.12 12.61 Example 48 ~: ~: ', .
2-L~N-12-(3,4-Dimethoxy-phenyl)-ethYl)-piPerid- : '' ,,:
3-yl)-methYl]-6~7-dimethoxy-l~2~3~4-tetrahydro-.
isoquinoline-dihydrochloride ~
~'' . " ' Prepared from 2~[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4- ;
tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3. ~-~
Yield: 92.8% of theory, Melting point: 175-176~C -~
Calculated: C 60.66 ~ 7.35 N 5.33 Cl 13.49 : : :
Found:60.58 7.56 5.32 13.22 ;~ ~

ExamPle 49 ~ ;
' ~
2-[(N-(3-~3-Methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-methylenedioxy-1~2~3~4-tetrahYdro- i~
isoquinoline-dihydrochloride '' Prepared from 2-~(N-(3-(3-methoxy-phenoxy~-propyl)-~: '~ '' ~ ~., ", .. .

,t ~33a993 piperid-3-yl)-methyl]-6,7-methylenedioxy-l~oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 96.6~ of theory, Melting point: 178-181C
Calculated: C 59.08 H 7.62 N 5.30 Cl 14.31 Found: 58.90 7.50 5.40 14.15 ~, Example 50 2-[(N-(3-(3-Methoxy-phenoxy)-propyl)-piperid-3-Yl)-methyl]-6~7-methylenedioxy-lt2r3~4-tetrahydr isoquinoline-dihydrochloride Prepared from 2-[(N-~3-(3-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example ' : :
Yield: 94.5% of theory, Melting point: 169-171C
Calculated: C 57.03 H 7.36 N 5.11 Cl 13.86 Found: 56.91 7.26 5.15 13.68 Example 51 2-L(N-(2-(3,4-Dimethoxy-phenyl)-ethyl)-piperid-3-Yl) -methyl]-6,7-dimeth~l-1,?,3,4-tetrahydro-isoquinoline-dihydrochloride Prepared from 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 91.3~ of theory, Melting point: 140-142C

~ ~ ' 133~

Calculated:C 62.00H 8.34 N 5.27Cl 13.44 Found: 61.858.27 5.31 13.33 Example 52 2-r(N-(3-(4-Methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride ~ , , Prepared from 2-[tN-(3-(4-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hyaride in tetrahydrofuran analogously to Example 3.
Yield: 88.3~ of theory, Melting point: 170-172C
Calculated: C 63.14 H 8.24 N 5.65 Cl 14.31 Found: 63.09 8.33 5.8214.02 Example 53 2-[(N-~2-(3,4-Dimethoxy-Phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-methylenedioxY-1,2,3,4-tetrahYdro- -~
isoquinoline-dihydrochloride Prepared from 2-[(N-(3-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 93.3% of theory, Melting point: 150-154C
Calculated: C 60.01 H 7.34 N 5.39 Cl 13.64 Found: 59.96 7.41 5.2513.43 '. '.'~",~-'' ~' -~ ~330993 Example 54 2-[(N-t3-(4-MethoxY-phenoxY)-propyl)-piperid-3-Yl)-methyl]-6~7-dimethoxy-l~2~3~4-tetrahydro-isoquinoline dihydrochloride Prepared from 2-[(N-(3-(4-methoxy-phenoxy~-propyl)-piperid-3-yl-3)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 95.3~ of theory, Melting point: 182-185C
Calculated: C 61.05 H 7.09 N 5.48 Cl 13.86 Found: 61.10 6.95 5.68 13.55 Exam~le 55 2-[2-(~-(3-(3,4-Methylenedioxy-phenoxy)-ProPYl)-piPerid-3-yl)-ethyl]-6~7-dimethoxy-l-oxo-l~2~3~4-tetrahydro-isoquinoline-hydrochloride ' ;:~.

Prepared from 2-[~piperid-3-yl)-ethyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxy-phenoxy)-propane analogously -~ ~
to Example 1. ~ ~-Yield: 35.5~ of theory, Melting point: 97-100C
Calculated: C 59.09 H 7.28 N 4.62 Cl 6.65 Found: 58.97 7.36 4.66 6.52 :
Example 56 2-[2-~N-(2-(3,4-Dimethoxy-phenyl)-ethyl)-piE~erid-3-yl)-ethyl]-6,7-d~methoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hydrochloride ~ `

Prepared from 2-[(piperid-3-yl)-ethyl~-6,7-dimethoxy~
l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-r 'tfr~

~L33~993 : ~

2-(3,4-dimethoxy-phenyl~-ethane analogously to Example 1. ~-Yield: 35.9~ of theory, Melting point: 103-105C
Calculated: C 62.60 H 7.79 N 5.21 Cl 6.83 Found: 62.41 7.82 5~09 7.19 ~xample 57 2-[3-(N-(2-(3~4-Dimethoxy-phenyl)-ethyl)-piperid~
3-yl)-Propyl]-6~7-dimethoxy-l-oxo-l~2~3~4-tetrahydr isoquinoline-hYdrochloride Prepared from 2-[3-~piperid-3-yl)-propyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy-phenyl)-ethane analogously to Example 1.
Yield: 32.6% of theory, Melting point: 102-106C
Calculated: C 63.20 H 7.86 N 5.08 Cl 6.43 Found: 63.39 7.90 4.86 6.13 Example 58 2-~3-!N-~3-(3,4-MethYlenedioxy-phenoxy ? -propyl)-:: :
pi~erid-3-yl)-propyl]-6~7-dimethoxy-1-oxo-1~2~3~4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-~3-(piperid-3-yl)-propyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxy-phenoxy)-propane analogously ~-to Example 1.
~ield: 29.7% of theory, ~ -Melting point: 97-100C
Calculated: C 61.63H 7.31N 4.96Cl 6.47 Found: 61.94 7.46 5.16 6.48 ...-33~93 Example 59 2-[~N-(3,4-Dimethoxy-benzyl)-piperid-3-yl)-methyl~-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-(piperid-3-yl-methyl)-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 3,4-dimethoxy-benzylbromide analogously to Exampl~
Yield: 53.3% of theory, Melting point: 127-132C ~ ;
Calculated: C 63.58 H 7.18 N 5.70 Cl 7.22 Found: 63.30 7.22 5.52 7.14 _xample 60 2-[(N-(3-(4-Methoxy-phenyl)-propyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahy~_o-isoquinoline-hYdrochloride .
Prepared from 2-(p~perid-3-yl-methyl~-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-3-(4-methoxyphenyl~-propane analogously to Example 1.
Yield: 42% of theory, Melting point: 229-231C
Calculated: C 66.31 H 7.63 N 5.73 Cl 7.25 Found: 66.27 7.64 5.65 7.33 Example 61 - - -2-12-(N-(3-(3-Methyl-phenoxy)-propYl)-piperid-2-yl)-ethyl]-6,7-dimethoxy-1-oxo-1,2~3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[2-~piperid-2-yl)-ethyll-6,7-dimethoxy- ~ ,:"'yr,~
l-oxo-1,2,3~4-tetrahydro-isoquinoline and l-chloro-3-~3-methyl--phenoxy)-propane analogously to Example 1.

~ 133~93 Yield: 52.4% of theory, Melting point: 142-144C
Calculated: C 66.85 H 7.81 N 5.57 Cl 7.05 Found: 66.73 7.68 5O53 6.94 Example 62 2-[2-(N-(2-(3,4-~imethoxy-pheny~)-e~hyl)-eiperid- '~
2-yl)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-iso~uinoline-hydrochloride Prepared from 2-[2-(piperid-2-yl)-ethyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l~bromo-2-(3,4-dimethoxy-phenyl)-ethane analogously to Example 1.
Yield: 47.3% of theory, Melting point: 150-155C
Calculated: C 64.72 ~ 7.68 N 5.39 Cl 6.82 Found: 64 40 7.83 5.27 6.90 ~ -~

Example 63 ~ ;r.

2-[2-(N-(3-Benzyloxy-propyl)-piperid-2-yl)-ethyl]~
6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-r2-(piperid-2-yl)-ethyl]-6,7-dimethoxy- ;-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-benzyloxy-propane analogously to Example 1. ~ ;
Yield: 56.3~ of theory, Melting point: 116-120C
Calculated: C 66.85 H 7.81 N 5.57 Cl 7.05 ~-Found: 66.60 7.75 5.25 7.25 ~.. , .." , """~,, .,., . ,~;,,~.

~` ` ~ 33~93 ~

Example 64 2-~2-(N-(4-~4-Methoxy-phenyl)-butyl)-p~eerid-2-yl)-ethyl]-6~7-dimethoxy-l-oxo-1,2~3~4-tetrahYdr isoquinoline-hYdrochloride Prepared from 2-[2-(piperid-2-yl)-ethyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-4-(4-methoxy-phenyl)-butane analogously to Example 1.
Yield: 42.8~ of theory, Melting point: 107-112C
Calculated: C 67.36 ~ 7.99 N 5.42 Cl 6.86 Found: 67.16 8.055.35 7.34 Example 65 2-[2-(N-(3-(3,5-Dimethoxy-phenoxy)-propyl)-piperid-2-yl)-ethyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hydrochloride ;;

Prepared from 2-[2-(piperid-2-yl)-ethyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,5-dimethoxy-phenoxy)-propane analogously to Example 1.
Yield: 56.3% of theory, Melting point: 127-132C
Calculated: C 61.41 H 7.64 N 5.10 Cl 6.46 Found:61.56 7.65 5.28 6.89 :
Example 66 . :: , 2-[2-(N-~3-~3,4-Methylenedioxy-phenoxy)-propyl)-piperid-2-yl)-ethyl]-6,7-dimethoxv-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[2-~piperid-2-yl)-ethyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-.

~ _. 133~93 ~ 99 ~ 27169-147 3-~3,4-methylenedioxy-phenoxy)-propane analogously to Example 1.
Yield: 49~ of theory, ~elting point: 118-120C
Calculated: C 63.09 H 7 . 00 N 5.26 Cl 6.65 Found: 62090 7.04 5.46 6.79 Example 67 2-[(N-~3-~3~5-Dimethoxy-phenoxY)-propyl)-piperld- ;`-~
3-Yl)-methyl~-6,7-dimethoxv-1-oxo-1,2 ! 3,~-tetrahydro~
iso~uinoline-hydrochloride ~

Prepared from 2-l~piperid-3-yl)-methyll-6,7-dimethoxy- ~ rJ
l-oxo-1,2,3,4-tetrahydro-l~oquinoline and l-chloro-3-(3,5-dimethoxy-phenoxy)-propane analogou~ly to ;~
Example 1.
Yleld: 37.5% of theoey, Melting point: 98-102C
Caloula~ed: C 62.85H 7.35N 5.24Cl 6.63 Found: 62.81 7.41 5.10 6.75 ;~;

Example 68 -~
,, 2-l(N-~3-~3,!4-MethyIenedioxy-phenyl)-propyl)-piperid-3-yl)-methYll-6,7-dlmethoxy-1-oxo-1,2,3,4-tetrahydro~
i~oquinollne-hydrochlorlde Prep~red from 2-l~plperld-2-yl)-metkyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxy-phenyl)-propane analoqously to Example l.
Yield: 50% of theory, Melting point: 236-238C
Calculate~d: C 64.46 H 7.01 N 5~57 Cl 7.04 Found: 64.30 6.97 5.59 7.08 , ,,,, ., . ~ .

L3~99~

Examp~e 69 2-[(N-(3-(3,4-MethYlenedioxy-phenoxy~-propyl)-piperid-3-Yl)-methyll-6l7-dimethoxy-l-oxo-lr2~3~4-tetrahydr isoquinoline-hydrochloride : ' Prepared from 2-[(piperid-2-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-methylenedioxy-phenoxy)-propane analogously to Example 1.
Yield: 46.2~ of theory, Melting pointo 149-153C
Calculated: C 60.38 H 6.94 N 5.21 Cl 6.60 Found: 60.30 6.93 5.29 6.37 Example 70 2-[(N-(3-(2~6-Dimethyl-phenoxy~-propyl)-piperid- ~ ~;
3-yl)-methYl]-6~7-dimethoxy-l-oxo-l~2~3~4-t-etrahydro- ~ /Yi'~
isoquinoline-hydrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(2,6-dimethyl-phenoxy)-propane analogously to Example 1.
Yield: 53.3% of theory, Melting point: 131-135C
Calculated: C 66.85 H 7.81 N 5.57 Cl 7.05 ~ : -.
Found: 66.88 7.95 5.59 6.85 ~`

.`".'''.'.'.. '. .:.

` ~33~9~`3 ExamPle 71 2-[(N-(4-(2,4-Dichloro-phenoxy~-butyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride --Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro~isoquinoline and l-chloro-4-(2,4-dichloro-phenoxy)-butane analogously to ;~
Example 1.
Yield: 54.1% of theory, Melting point: 125-128C --~ -Calculated: C 58.12 H 6.32 N 5.02 Cl 19.06 Found: 58.21 6.38 5.08 18.85 Example 72 2-[(N-(2-(3,4-Dimethoxy-phenyl)-ethyl)-E~perid-3-yl)-mathYl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hYdrochloride ~"~

Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy-phenyl)-ethane analogously to Example 1.
Yield: 57.5% of theory, Melting point: 118-121C
Calculated: C 64.21 H 7.38 N 5.55 Found: 64.18 7.36 5.19 Example 73 2-[(N-(3-(3!4-Dimethoxy-phenoxy~-~ropyl)-piperid-3-yl)-methyl]-6,7-dimethoxv-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride .: .
Prepared from 2-[(piperid~3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-~ .
~'" ~ ' '"~' , ` , ~ lb ~ - , 133099~
3-(3,4-dimethoxy-phenoxy)-propane analogously to Example 1.
Yield: 62.5~ of theory, Melting point: 112-115C ~
Calculated: C 60.80 H 7.47 N 5.24 ~:
Found: 60.65 7.69 5.27 Example 74 2-[(N-(3-(3~4-Dimethoxy-phenoxy)-propyl)-~iperid-3-Y1)-methyl]-6~7-methylenedioxy-1-oxo-1,2~3,4-tetrah~dro~
isoquinoline-hydrochloride ~ ~ -Prepared from 2-[(piperid-3-yl)-methyl]-6,7-methylenedioxy-. .~.^r ~ 4;~
1-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(3,4-dimethoxy-phenoxy)-propane analogously to Example 1.
Yield: 60~ of theory, ~ -Melting point: 97-100C
Calculated: C 60.38 H 6.94 N 5.40 Cl 6.60 Found: 60.20 6.97 5.21 6.83 Example 75 . -2-[(N-(2-(4-Methoxy-Phenyl)-ethyl)-piperid-3-Yl)-methyl]-6,7-methYlenedioxY-l-oxo-1,2,3,4-tetrahYdro-isoquinoline-hYdrochloride , '~
Prepared from 2-[(piperid-3-yl)-methyl]-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-2-(4-methoxy-phenyl)-ethane analogously to Example 1.
Yield: 71.4~ of theory, Melting point: 195-197C
Calculated:C 62.94H 6.97 N 5.87 Cl 7.73 Found: 62.90 6.98 5.68 8.04 '.','"''"'' ~ '. ''` ~
Example 76 ~ ~

, ~ . .
' ' ~' ''': "

: : ~ . .:

~` 133~
- 103 - ~
2-[(N-(2-(3,4-DimethoxY-phenyl)-ethyl)-piPerid- , r.
3-Yl)-methyl]-6~7-dimethyl-l-oxo-l~2~3~4-tetrahydr isoquinoline-hydrochloride .: . .:
Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethyl-l-oxo-1,2,3,4-te~rahydro-isoquinoline and l-bromo-2-(3,4-dimethoxy-phenyl)-ethane analogously to Example 1.
Yield: 41.9% of theory, Melting point: 132-134C
Calculated: C 63.57 H 8.10 N 5.49 Cl 6.95 Found: 63.70 8.26 5.45 7.13 Example 77 '., : .:~
2-[tN-(3-(4-Methoxy-phenoxy)-propyl)-piperid-3-yl)-methY-]-6~7-dimethyl-l-oxo-l~2~3~4-~etrahydr isoquinoline-hYdrochloride Prepared from 2-[(piperid-3-yl)~methyl]-6,7-dimethyl-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(4-methoxy-phenoxy~-propane analogously to Example 1.
Yield: 57.8% of theory, Melting point: 144-146C
Calculated:C 68.55H 7.88N 5.92Cl 7.49 Found: 68.45 7.80 6.11 7.33 , Example 78 : , 2-[(N-(3-(3-Methoxy-phenoxy)-Propyl)-piperid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hYdrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 1-chloro-3-(3-methoxy-phenoxy)-propane analogously to Example 1.
Yield: 32.5% of theory, ~
Melting point: 142-145C `~ ~' ~ ~33~993 Calculated:C 60.58H 6.95 N 5.52Cl 6.99 Found: 60.426.92 5.50 7.18 Example 79 2-[(N-(3-(3-MethYl-phenoxY~-propyL)-piperid-3-y~
methyl~-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-methylenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(3-methyl-phenoxy)-l-chloro-propane analogously to Example 1.
Yield: 31.6~ of theory, Melting point: 178-180C
Calculated: C 63.59 H 6.97 N 5.70 Cl 7.22 ~ -~
Found: 63.59 6.92 5.86 7.50 . .
Example 80 2-[(N-(3-(4-Methoxy-~-methyl-phenylamino)-Propyl)-i~erid-3-Yl)-methYll-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoIine-dihydrochloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethoxy- ~-l-oxo-1,2,3,4-tetrahydro-isoquinoline and l-chloro-3-(4-methoxy-N-methyl-phenylamino)-propane analogously ~ ;
to Example 1.
Yield: 52.5~ of theory, Melting point: 180-183C
Calculated:C 60.64H 7.45N 7.58 Cl 12.79 -;~
Found: 60.50 7.35 7.56 12.87 .. .. ~;
''~ ~ "'' -"'., "..' ~: , ~33~99~

Example 81 2-[ tN-(3- t4-MethoxY-~henoxY)-propY1~-Pyrrolid-3-Yl)-methyll-6,7-dimethoxy-1-oxo-1,2,3 4-tetrahYdro-isoquinoline-hydrochloride .
Prepared from 6 7-dimethoxy-1-oxo-1,2 3 4-tetrahydro-isoquinoline and N-(3-(4-methoxy-phenoxy)-propyl~
3-benzenesulphonyloxymethyl-pyrrolidine analogously to Example 2.
Yield: 84.4~ of theory, Melting point: 142-144C
Calculated: C 63.60 H 7.18 N 5.71 Cl 7.22 Found: 63.75 7.12 5.64 7.32 ;,, ~, Example 82 2-[(N-(3-(6-Methoxy-naphthyl-2-oxy)-propyl)-pyrrolid- `
3-yl)-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline Prepared from 6,7-dimethoxy-1-oxo-1,2 3,4-tetrahydro-isoquinoline and 3-(p-toluenesulphonyloxymethyl)-N-(6-methoxy-naphthyl-2-oxy)-pyrrolidine analogously to Example 2.
Yield: 47% of theory, Melting pointo 142-144C
Calculated: C 71.41 H 7.19 N 5.55 Found: 71.14 7.16 5.53 Example 83 2-1(N-~3-(4-Methoxy-phenoxy)-Prop~ pyrrolid-3-Yl)-methyl]-6~7-dimethoxy-l~2~3~4-tetrahydro-isoquinoline dihYdrochloride Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3 4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3.

~330~3 Yield: 90.9~ of theory, Melting point: 248-250C
Calculated: C 60.81 H 7.46 N 5.46 Cl 13.81 Found: 60.79 7.61 5.48 13.84 -Exam~le 84 2-[(N-(3-(4-Methoxy-phenoxy)-propYl)-pyrrolid-3-Yl)-methyl]-6,7-dimeth~l-1-oxo-1,2,3,4-tetrahyaro-isoquinoline-hYdrochloride Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahyaro-isoquinoline and N-[3-(4-methoxy-phenoxy)-propyl]-3-benzenesulphonyloxymethyl-pyrrolidine analogously to Example 2.
Yield: 60.5% of theory, Melting point: 118-121C
Calculated: C 68.03 H 7.69 N 6.10 Cl 7.72 Found: 67.90 7.71 6.04 7.90 Exam~le 85 '', '".'.'.''''`.'`,"~' 2-[(N-(2-(3,4-Dimethoxy-phenyl)-ethyl)-pyrrolid-3-Yl)-methyl]-6~7-dimethoxy-l-oxo-l~2~3~4-tetrahydr isoquinoline-hydrochloride Prepared ~rom 6,7~dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(3,4-dimethoxy-phenoxy)-ethyl]- - - -3-benzenesulphonyloxymethyl-pyrro7idine analogously ~-~
to Example 2.
Yield: 56.7~ of theory, Melting point: 116-118C
Calculated: C 63.60 H 7.19 N 5.71 Cl 7.22 ;~
Found: 63.82 7.32 5.60 7.66 ~'.

',. ::, ,. -.

~ ` ` 133~993 F.xample 86 2-[(N-(3-(4-MethoxY-~henoxy)-propyl)-pyrrolid-3-~,)-methyl]-6~7-dimethyl-1,2,3,4-tetrahYdro-isoquinoline dihyarochloride .
Prepared from 2-[N-(3-(4-methoxy-phenoxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lil:hium aluminium hydride in tetrahydrofuran analogously to Example 3.
Yield: 90.9% of theory, Melting point: 243-2465C
CalculatedoC 64.85H 7.95N 5.82Cl 14.73 Found: 64.88 7.92 5.63 14.80 .
Example 87 : . .'"
2-[(N-(2-(3,4-Dimethoxy-phenyl)-ethYl)-pyrrolid-3-Yl)-methy~]-6,7-dimethoxy-1,2~3,4-tetrahYdro-isoquinoline-dihydrochloride Prepared from 2-t(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran analogously to Example 3. i~
Yield: 92.9% of theory, Melting point: 240-242C
Calculated: C 60.81 H 7.46 N 5.46 Cl 13.81 Found: 60.64 7.61 5.31 13.50 -Example 88 2-[(N-(3-(Pyrid-4-yl)-prop~l)-pyrrolid-3-yl)-methyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole-dihydrochloride-semihYdrate ~
:: .
Prepared from 2-[(N-(3-pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethyl-phthalimide and zinc/gl2cial acetic acid analogously to Example 4.

- I0~ 3 3 ~ 9 9 3 Yield: 65~ of theory, Melting point: 119-122C
Calculated: C 62.02 H 7.24 N 9.43 Cl 15.92 Found: 62.25 7.47 9.39 15.90 Example 89 2-[3-(N-(3-(PYrid-3-yl) -~ropYl) -PiPerid-3-yl)-propy-l]
5~6-dimethoxY-l-oxo-1~3-dihYdr--isoindole-dihydrochloride monohYdrate Prepared from 2-[3-(N-(3-tpyrid-3-yl)-propyl)-piperid-3-yl)-propyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid analogously to Example 4.
Yield: 72% of theory, '~
Melting point: 118-121C
Calculated: C 59.08 H 7.43 N 7.95 Cl 13.41 Found: 59.02 7.23 7.12 13.27 Example 90 2-~(N-(3-(Pyrid-3-Yl)-propyl)-Pi~erid-3-yl)-methyl]- -` ;
5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole-dihydrochloride-monohYdrate Prepared fro~ 2-[(N-t3-tpyrid-3-yl)-propyl)-piperld-3-yl)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial ;~
acetic acid analogously to Example 4.
Yield: 42% of theorY, Melting point: 91-96C
Calculated: C 59.08H 7.43N 7.95Cl 13.41 ~
Found: 59.02 7.23 7.12 13.27 ;

ExamPle 91 2-[(N-t2-t6,7-Dimethoxy-isoquinol~4-yl)-ethy~
piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihYdro- ,,'~
isoindole ~3~93 Prepared from 2-[(N-(2-~6,7-dimethoxy-isoquinol-4-yl)-ethyl)-piperid~3-yl)-methyl]-5,6-dimethoxy-phthaLimide and zinc/glacial acetic acid analogously to Example 4.
Yield: 64% of theory, Melting point: 85-88C
Calculated: C 65.39H 7.19 N 7.88 Found~ 65.16 7.27 7.S3 Example 92 . .
2-[2-(N-(3-(Pyrid-4-yl)-propyl)-piperid-2-yl~-ethYl]-5,6-dimethyl-1-oxo-lL3-dihydro isoindole ~-Prepared from 2-[2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethyll-5,6-dimethyl-phthalimide and zinc/glacial acetic acid analogously to Example 4. -~
Yield: 73% of theory, Melting point: 103-104C
Calculated: C 76.68 H 8.49 N 10.73 Found: 76.57 8.54 10.60 ExamE~e 93 ~:

2-[(N-(3-(Pyrid-4-yl)-propyl)-pyrrolid-3-Yl)-methyl]-5~6-dimethyl-1~3-dihydro-isoindole-trihYdrochloride semihYdrate .- ..
Prepared from 2-[lN-~3-(pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 68% of theory, Melting range: 118-127C (amorphous) Calculated: C 59.03 H 7.54 N 8.98 Cl 22.73 Found: 58.93 7.48 8.84 22.92 Example 94 ~" ` 13309~3 2-[2-(N-(3-(PYrid-4-yl)-Propyl)-piperid-2-yl)-ethYl]-5,6-dimethyl-1,3-dihydro-isoindole Prepared from 2- E 2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-5,6-dimethyl-1-oxo-1,3-dihydro-isoindole and lithium aluminium hydride in tetrahydrofuran/ether ~ ` .
analogously to Example 3.
Yield: 70% of theory, ~ -:
Melting range: 135-148C (amorphous) Calculated: C 54.59 H 8.24 N 7~63 Cl 19.33 Found: 54.48 8.26 7.51 19.60 ~ . :

ExamPle-95 2-[(N-(Pyrid-4-yl-methyl)-~perid-3-~Yl)-methyl]- ~;
5,6-dimethoxY-1,3-dihydro-isoindole-trihydrochloride-trihYdrate Prepared from 2-[(N-(pyrid-4-yl-methyl)-piperid- - ~ ~-3-yl)-methyl]-5,6-dimethoxy-phthalimide and lithium a~uminium hydride in ether analogously to Example 3.
Yield: 68% of theory, : :-~
Melting range: 176-189C (amorphous) Calculated: C 49.76H 7.21 N 7.91 Cl 20.03 ~.
Found:49.93 7.12 8.00 20.44 ~.

~: ' ' `

- :
:...; ~.

33~3 Example_96 :, ' 2-[(N-(2-(6,7-Dimethoxy-isoquinol-4-yl_-ethy~-piperid-3-yl) -methyl]-5~6-dimethYl-l~3-dihydro-isoindole-dihydrochloride-semihydrate ~-Prepared from 2-[(N-(2-(6,7-dimethoxy-isoquinol-4-yl)-ethyl)-piperid-3-yl)-met:hyl]-5,6-dimethyl-l-oxo-1,3-dihydro-isoindole and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 22.7% of theory, Melting range: 222-236C (amorphous~
Calculated: C 62.22 H 7.20 N 7.50Cl 15.83 Found: 62.01 7.64 7.08 15.79 - -~
~ ;.' ~'' ~' Example 97 2-[(N-(Pyrid-4-yl-methYl)-piperid-3-yl)-methyl]-5,6-methylenedioxy-1,3-dihyd_o-isoindole-trihydrochloride-semihydrate : . .
Prepared from 2-[(N-(pyrid-4-yl-methyl)-piperid-3-yl)-methyl]-5,6-methylenedioxy-phthalimide and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3. ;
Yield: 55% of theory Melting range: 215-225C (amorphous) Calculated: C 53.68 H 6.22 N 8.94Cl 22.63 Found: 53.60 6.45 8.65 22.28 Example 98 ~ ~
2-[(N-(3-(Pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline-trihydro- ;
chloride-monohydrate 33~93 Prepared from 2-[(N-(3-(pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydro-furan/ether analogously to Example 3.
Yield: 63~ of theory, ~ -~
Melting point: 254-256C ~ ~
Calculated: C 58.71 H 7.80 N 8.56 Cl 21.66 -Found: 58.53 7.72 8.25 21.53 ExamPle 99 2-[!N-(PYrid-4-Yl-methyl)-piPerid- 3 yl)-methYl]~
6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-trihydro-chloride-dihYdrate -Prepared from 2-[(N-~pyrid-4-yl-methyl)-piperid~
3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- ~ -`
isoquinoline and lithium aluminium hydride in tetrahydro-furan/ether analogously to Example 3. ~ -Yield: 63~ of theory, Melting range: 158-169C lamorphous) Calculated: C 52.42 H 7.27 N 7.97Cl 20.18 Found: 52.55 7.49 7.57 20.25 Example 100 2-[2-(N-(3-(Pyrid-4-yl)-propyl)-piperid-2-Yl)-ethyl]-6,7-methYlenedioxy-1,2,3,4-tetrahydro-isoquinoline-trihYdrochloride-trihydrate Prepared from 2-r2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl~-ethyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro- `-~
isoquinolin~ and lithium aluminium hydride in tetrahydro-furan/ether analogously to Example 3.
Yield: 90~ of theory, `
Melting range: 108-119C (amorphous) Calculatad: C 52.58 H 7.41 N 7.36Cl 18.62 Found: 52.56 7.25 7.38 19.49 ~
- ': , `-```` . `` ` ` ~ 33~3 .

Example 101 ~ ~ -2-~(N-(3-~Pyrid-3-yl)-Pro~yl)-piperid-3-Yl)-methYl]-6,7-methylenedioxy-l,2,3,4-tetrahydro-isoqUinoline-dihyarochloride-monohy-drate Prepared from 2-[(N-(3-~pyrid-3-yl)-propyl)-piperid~
3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4~
tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 72~ of theory, Melting range: 126-138C (amorphous) Calculated: C 59.50 H 7.28 N 8.67 Cl 14.64 Found: 59.57 7.29 8.49 14.51 ~ ~
- ' ~, Example 102 ~;

2-[~N-(3-(Pyrid-3-yl)-propyl)-piperid-3-Yl)-methyl]-6~7-dimethyL-1~2~3~4-tetrahydro-isoquinoline-trihydro-chloride Prepared from 2-[(N-(3-(pyrid-3-yl)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydro-furan/ether analogously to Example 3.
Yield: 59~ of theory, Melting range: 138-154C (amorphous) Calculated: C 61.66 H 7.86 N 8.62 Cl 21.a4 Found: 61.53 8.00 8.64 21.35 ~, Example 103 2-~(N-(3-(Pyrid-4-Yl)-propyl)-p~_rolid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride-monohydrate 33a~s3 .:

Prepared from 6,7-dimethyl 1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(pyrid-4-yl)- ~ ~-propyl]-pyrrolidine analogously to Example 2.
Yield: 39~ of theory, ;
Melting range: 74-86C (amorphous) Calculated: C 61.53 H 7.53 N 8.97 C1 15.13 Found: 61.42 7.62 8.83 15.05 Example 104 2-[~N-(3-(Pyrid-3-Yl)-~ropyl)-piperid-3-yl)-methYl]- -~
6 r 7-dimethoxY-1-oxo-1,2,3,4-tet_ahYdro-isoquinoline-dihYdrochloride-monohYdrate Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(benzenesulphonyloxy-methyl-N-[3-(pyrid-3-yl)-propyl]piperidine in dimethylsulphoxide with potassium tert.butoxide analogously to Example 2.
Yield: 45% o theory, Melting range: 140-148C (amorphous) Calc. (x 2 HC1 x H2O): C 58.36 H 7.25N 8.16 Cl 13.78 Found: 58.35 7.32 8.04 13.65 Example 105 ..;.^, ~ ~ .
2-E3-(N-(3-(Pyrid-4-yl)-propyl)-piperid-3-yl)-propyl]
6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride-dihydrate Prepared from 2-[3-(piperid-3-yl)-propyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 4-(3-chloropropyl)-pyridine analogously to Example 1.
Yield: 48% of theory, Melting range: 85-96C (amorph) Calculated:C 57.84H 7.73N 7.49Cl 12.65 Found: 57.71 7.91 7.35 13.04 Example 106 " .:
: ~

~` ~
` 13~9~

2-[3-tN-t2-~6,7-Dimethoxy-isoquinol-4-yl~-ethYl)-pi~erid-3-yl)-propyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihYdrochloride-monohYdrate , Prepared from 2-[3-(pyrid-3-yl)-propyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 4-(2-chloroethyl1-6,7-dimethoxy-isoquinoline analogously to Example 1.
Yield: 34% of theory, Melting range: 162-171C (amorphous) Calculated: C 60.17 H 7.10 N 6.57 Cl 11.10 Found: 59.85 7.00 6.86 11.04 ExamPle 107 2-[(~-53-(Pyrid-3-yl)-propyl)-piperid-3-yl)-methYl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochlorîde ~ -Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4- ~ ~
tetrahydro-isoquinoline and 3-chloromethyl-N-[3- ~;
(pyrid-3-yl)-propyl]-piperidine analogously to Example 2.
Yield: 60~ of theory, Melting range: 194-196C (amorphous) Calculated: C 64.92 H 6.81 N 9.46 Cl 7.98 Found: 64.91 6.95 9.67 7.80 Example 108 ~'~
2-[(N-(Pyrid-4-Yl-methyl)-piperid-3~yl)-methYl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-dihydrochloride-monohydrate ' Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline in dimethylsulphoxide with potassium tert.butoxide and 3-chloromethyl-N-[pyrid-4-yl-methyl]-piperidine analogously to Example 2.

~33~3 Yield: 41% of theory, ~ -Melting range: 142-158C (amorphous) Calculated: C 56.78 H 6.83 N 8.63Cl 14.58 ~
Found: 56.45 6.59 8.66 14.62 ~-ExamPle 109 :.

2-[(N-(2-(6,7-Dimethoxy-isoquinol-4-yl)-ethyl)-piperid-3-yl)-meth~1]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahYdro-isoquino-line-dihydrochloride Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline in dimethylsulphoxide with potassium tert.butoxide and 3-chloromethyl-N-[2-(6,7-dimethoxy-isoquinol-4-yl)-ethyl]-piperidine analogously to Example 2.
Yield: 62% of theory, ~-~
Melting range: 148-162C ~amorphous) Calculated: C 64.27 H 7.01 N 7.49Cl 12.65 Found: 64.11 7.20 7.59 12.89 Example 110 2-L2-(N=~3-(PYrid- 4-Yl) -~ropYl)-~iperid-2-yl)-ethyl]-6~7-methylenedioxy-l-oxo-1~2,3~4-tetrahYdro-isoquinoline- ~ -~
dihYdrochloride-dihydrate Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4- -~
tetrahydro-isoquinoline and 2-(2-chloroethyl)-N-r3-(pyrid-4-yl)-propyl]-piperidine analogously ... ..
to Example 2.
Melting range: 115-128C (amorphous) Calculated: C 56.59 H 7.03 N 7.92 Cl 13.37 Found: ~ 56.61 6.90 7.8413.41 ` ` 133~93 - 1~7 -Example 111 2-[ (N- (3-tPyrid-3-~1)-propyl~-piperid-3-yl)-methyl]-6,7 dimethyl-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-dihYdrochloride-dihydrate Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline in dimethylsulphoxide with potassium tert.butoxide and 3-chloromethyl-N-[3-~pyrid-3-yl)-propyl]-piperidine analogously to Example 2.
Yield: 62% of theory, Melting range: 118-127C (amorphous~
Calculated: C 60.00 H 7.85 N 8.39 Cl 14.16 Found: 60.24 8.07 8.36 14.62 Example 112 2-~(N-(3-(Pyrid-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-6,7-methYlenedioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline-dih~drochloride Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4 tetrahydro-isoquinoline and 3-chloromethyl-N-[3-(pyrid-3-yl)-propyl]-pyrrolidine analogously to Example 2.
Yield: 26% of theory, Melting range: 102-113C (amorphous) Calculated: C 59.22 H 6.27 N 9.01 Cl 15.20 ~ ;~
Found: 59.27 6.49 8.92 14.48 ;~
::
Example 113 2-[(N-~3-(Pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methYl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazePine-dihydro~hloride Prepared from 7,8-methylenedic~xy-2-oxo-1,3-dihydro-2H-3-benzaze~pine and 3-chloromethyl-N-[3-~pyrid-4-' ~` .", ~"~.

~l3309~

yl)-propyl]-pyrrolidine analogously to Example 2.
Yield: 58~ of theory, - ~
Melting range: 132-141C (amorphous) ~ -Calculated: C 60.25 H 6.11 N 8.78Cl 14.82 Founa: 60.00 6.40 8.52 14.56 .`
Example 114 2-[(N-(3-(Pyrid-3-yl)-propvl)-piperid-3-Yl)-methyl]- `~
7,8-dimethoxY-2-oxo-1,3-dihydro-2H-3-benzazepine-....
dihydrochloride-dihydrate Prepared from 7,8-dimethoxy 2-oxo~1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[3-(pyrid-3-yl)-propyl]-piperidine analogously to Example 2.
Yield: 67% of theory, Melting range: 128-134C (amorphous) Calculated: C 57.34 H 7.21 N 7.71Cl 13.02 Found: 57.80 7.37 7.92 13.06 Example llS

3-[(N-(3-(Pyrid-3-yl)-proPYl)-piperid-3-Yl)-methYl]
7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine~
dihydrochloride-dihydrate -Prepared from 7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[3-(pyrid-3-yl)- ~ `
propyl]-piperldine analogously to Example 2.
Yield: 94% of theory, Melting range: 77-86~C (amorphousi Calculated:C 60.92H 7.67N 8~19Cl 13.83 Found: 60.75 7.60 8.37 13.72 .'' ' :
~'` ~,.
~.. ~ ,.

~'` ': ' ,~:

~ 133~93 Example 116 3-[2-(N-(3-(Pyrld-4-Yl)-propyl)-piperid-2-yl)-ethYl~-7,8-dimethyl-2-oxo-1,3-dihYdro-2H-3-benzazepine-dihydrochloride Prepared from 7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 2-(2-chloroethyl)-N-[3-(pyrid-4-yl)-propyl]-piperidine analogously to Example 2.
Yield: 94% of theory, Melting range: 118-130C ~amorphou~) Calculated: C 66.11 H 7.60 N 8.56 Cl 14.45 Found: 65.92 7.86 8.33 14.09 Example 117 , 3-[(N-(2-~6,7-Dimethoxy-isoquinol-4-yl)-ethyl)-piperid-3-Yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine-monohydrate Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2 3-benzazepine and 3-chloromethyl-N-[2-(6,7-dimethoxy-isoquinoL-4-yl)-ethyL]-piperidine analogously to Example 2.
Yield: 69% of theory, -Melting range: 85-96C (amorphous) ~ -Calculated: C 67.73 H 7.15 N 7.64 Found: 67.96 7.19 7.75 Example 118 3-[3-(N-(3-(Pyrid-3-yl)-propyl)-piperid-3-yl)-propyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazePine-dihydrochloride-monohYdrate Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-(3-chloropropyl)-N-[3-(pyrid-3-yl)-propyl]-piperidine analogously to Example 2.

-L33~39~

~ield: 72~ of theory, Melting range: 94-106~ (amorphous) Calculated: C 60.64 H 7.45 N 7.57 Cl 12.78 Found: 60.80 7.44 7.46 12.59 Example 119 3-[2-(N-(3-~Pyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-7,8-methylened_ oxY-2-oxo-l, 3-dihydro-2~-3-benzazepine-dihydrochloride-dihy~t~

Prepared from 7,8-methylenedioxy-2-oxo-1,3-dihydro-2~-3-benzazepine and 2-(2-chloroethyl)-N-13-(pyrid-4-yl)-propyll-piperidine in dimethylsulphoxide and potassium tert.butoxide analogously to Example 2.
Yield: 67% of theory, ~ ~
Melting range: 148-161C (amorphous) - ~ ~ -Calculated: C 57.56 H 6.87 N 7.74 Cl 13.07 Found: 57.72 7.03 7.61 13.62 Example 120 3-[(N-(Pyrid-4-yl-methyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3-dihYdro-2H-3-benzazepine dihYdrochloride-monohydrate Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[pyrid-4-yl-methyl]-piperidine in dimethylsulphoxide and potassium tert.butoxide analogously to Example Yield: 75~ of theory, Melting range: 113-127C ramorphous) Calculated: C 61.79H 7.13 ~ 9.01 Cl 15.20 Found:61.55 7.32 9.04 15.11 .' ` ~' .

.
:

,'' I A ' ~L33~3 Example 121 3-[(N- ( 3-(Pyrid-4-yl)-propyl)-pyrrolid-3-yl~-methY1~-7~8-methylenedioxy-2-oxo-l~3r4~5-tetrahyaro-2H
3-benzazepine-dihydrochloride-monohydrate Prepared from 3-[~N-(3-(pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro- ~-2H-3H-benzazepine and 10~ palladium/charcoal under a hydrogen pressure of 5 bar at ambient temperature analogously to Example 5.
Yield: 71% of theory, Melting range: 95-106C (amorphous) Calculated: C 57.83 H 6.67 N 8.43Cl 14.22 Found: 57.67 6.82 8.27 14.05 Example 122 3-[2-(N-(3-~Pyrid-4-yl)-propyl)-piperid-2-yl)-ethYl~
7,8-dimethyl-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazepine- -dihydrochloride-semihydrate ~ . ' Prepared from 3-[2-(N-(3-tpyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 10% palladium/charcoal under a hydrogen pressure of 5 bar at 80C analogously to Example 5. ;~
Yield: 73% of theory, Melting point: 236-238C
Calculated: C 64.65 H 8.04 N 8.37 Cl 14.14 Found: 64.91 8.02 8.2513.92 ^: ~ 133~3 ..
..

Example 123 3-[3-(N-t2-(2-Methyl-pYrid-6-yl)-ethyl)-piperid-3-yl)-propyl]-7,8-dimethoxY-2-oxo-l~3~4~5-tetrahydr 2H-3-benzazepine-dihydrochlori;de-monohYdrate -~

Prepared from 3-[3-(piperid-3-yl)-propyl)]-7,8-dimethoxy-2-oxo~1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(benzenesulphonyloxy-ethyl)-6-methyl-pyridine in dimethylsulphoxide with potassium carbonate at 120C analogously to Example 1.
Yield: 29% of theory, Melting range: 105-113C (amorphous) Calculated: C 60.42 H 7.78 N 7.55 Found: 60.68 7.50 7.42 Exam~le 124 3-[(N-(3-(Pyrid-3-yl)-pro~yl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro~2H-3-benzaze~e-dihydrochloride , ~ .
Prepared from 3-[(N-(3-(pyrid-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine by hydrogenation at 5 bar hydrogen pressure in ethanol with 10~ palladium charcoal at 70C analogously to Example 5.
Yield: 52% of theory, Melting range: 113-122C (amorphous) Calculated: C 61.17 H 7.30 N 8.23 Found: 61.31 7.50 8.28 , - `` . ` ~L33~3 .

Example 125 3-[(N-~2-(6,7-Dimethoxy-isoauinol-4-yl~-ethyl)-piperid-3-yl)-methYl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazePine x ~ H20 Prepared from 3-[(N-(2-(6,7-dimethoxy-isoquinol-4 yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine by hydrogenation at 5 bar hydrogen pressure with 10% palladium/charcoal in ethanol at 70C analogously to Example 5.
Yield: 50~ of theory, -Melting range: 82-86C (amorphous) Calculated: C 66.40 H 7.55 N 7.48 Found: 66.26 7.50 7.59 ~ ;

Example 126 3-[3-(N-~3-(Pyrid-3-yl)-propyl~-piperid-3-Y1)-propyl]- ~ ~ -7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-dihydrochloride-dihydrate '` ' ~':
Prepared from 3-~3-(N-(3-~pyrid-3-yl)-propyl)-piperid-3-yl)-propyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H~
3-benzazepine by hydrogenation at 5 bar hydrogen pressure with 10% palladium/charcoal in ethanol at 70C analogously to Example 5.
Yield: 64~ of theory, Melting range: 106-115C (amorphous) ~ -~
Calculated: C 58.53 H 7.89 N 7.31 Cl 12.34 Found: 58.46 7.61 7.14 12.57 ~ ' : ::

~; ` i33~93 Example 127 3-l(N-(3-(Pyrid-3-y~-eropyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrah~dro-2H-3-benzazepine-dihydrochloride-monohydrate Prepared from 3-[(N-(3 (pyrid-3-yl~-propyl~-piperid- ::
3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine at 5 bar hydrogen pressure with 10% palladium/charcoal in ethanol at 80C analogously to Example 5.
Yield: 81% of theory, Melting range: 126-138C (amorphous) CalculatedsC 58.58 H 6.88 N 8.19 Cl 13.83 Found:58.43 7.00 7.85 13.71 .

Example 128 ..
, ~ : ::
3-[2-(N-(3-(Pyrid-4-yl)-propyl)-piperid-2-Yl)-ethyl]-7,8-methy~enedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-dihydrochloride-monohydrate - "' Prepared from 3-[2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro- :~
2H-3-benzazepine at 5 bar hydrogen pressure with 10% palladiumjcharcoal in ethanol at 80C analogously ::
to Example 5.
Yield: 74% of theory, Melting range: 132-146C (amorphous) :-:
Calculated: C 59.31 H 7.08 N 7.98 Cl 13.46 .
Found: 59.18 7.41 7.80 13.25 .

~ ~ 3 3 ~

Example 129 3-[(N-(3=(Pyrid-3-yl)-Propyl)-piperid-3 Yl~-methyll-7 ! 8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzaze~ine-dihydrochloride Prepared from 3-[(N-~ 3-~pyrid-3-yl)-propyl~-piperid-3-yl)-methyll-7,8-dimethyl-2-oxo~1,3-dihydro-2H- ~:
3-benzazepine and 5 bar hydrogen pressure with 10~ palladium/charcoal in ethanol at 80C analogously to Example 5.
Yield: 54% of theory, Melting range: 92-105C (amorphou~
Calculated: C 62.90 H 7.92 N 8.46Cl 14.28 Found: 63.19 7.90 8.45 14.30 Example 130 ~;!r-~

3-[( N- ( 3-(Pyrid-4-yl)-propyl)-pyrrolid-3-yl)-methyl~-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride-monohydrate Prepared from 3-[(N-(3-(pyrid-4-yl) propyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 73% of theory, Melting range: 96-108C (amorphous~
Calculated: C 55.53 H 6.97 N 8.06Cl 20.42 Found: 55.06 7.28 7.77 20.07 ;

Example 131 3-[(N-(3-tPyrid-3-yl)-propyl)-piperid-3-yl)-methyl~
7,8-dimethoxy-1,3,4,5-tetrahYdro-2H-3-benzazepine-dihydrochloride `''`~'`~''''''' r~ ; ' `
` ~33~993 Prepared from 3-[(N-(3-(pyrid-3-yl)-propyl~-piperid-3-yl)-methyl~-7,8-dimethoxy-2-oxo-],3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 71~ of theory, ;~
Mielting point: 208-210C
Calculated: C 62.89 H 7.91 N 8.46 Cl 14.28 Found: 62.70 7.53 8.2214.50 Example 132 3-[2-(N-~3-(PYrid-4-yl)-propYl)-piperid-2-yl)-ethYl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride Prepared from 3-[2-(N-(3-(pyrid-4-yl)-propyl)-piperid-2-yl)-ethyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
~ield: 63% of theory, Melting range: 123-136C (amorphous) Calculated: C 58.81 ~ 7.21 N 7.91 Cl 20.00 Found: 58.51 7.41 7.92 19.86 Example 133 3-~(N-(3-(Pyrid-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride-semihydrate ;

Prepared from 3~[(N-(3-(pyrid-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3. `
Yield: 75~ of theory, Melting range: 126-138C (amorphous) Calculated: C 57.09 H 7.10 N 7.99Cl 20.22 ` ~330993 Found: 57.05 7.32 8.05 20.37 Example 134 . .
3-[2-(N-~3-~PYrid-4-yl)-pro~yl~-PiPerid-2-yl)-ethyl]-7,8-dimethyl-1,3,4,5-tetrahydro-2H-3-benzazepin~
_ihydrochloride Prepared from 3-[2-(N-(3-(pyrid-4-yl~-propyl~-piperid-2-yl~-ethyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride "'~ `'5'~
in tetrahydrofuran/ether analogously to Example 3.
Yield: 92~ of theory, Melting point: 180-182C
Calculated: C 62.96 H 8.22 N 8.16 Cl 20.65 Found: 63.00 8.29 8.1620.34 Example 135 ~ .
3-r(N-(3-(Pyrid-3-yl)-propyl)-piperid-3 yl)-methYl]-7,8-dimethyl-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride Prepared from 3-[(N-(3-(pyrid-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride -in tetrahydrofuran/ether analogously to Example 3. -Yield: 81% of theory, Melting range: 184-196C (amorphous~
Calcuiated: C 60.17 H 8.16 N 8.10Cl 20.49 -Found: 60.28 8.25 8.00 20.39 Example 136 .``'', '~:". '`' 3-L2-(N ~2-(6-MethoxY-naphth-2-yl)-ethyl)-piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride ~ ~33~93 ~
~. ~
- 128 - ~-Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-dimethoxy- -~
2-oxo~1,3,4,5-tetrahydro-2H-3-benzazepine and 2- -~
(6-methoxy-naphth-2-yl)-ethyl bromide analogously to Example 1.
Yield: 20~ of theory, Melting point: 158-160C
Calculated:C 69.48H 7.47 N 5.06Cl 6.41 Found: 69.40 7.56 5.17 6.62 ~
,.:
Example 137 ~
~ .'' :~`
3-[2-(N-~2-~5-~ethyl-6-methoxy-n~hth-2-yl)-ethyl)-piperid-2-Yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride ': ~
Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-dimethoxy- ~ ~ -2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl bromide analogously to Example 1.
Yield: 28~ of theory, Melting point: 140-143C
Calculated: C 69.88 H 7.64 N 4.94 Cl 6.25 - Found: 69.06 7.574.846.44 ~
~: ` :, ' Example 138 3-[2-(N-(2-(NaphthYl-l-oxy)-et~yl)-piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3j4,5-tetrahyaro-2H-3-benzazepine-hydrochloride Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-beniazepine and 2-. -. . .
(naphthyl-l-oxy)-ethyl bromide analogously to Example 1.
Yield: 27~ of theory, Melting pOillt: 146-148C ~-. . . -Calculated: C 69.06 ~ 7.29 N 5.20 Cl 6.58 Found: 69.00 7.075.31 6.68 " . ~33~3 :~ .

Example 139 3-[ 2- (N- ~2- (Naphth-l-Yl~ -ethYl)-piperid-2-yl)-ethyl]-7,8-dimethoxv-2-oxo-1,3,4,5-tetrahydro-2H-3-benZazepine- y;~
hydrochloride Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-di~ethoxy-2-oxo-1,3,4,5-tetrahydro-2~-3-benzazepine and 2- -(naphth-l-yl)-ethyl bromide analogously to Example 1.
Yield: 24% of theory, Melting point: 148-150C
Calculated: C 71.18 H 7.51 N 5.36 Cl 6.78 Found: 70.92 7.44 5.57 7.06 - .
Example 140 3-[2-(N-~4-(Naphthyl-2-oxy)-butyl)-~e_rid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-benzazepine-hydrochloride Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 4-(naphthyl-2-oxy)-butyl bromide analogously to Example 1.
Yield: 39% of theory, Melting point: 112-114C
Calculated: C 69.88 H17.64 N 4.64 Cl 6.25 Found: 69.69 7.5a 4.82 6.52 Example 141 -3-[2-(N-(2-(Naphth-2-yl)-ethyl)-piperid-2-yl)-ethyl]- ;
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benZazepine- - -hydrochloride Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphth-2-y:L)-ethyl bromide analogously to Example 1 Yield: 41~ of theory, ~` ~330~93 Melting point: 120-122C ~
Calculated: C 71.l8 H 7.51 N 5.36 C1 6.78 ~-Found: 71.10 7.31 5.40 7.05 ~-Example_142 3-[2-(N-((2-Methyl-naphth-l-yl)-methyl~-piperid- -~
2-yl?-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride Prepared from 3-[2-(piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5- etrahydro-2H-3-benzazepine and 1-chloromethyl-2-methyl-naphthalene analogously to Example 1.
Yield: 24~ of theory, Melting point: 144-146C
Calculated: C 71.18 H 7.51 N 5.36 Cl 6.78 Found: 70.93 7.38 5.48 6.89 "~ ' ' '~
Example 143 3-[(N-(2-(Naphth~2-Yl)-ethyl)-hexahydro-azepin-3-Yl)-methyl]-7~8-dimethoxy-2-oxo-l~3~4~s-tetrahydr 2H-3-benzazepine-hydrochloride Prepared from 3-[thexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphth-2-ylj-ethyl bromide analogously to Example 1.
Yield: 58~ of theory, Melting point: 204-205C
Calculated: C 71.18 H 7.52 N 5.36 Cl 6.78 Found: 71.41 7.51 5.35 6.50 ~` 133~93 Example 144 3-[(N-t2-(Naphth-2-Yl)-ethyl)-~iperid-3-yl)-methYl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazepine- - -hydrochloride Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro~2H-3-benzazepine and 2-~naphth-2-yl)-ethylbromide analogously to Example 1.
Yield: 35% of theory, Melting point: 239-240C
Calculated: C 70.78 H 7.33 N 5.50 Cl 6.96 Found: 7Q.70 7.10 5.46 7.15 . '':
Example 145 3-[(N-((NaPhth-2-yl)-methyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazePine ~-Prepared from 3-[~piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H 3-benzazepine and 2-bromomethyl-naphthalene analogously to Example -;

Yield: 27% of theory, Melting point: 176-177C ~ ~
Calculated: C 75.95 H 7.47 N 6.11 P - ~ -Found: 76.11 7.28 6.10 Example 146 3--[(N-(4-(NaphthYl-2-oxy)-butyl)-pipe~id-3-Yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride Prepared from 3-E(piperid-3-yl)-methyl]-7,8-dimethoxy- -2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 4- -~naphthyl-2-oxy)-butylbromide analogously to Example 1. ~
. .

~330993 Yield: 24% of theory, Melting point: 196-197C
Calculated: C 69.48 H 7.47 N 5.06 Cl 6.4l Found: 69.30 7.36 4.99 6.56 Example 147 3-[(N-(4-(Naphth-l-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hYdrochloride Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphth-l-yl)-ethyl bromide analogously to Example 1.
Yield: 18~ of theory, Melting point: 230-231C
Calculated: C 70.78 H 7.33 N 5.50 Cl 6.96 -~-Found: 70.71 7.07 5.67 6.99 Example 148 3-[(N-(2-(Naphthyl-l-oxy)-ethyl)-piperid-3-yl)~
methY1~-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazepine-hydrochloride ~ :.. . : .
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(naphthyl-l-oxy)-ethyl bromide analogously to Example 1.
Yield: 40% of theory, ~-Melting point: 214-215C
Calculated: C 68.62 H 7.10 N 5.34 Cl 6.75 Found: 68.40 7.10 5.21 6.77 Example 149 : ' 3-r(N-((2-Methyl-naphth-l-yl)-methyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride ` -`` 1330~93 - l33 -Prepared from 3-[(piperid-3-yl~-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 1-chloromethyl-2-methyl-naphthalene analogously to Example 1.
Yield: 67% of theory, Melting point: 242-243C
Calculated: C 70.78 H 7.33 N 5.50 Cl 6.96 Found: 70.50 7.22 5.34 6.89 ~`

Example 150 ~ ~
' '' '` .' 3-[(N-(2-(6-Methoxy-naphth-2-yl)-ethyl)-piperid-3-Yl)-methyl]-7~8-dimethoxy-2-oxo-l~3r4~5-tetrahydr 2H-3-benzazepine-hydrochloride -~

Prepared from 3-[~piperid-3-yl)-methyl]-7,8-dimethoxy- ~--2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2- ~ ~ -(6-methoxy-naphth-2-yl)-ethyl bromide analogously to Example 1. -~
Yield: 50% of theory, Melting point: 156-157~C
Calculated: C 74.07 H 7.62 N 5.57 Found: 73.90 7.55 5.64 Example 151 3-[(N-(2-(5-Methyl-6-methoxy-na~hth-2-yl)-ethyl)-piPerid-3-yl)-methyl]-7,8-dimethoxy-2-~xo-1,3,4,5-tetrahydro-2H-3-benzaze~ine-_ydrochloride `~
." ,~. .. .. ..
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy- ~``
2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2- `
(5-methyl-6-methoxy-naphth-2-yl)-ethyl bromide analogously to Example 1.
Yield: 53% of theory, Melting pOillt: 240-241C
Calculated: C 69.48 H 7.47 N 5.06 Cl 6.41 Found: 69.58 7.48 5.00 6.54 -` ~33~33 Example 152 2-[N-(2-(3,4-Dimethoxy-phenYl)-ethyl)-piperid-3-vl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihYdro-isoindole-hydrochloride Prepared from 2-[(piperid-3-yl)-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole and 2-t3,4-dimethoxy-phenyl)-ethyl bromide analogously to Example 1. -~
Yield: 68% of theory, Melting point: 225-226C
Calculated: C 63.60 H 7.18 N 5.20 Cl 7.22 Found: 63.61 7.30 5.70 7.44 -~

Example 153 ~ -2-[(N-(2-(6-Methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-5~6-dimethoxy-l-oxo-1~3-dihYdro-isoindole-hydrochloride ~ -Prepared from 2-[(piperid-3-yl)-methyl]-5,6-dimethoxy-l-oxo-1,3-dihydro-isoindole and 2-(6-methoxy-naphth- ~ ~x~
2-yl)-ethyl bromide analogously to Example 1. ~ -Yield: 75% of theory, Melting point: 234-236C
Calculated: C 68.16 ~ 6.90 N 5.48 Cl 6.94 -~
Found: 68.10 7.10 5.39 7.10 Example 154 ! ' ~ ' 2-[(N-(2-(Naphthyl-l-oxy)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-I,3-dihydro-isoindole-hYdrochloride ' ~ .. .
Prepared from 2-[(piperid-3-yl)-methyl]-5,6-dimethoxy-l-oxo-1,3-dihydro-isoindole and 2-(naphthyl-1-oxy)-ethyl bromide analogously to Example 1.
Yield: 60~ of theory, ~33~993 . ~ .
, Melting point: 150-152C
Calculated: C 67.66 H 6.69 N 5.63 Cl 7.13 Found: 67.50 6.76 5.74 7.54 ~ -Example 155 2-[(N-(2-(4-Methyl-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro~isoindole Prepared from 2-r~piperid-3-yl~-methyll-5,6-dimethoxy-l-oxo-isoindole and 2-(4-methyl-phenyl)-ethyl bromide analogously to Example 1. -~
. .
Yield: 57% of theo~y, -~
Melting point: 134-136C
Calculated: C 73.50 H 7.90 N 6.86 Found: 73.40 8.04 7.06 Example 156 2-[(N-(2-(3-Methoxy-phenYl)-ethYl)-pi~erid-3-Yl)-methyl] 5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole- -~
hydrochloride Prepared from 2-r(piperid-3-yl)-methyl]-5,6-dimethoxy-l-oxo-isoindole and 2-(3-methoxy-phenyl)-ethyl bromide analogously to Example 1.
Yield: 54% of theory, Melting point: 226-228C -~
Calculated: C 65.28 H 7.01 N 6.09 Cl 7.71 Found: 65.30 7.37 5.91 7.61 Example 157 .
2-[(N-(2-(S-Methyl-6-methoxy-naphth-2-yl)-ethyl)-... ~;
piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole-hydrochloride ^ 133~93 Prepared from 2-[(piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole and 2-(5-methyl-6-methoxy-naphth-2-yl~-ethyl bromide analogously to Example 1. -Yield: 38~ of theory, ~-Melting point: 214-216C
Calculated: C 68.62 H 7.10 N 5.33 Cl 6.75 Found: 68.94 7.23 4.98 6.61 Example 158 2-[(N~(2-(4-Nitro-phenyl)-ethyl)-piperid-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihYdro-isoindole- -hYdrochloride ~ -. - ~ :
Prepared from 2-[(piperid-3-yl)-methyl~-5,6-dimethoxy-l-oxo-1,3-dihydro-isoindole and 2-(4-nitro-phenyl)-ethyl bromide analogously to Example 1.
Yield: 79~ of theory, Melting point: 215-218C
Calculated: C 60.56 H 6.35 N 8.83 Cl 7.45 Found: 60.41 6.26 8.84 7.62 Example 159 3-[rN-(Z-(Thien-2-yl)-ethYl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazePine-hydrochloride ::
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy~
2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(2-bromo-ethyl)-thiophene analogously to Example 1.
Yield: 43% of theory, Melting point: 232-236C
Calculated- C 61.99 H 7.15 N 6.02 Cl 7.62 S 6.89 Found: 61.90 7.06 5.78 7.96 6.84 ~-~
, . . :
Example 160 ~--; ~3~993 ,~

3-[ (N- t2-(Thien-3-yl)-ethyl)-piperid-3-yl)-methyl~
7~8-dimethoxy-2-oxo-1,3~4~5-tetrahydro-2H-3-benzazepine- ~-.
hydrochloride -Prepared from 3-[(piperid-3-yl~-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-t2-bromo-ethyl)-thiophene analogously to Example 1.
Yield: 36~ of theory, Melting point: sinters at 75-80~, melts at 225-230C
Calculated: C 61.99 H 7.15 N 6.02 Cl 7.62 S 6.89 Found: 62.00 7.08 5.98 8.43 6.62 ExamPle 161 . .
3-[(N-(4-(Thien-2-yl)-butyl)-piperid-3-yl)-methyl]-.
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazePine- -hydrochloride '~ ":
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2- -~
(4-bromo-butyL)-thiophene analogously to Example 1. `
Yield: 68% of theory, Melting range: 190-196C
Calculated: C 63.33 H 7.56 N 5.68 Cl 7.19 S 6.50 Found: 63.18 7.72 5.72 7.29 6.59 Example 162 ~ -3-[(N-(2-(Benzo[b]fur-2-yl)-ethyl)-piperid-3-Yl)-methyl]-7,8-dimethoxy-2-oxo-1,2,3,4-tetrahYdro-2H-3-benzazepine-hydrochloride ~ `
: ~
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy- ;~
2-oxo-1,3,4,5-tetrahydro-2~-3-benzazepine and 2-(2-bromo-ethyl)-benzo[b]furan analogously to Example 1.
Yield: 22% of theory, Melting point: above 216C (decomp.) Calculated: C 67.39 H 7.07 N 5.61 : ~ , 33~3 Found: 67.14 7.36 5.53 Example 163 3-[(N-(2-(Benzo[~]thien-3-yl)-lethylj-piperid-3-Yl)-methyl]-7~8-dimethoxy-2-oxo-l~3~4~5-tetrahydro- ;~
2H-3-benzazepine-hydrochloride Prepared from 3-[(piperid-3-yl~-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(2-bromo-ethyl)-benzo[b]thiophene analogously to -~
Example 1.
Yield: 73~ of theory, ;~
Melting range: 70-75C (decomp.) Calculated: C 65.29 H 6.85 N 5.44 Found: 65.10 6.87 5.73 --Example 164 3-[(N-(2-(4-Methoxy-benzo[b]thien-3-yl)-ethyl)-piperid-3-yl)-methYl]-7,8-dimethoxy-2-oxo-1,3,4~5 tetrahYdro-2H-3-benzazepine-hydrochloride ~ ~ , '" ?. ~ .
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(2-chloroethyl)-4-methoxy-benzo[b]thiophene analogously to Example 1.
Yield: 25% of theory, Mel~ing range: 85-105 (decomp.) Calculated: C 63.96 H 6.84N 5.14Cl 6.50S 5.88 Found: 63.95 6.85 4.99 6.53 5.75 Example 165 3-[(N-(2-(6--Methylsulphonyloxy-benzo[b]thien-3- ~ ~;
yl)-ethyl)-piperid-3-yl)-methyl]-7~8-dimethoxy-2-oxo 1,3,4~5-tetrahydro-2H-3-benzazepine-hydrochlori~de ~33~993 ~

Prepared from 3-[(piperid-3-yl~-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3~
[2-(methylsulphonyloxy~-ethyl]-6-methylsulphonyloxy-benzo~b]thiophene analogously to Example 1.
Yield: 55% of theory, Melting point: 90C tdecomp.) ~alculated: C 57~18 H 6.12N 4.60Cl 5.82S 10.53 Found: 57.25 6.14 4.50 5.97 10.36 Example 166 , 3-[~N-(5-rThien-2-yl)-pentyl)-eiperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine~
. :., ~
hydrochloride ~ ~
. .
Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(5-methylsulphonyloxy-pentyl)-thiophene analogously to Example 1.
Yield: 39~ of theory, Melting point: 177C
Calculated: C 63.95H 7.75N 5.52Cl 6.99S 6.32 Found: 63.70 7.92 5.40 7.24 6.62 Example 167 :
3-rtN-(2-(Fur-2-Yl)-ethYl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(2-methylsulphonyloxy-ethyl)-furan analogously to Example 1.
Yield: 44% of theory, Melting range: 205-215C
Calculated: C 64.20 H 7.41 N 6.24 Cl 7.90 Found: 64.007.45 6.00 7.80 `~` ` 133~3 Exam~e 168 3-[(N-(3-(Fur-2-yl)-propY1)-piperid-3-yl)-methyl-7~8-dimethoxy-2-oxo-1~3~4~5-tetrahydro-2H-3-benzazePine hvdrochloride ' Prepared from 3-[~piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(fur-2-yl)-propionaldehyde anaLogously to Example 9.
~ield: 11% of theory, Melting point: 201-206C
Calculated: C 64.85 H 7.62 N 6.05 Cl 7.66 Found: 64.88 7.76 5.93 7.55 Example 169 3-[(N-(6-(Thien-2-yl)-hexyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazePine-hydrochloride Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 2-(6-methylsulphonyloxy-hexyl)-thiophene analogously to Example 1. -~
Yield: 27~ of theory, Melting point: 160C
CaLculated: C 64.39H 8.10N 5.40 Cl 6.79 Found: 64.55 7.90 5.23 7.00 Example 170 3-~(N-(3-(Indol-3-yl)-propyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-~etrahydro-2~-3-benzaze~ine-hydrochloride Prepared from 3-[(piperid-3-yl)-methyl]-7,8-dimethoxy- ~ ~
2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3- ~ -!3-methylsulphonyloxy-propyl)-indole analogously to Example 1.
, ~ ~33~93 Yield: 19% of theory, Melting point: greater than 80C (decomp.
Calculated: C 60.42 H 6.30 N 6.45 Found: 60.32 6.57 6.67 ~;

Example 171 ~.. ' 3-[(N-(2-tIndol-3-yl)-ethYl)-piperid-3-yl)-methyl~-7r8-aimethoxy-2-oxo-l~3~4~s-tetrahydro-2H 3-benzazepine-hydrochloride Prepared from 3-[~piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3- ;~
(2-methylsulphonyloxy-ethyl)-indole analogously to Example 1.
Yield: 23% of theory, Melting point: greater than 80C (decomp.) Calculated: C 65.53 H 6.42 N 7.69 Found: 65.33 6.55 7.80 2-[(N-(3-(Naphthyl-2-oxy)-propyl)-hexahYdro-azepin- ~-3-yl)-methYl]-6~7-methylenedioxy-l-oxo-l~2~3~4-tetra hydro-isoquinoline Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-[N-(3-naphthyl-2-oxy)-propyl]-hexahydro-azepine analogously ;
to Example 2.
Yield: 21% of theory, Melting point: 74-76C
Calc. (x 2 H2O): C 64.45H 7.02N 5.01Cl 6.34 -Found: 64.32 7.20 5.28 6.44 :~

Example 173 ,: ,. ' 2-[(N-(3-(Naphth-2-Yl)-propyl)-p~rrolid-3-yl) -methYlL-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline 33~993 , Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulphonyloxymethyl)-N-[3-(naphth-2-yl)-propyl]-pyrrolidine analogously to Example 2.
Yield: 20% of theory, Melting point: 72-76C
Calc. (x H2O): C 72.41H 7.75N 5.82Cl 7.36 Found: 72.27 7.85 5.70 7.96 Example 174 .
2-[(N-(3-(5;6-DimethoxY-naphthyl-2-oxy)-propyl)-~yrrolid-3-Yl)-meth~l]-6~7-dimethoxy-l-oxo-l~2~3t4 tetrahYdro-isoquinoline-hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulphonyloxymethyl)-N-[3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl]-pyrrolidine analogously to Example 2.
Yield: 9.5~ of theory, Melting point: 60-63C
Calc. (x H2O): C 63.20H 7.01N 4.75Cl 6.02 Found: 63.40 7.04 4.49 6.38 ~ ~
: .
Example 175 2-[(N-(3-(5,6-Dimethoxy-naphthyl-2-oxy~-E~ropyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulphonyloxymethyl)-N-[3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl~-hexahydro-azepine analogously to Example 2. ~
Yield: ~3.2~ of theory, ~--Melting point: 199-201C
Cal~ulated: C 66.15 H 7.23 N 4.67 Cl 5.92 Found: 65.99 7.00 4.44 6.02 ,'. ~:

33~993 Example 176 2-[~N-(3-(5,6-DimethoxY-na~hthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methY1]-6 ! 7-dimethoxy-1,2,3,4-tetrahydro-lsoquinoline~dihydrochloride ~;

Prepared from 2-~ tN-(3- (5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-6,7-dimethoxy-l-oxo-l, 2, 3, 4-tetrahyaro-isoquinoline and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 86.3~ of theory, Melting point: 114-116C
Calculated: C 61.97 H 7.56 N 4 . 38 Cl 11.08 -Found: 62.05 7.65 4.06 10.84 Example 177 2-~(N-(2-(4-Methoxy-phenyl)-ethYl)-pyrrolid-3-yl)-methyl]-6,7-methYlenedioxy-1,2~3,4-tetrahydro-isoquinoline~
dihydrochloride Prepared from 2-[(N-(2-(4-methoxy-phenyl)-ethyl)- -~
pyrrolid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride/tetrahydrofuran analogously to Example 3.
Yield: 86.7~ of theory, ~-Melting point: 213-215C
Calculated: C 60.49 H 6.98 N;5.87 Cl 14.88 Found: 60.59 6.96 5.84 14.98 Example 178 2-[tN-(3~(3~4-Dimethoxy-phenoxy)-propyl)-pyrrolid 3-yl)-methyl]-6,7~methylenedioxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hydrochloride .
:

~33~9~ _ - 14~ - 27169-1~7 Prepared from l-oxo~1,2,3,4-tetrahydro-6,7-methylenedioxy-~oquinoline and N-[3-~3,4-dimethoxy-phenoxy)-propyl]-3-benzo~ulphonyloxymethyl-pyrrol~dine analogou ly to Example 2.
Yield: 57.4% of theory, Meltlng point: 108-110C
Calculated: C 59.76 ~ 6.74 M 5.35 Cl 7.02 Found: 60.07 6~87 5.23 7.61 ' ~xamplq 179 2-[~N-~2-(4-Methoxy-phenyl~-ethYl) pYrrolid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahYdro-isoquinoline-hydrochlorlae - ~ ~
Prepared from l-oxo-1,2,3,4-tetrahydro-6,7-methyl~ne-dloxy-i30quinoline ~nd N-[2-(4-methoxyphenyl)-ethyl~-3-benzenesulphonyloxymethyl-pyrrolldine analogously to Example 2.
Yield: 54.7~ of theory, Melting point: 105-108C
Calculated: C 62.26 R 6~74 N 6.05 Cl 7.97 Found:62.34 6.74 5.88 8.05 ~ --. , ...,~, :. , .
:, ~`'~;', ' ' ~;,' `~ ~33~3 .

Example 181 3-[ (N- (2- ~6-~ethyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl~-methyll-7,8-dimethyl 1,3,4,5-tetrahydro-2H-3-benzazepine x 2.5 ~Cl x H2O

Prepared from 3-[~N-(2-(6-methyl-pyrid-2-yl)-ethyl)~
pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in diethylether and tetrahydrofuran analogously to Example 3.
Yield: 50% of theory, Melting point: 80-91C amorphous Calculated: C 61.68 H 8.18 N 8.63 Cl 18.21 Found: 61.55 8.36 8.44 18.10 Fxample 182 3-[(N-(2-(6-Methyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-di_ethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-dihvdrochloride-semihydrate Prepared from 3-[(N-(2-(6-methyl-pyrid-2-yl)-ethyl)-pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine with 10~ palladium/charcoal at -~
5 bar hydrogen and at 80C in ethanol analogously to Example 5.
YieId: 92~ of theory, Melting point: 86-94C amorphous Calculated:C 63.41H 7.66N 8.87Cl 14.97 Found: 63.52 7.14 8.81 14.94 ~ ' :` :' .,`, .
Example 183 ~ .
2-[(N-(3-(6-Methoxy-naphthyl-2-oxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4~tetrahydro-isoquinoline ' 33~993 Prepared from 6,7-dimethoxy-1-oxo-1,2, 3, 4-tetrahydro-isoquinoline and 3-(p-toluenesulphonyloxymethyl)-N-[3-~6-methoxy-naphthyl-2-oxy)-propyl]-pyrrolidine analogously to Example 2.
Yield: 44.7~ of theory, Melting point: 102-104C
Calculated: C 76.24 H 7.68 N 5.93 Found: 75.90 7.62 5.94 Example 1_4 -2-[(N-(3-(6-Methoxy-naph~hyl-2-oxy)-propyl)-~yrrolid 3-Yl) -methyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline Prepared from 2-[N-(3-(6-methoxy-naphthyl-2-oxy~
propyl)-pyrrolid-3-yl)-me~hyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and l~thium aluminium hydride in ~etrahydrofuran and ether analogously to Example 3.
Yield: 68% of theory, -Melting point: 106-108C
Calculated: C 73.44 H 7.82 N 5.71 Found: 73.26 7.72 5.81 Example 185 3-[(N-(3-~Indol-3-~l)-propyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-monohydrate Prepared from 3-[(N-~3-(indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3-dihydro-2H-3-benzazepine with 20% palladium/charcoal at 5 bar hydrogen in ethanol at 80C anaLogously to Example 5.
Yield: 40% of theory, Melting ranc1e: 67-74C

` " 133~993 Calculated:C 69.95H 7.17N 9.06 Found: 70.00 7.03 8.97 Example l86 ~ ' 3-[(N-(2-(6-Methyl-~Yrid-2-yl~-ethyl~-pyrrolid-3-yl~-methyl]-7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine-dihydrochloride-semihydrate Prepared from 7,8-dimethyl-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[2-(6-methyl-pyrid-2-yl)-ethyl]-pyrrolidine analogously to Example 2.
Yield: 81% of theory, Melting point: 86-98C amorphous Calculated: C 63.68 H 7.27 N 8.91 Cl 15.04 Found: 63.39 7.43 8.87 14.93 ~-:-. .. ~
Example 187 2- r (N-~3-(3-MethYlphenoxy)propyl)-piperid-3-yl)-methYl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro- ~ `
isoquinoline-hYdrochloride -~
' .'.:
Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methylphenoxy?-propyl]~
3-benzenesulphonyloxymethyl-piperidine analogously to Example 2.
Yield: 75.6% of theory, Melting Point: 106-109C amorphous -Calculated: C 63.95 H 7.75 N 5.52 Cl 7.25 Found: 64.66 7.91 5.48 7.28 Example 188 2-[lN-(2-15-Methyl-6-methoxy-na~hth-2-yl)-pyrrolid-3-Yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-.
tetrahydro-isoquinoline-hYdrochloride ~. ' ~ 33~93 - 1~8 -Prepared from 6,7-methylenedioxy-1-oxo--1,2,3,4-tetrahydro-iso~uinoline and 3-(p-toluenesulphonyloxy-methyl)-N-[2-t5-methyl-6-methoxy-naphth-2-yl~-ethyl]-pyrrolidine analogousLy to Example 2.
YieLd: 27.1~ of theory, Melting point: 249-251~C
Calculated: C 68.43 H 6.53 N 5.50 Cl 6.96 Found: 68.47 6.66 5.30 7.16 ExamPle 189 2-[~N-(3-(Naphth-2-yl)-propyl)-pyrrolid-3-Y1)-methyl]-6,7-dimethoxy-1-oxo-isoquinoline-hYdrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(p-toluenesulphonyloxymethyl)-N-[3-~naphth-2-yl) propyl]-pyrrolidine analogously to Example 2.
Yield: 20.2% of theory, Melting point: 84-86C
Calculated: C 67.88H 7.26N 5.46Cl 6.91 Found: 67.86 7.40 5.40 7.17 Example 190 ,~
2-[(N-(3-(3,4-DimethoxY-phenoxy)-propyl)-pyrrolid-3-Yl)-methYl]-6,7-dimethoxy-1,2,3,4-tetrahYdro-isoquinoline-dihydrochloride . : :
Prepared from 2-r(N-[3-(3,4-dimet4Oxy-phenoxy)- ~-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in diethyl ether and tetrahydrofuran analogously to Example 3.
Yield: 92.3% of theory, Melting point: 220-221C
Calculated: C 59.20 H 6.88 N 5.31 Cl 13.44 Found: 59.28 6.97 5.20 13.44 : "

.` 1330~g3 Example 191 ~ .
2-[(N-(2-(3,4-DimethoxYphenYl)-ethY1)-pyrrolid-3-~1)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-iso~uinoline Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro~
isoquinoline and N-[2-(3,4-dimethoxyphenyl)-ethyl]-3-benzenesulphonyloxymethyl-pyrrolidine analoqo~sly to Example 2.
Yield: 70~ of theory, - -Melting point: 168-170C
Calculated: C 73.90 H 8.11N 6.63 -~
Found: 73.96 8.11 6.55 Example 192 ~ : -2-[ (N- (3- (4-Methoxyphenoxy)-Propyl)-piperid-3-yl)- -methYl~-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahvdro-isoquinoline-hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxyphenoxy)-propyl]- -3-benzenesulphonyloxymethyl-piperidine analogously to Example 2.
Yield: 78.7~ of theory, Melting point: 98-102C
Calculated: C 63.08~ 7.51N 5.3SCl 7.02 Found: 62.87 7.69 5.16 7.28 :
Example 193 2-[(N-(3-(3-MethoxyphenoxY)-propY1)-piperid-3-yl)-methyl]-6,7--dimethoxy-1-oxo-1,2,3,4-tetrahYdro-., isoquinoline-hydrochloride : :,: :
Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methoxyphenoxy)-propyl]- -.,. ~, :. :

133~9~

3-benzenesulphonyloxymethyl-piperidine analogously to Example 2.
Yield: 87% of theory, Melting point: 103-105C
Calculated: C 64.21 H 7.38 N 5.55 Cl 7.02 Found: 64.00 7.55 5.37 7.12 Example 194 2-[(N-(3-(3-Methoxyphenoxy)-~ropyl)-piperid-3-yl)- -~
methyl]-6,7-dimethoxy-1,2,3,4-t:etrahydro-isoquinoline~
dihydrochloride ;~
.'1~4V` ' Prepared from 2-[tN-(3-(3-methoxyphenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in diethylether and tetrahydrofuran analogously to Example 3.
Yield: 95.4~ of theory, Melting point: 170-173C
Calculated: C 60.43 H 7.70 N S.22 Cl 13.21 Found: 60.50 7.71 4.91 12.97 Example 195 2-1(N-t2-(3,4-Dimethoxye__ny~)-ethyl)-pyrrolid-3-Yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline-dihYdrochloride ~ -~
: .
Prepared from 2-[(N-(2-(3,4-dimethoxyphenyl)-ethyl)- -pyrrolid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in diethylether and tetrahydrofuran analogously to Example 3.
Yield: 94.1% of theory, Melting point: 260-262C
Calculated: C 64.85 H 7.96 N 5.82 Cl 14.73 Found: 64.60 8.11 S.91 14.67 '`'-, ' . ' ,'':"' ~33~9~

~xample 196 ~ ;-2-[~N-t3-(6-Methoxy-naphthyl-2-oX~)-proPyl)-azaCYclo- ~
oct-3-yl)-methYl~-6~7-dimethox~-1-oxo-1,2,3,4-tetrahydro- ~ -isoquinoline-hydrochloride Prepared from 2-[(azacyclooct-3-yl)-methyl]-6,7-dimethoxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-6-methoxy-naphthalene analogously to Example 1.
Yield: 24.4% of theory, Melting point: 176-178C
Calculated: C 67.96 H 7.43 N 4.80 Cl 6.08 Found: 67.74 7.29 4.71 6.23 Example 197 .
3-[(N-(3-(Indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]
7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-hydrochloride ~ ~
.: ' ' :' Prepared from 3-l(pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,2,3,4-tetrahydro-2H-3-benzazepine and 3-(3-benzenesulphonyloxy-propyl)-indole analogously to Example 1.
Yield: 62% of theory, Melting point: 106-108C
Calculated:C 69.47H 7.91N 8.68Cl 7.32 Found: 69.57 7.80 8.67 8.51 . -',' ' .' . '~

:~

133~3 Example 198 3-[(N-(3~(6-Methoxy-naphthyl-2-oxy)-propyl)-hexahvdro- ;~
a~ein-3-yl3-methYl]-7,8-dimethoxy-1,2,3,4-tetrahYdro-2H-3-benzazepine ., ,r ;~i"~
Prepared from 3-[(N-(3-(6-methoxy-naphthyl-2-oxy3-propyl)-hexahydro-azepin-3-yl)~-methyl~-7,8-dimethoxy-1,2,3,4-tetrahydro-2-oxo-2H-3-benzazepine and lithium aLuminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 26.8~ of theory, Melting point: 98-100C
Calc. (x H20): C 71.97 H 8.42 N 5.09 Found: 72.07 8.23 5.10 . .'' Example 199 3-~(N-(3-(6-Methoxv-naphthyl-2-oxy~-propyl3-hexahydro-azepin-3-yl)-methYl~-l,2,3,4-tetrahydro-2-oxo-2H- -3-benzazepine Prepared from 3-[thexahydro-azepin-3-yl)-methyl]-1,2,3,4-tetrahydro-2-oxo-2H-3-benzazepine and 2- ~;
(3-chloropropoxy)-6-methoxy-naphthalene analogously to Example 1.
Yield: 45% of theory, Melting point: 109-111C
Calculated:C 72.50H 7.74N 5.12 Found: 72.35 7.68 4.93 - -: -~.,.:. :,.
Example 200 ;~
~ -.~: .:: :.:
,:.'- ~. .: ,:
2-~(N-(3-(-Methoxy-naphthyl-2-oxy)-pro~l)-hexahydro- -~ ~-azepin-3-yl)-methYl]-1,3-dihydro-5,6-dimethoxy~
isoindole 33~93 Prepared from 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl~-5,6-dimethoxy-phthalimide and lithium aluminium hydride in teteahydro-furan/ether analogously to Example 3.
Yield: 49.2% of theory, ~;
Melting point: 104-146C
Calculated: C 73.78 H 7.99 N 5.55 Found: 73.63 7.99 5.39 Exam~ 201 : .
3-[~N-(3-(Indol-3-yl~-propyl)-pyrrolid-3-Yl)-methYl]-7,8-dimethyl-1,3,4,5-tetrahydro-2H-3-benzazepine- ~
dihydrochloride-monohydrate ~ -Prepared from 3-[~N-~3-(indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-dimethyl-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 65~ of theory, Melting point: 168-170C
Calculated: C 66.39 H 8.16 N 8.29 Cl 13.99 Found: 66.29 8.44 8.08 14.08 Example 202 3- UN-(3-(6-Methoxy-naphthyl-2-oxy)-propyl)-hexahydro- ~ - -azepin-3-yl)-methyl]-1,3,4,5-tetrahYdro-7,8-methylenedioxy- ;~
2H-3-benzazePine ;;

Prepared from 3-[~N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl~-1,3,4,5~
tetrahydro-7,8-methylenedioxy-2-oxo-2H-3-benzazepine and lithium aluminium hydride/tetrahydrofuran/ether ~d analogously to Example 3.
Yield: 25% of theory, Melting poin~: 109-111C
Calculated: C 74.39 H 7.80 N 5.42 Found: 74.27 7.94 5.43 .

~33~93 Example 203 3-[ tN- ( 3-(6-Methoxy-naphthYl-2-oxy)-propYl)-hexahydro-azepin-3-yl)-methYl]-1,3,4,5-tetrahYdro-7,8-methylenedioxy-2-oxo-2H-3-benzazepine-hYdroch~oride Prepared from 3-[(hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-methylenedioxy-2~oxo-2H-3-benzazepine and 2-(3-chloropropoxy)-6-methoxy-naphthalene analogously to Exasnple 1.
Yield: 68.1~ of theory, Melting range: 104-108C
Calc. (x 2 H2O): C 65.46 ~I 7.38 N 4.79 Cl 6.06 Found: 65.60 7.25 5.01 6.43 , Example 204 2-[(N-(3-(6-Methoxy-naphthyl-2~oxy)-propyl)-hexahydro-azepin-3-yl~-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-r(hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloro-propoxy)-6-methoxy-naphthalene analogously to Example 1.
Yield: 18.2~ of theory, ~
Melting point: 65-67C `-Calc. (x H2O): C 65.19H 6.88 N 4~90 Cl 6.20 Found: 65.20 6.75 4.82 6.54 Example 205 ;

2-[(N-(3-(6-Methoxy-naphthyl-2-ox~)-~ropyl)-piperid-3-Yl)-methyl]-6~7-methylenedioxy-l-oxo-l~2~3~4 tetrahYdro-isoquinoline . .
Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(benzenesulphonyloxYmethyl)-:::, '. :"

~33~93 N-[3-(6-methoxy-naphthyl-2-oxy)-propyl]-piperidine analogously to ExampLe 2.
Yield: 5.3% of theory, Melting point: 144-146C
Calculated: C 71.69 H 6.82 N 5.57 Found: 71.52 6.62 5.46 ... .
Example 206 2-[~N-~3-(6-Methoxy-naphthyl-2-oxy)-~ropyl)-hexahYdro-azepin-3-yl)-methyl]-5,6-2imeth 1-1,3-dihy~ro-1-oxo-isoindole .
Prepared from 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethyl-phthalimide and æinc/glacial acetic acid analogously to Example 4. ~ ~ ~
Yield: 18.2~ of theory, --~ -Meltinq point: 232-234C
Calc. (x acetone): C 74.97 H 8.14 N 5.14 ~ -Found: 74.96 7.90 5.30 Example 207 :~' ~''. . :,,:.
2-[(N-(3-(6-Methoxy-naphthyl-2-oxy)-propyl)-hexahydro~
azepin-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-. : . . .
~ tetrahYdro-isoquinoline-hydrochloride ..: . ~ . .
Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloro-propoxy)-6-methoxy-naphthalene analogously to Example 1.
Yield: 17.3~ of theory, ~-Melting range: 68-73C
Calc. (x 2 H2O): C 67.06 H 7.93 N 4.46 Cl 6.66 Found: 67.05 7.73 4.88 6.18 ' Example 208 ~ ` ` 133~9~

2- [ (N- ( 3- (6-MethoxY-naEhthyl-2-oxy)-propyl~-piperid-3-Yl)-methyl]-6,7-dimethox~l-oxo-l,2,3,4-tetrahydro-isoquinoline Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(benzenesulphonyloxymethyl)-N-[3-(6-methoxy-naphthyl-2-oxy)-propyl~-piperidine analogously to Example 2.
Yield: 12.9% of theory, Melting point: 124-126C
Calculated: C 71.79 H 7.38N 5.40 ;
Found: 71.83 7.33 5.21 Example 209 .

3-[(N-(3-(5~6-Dimethoxy-naphthyl-2-oxy)-propYl)-hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahYdro-7,8-dimethoxy-2H-3-benzazepine -~
. .,, :,. .....
Prepared from 3-r(N-(3-(5,6-dimethoxy-naphthyl- Y~
2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2-oxo-2H-3-benzazepine and lithium aluminium hydride/tetrahydrofuran/ether analogously to Example 3.
Yield: 29.1% of theory, Melting point: 94-96C
Calculated: C 72.57H 8.24N 4.98 Founù: 72.56 9.35 4.94 . . .

~33~ 3 Example 210 2 - [ (N- ( 3-(6-Methoxy-naPhthyl-2--oxy)-propyl)-hexahydro-azepin-3-yl)-methy~ 3-aihydro-s~6-dimeth l-oxo-isoindole Prepared from 2-[ ( N- (3-(6-methoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)~methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid analogously to Example 4.
Yield: 20.5~ of theory, Melting point: 265-267C
Calc. (x 2 H2O): C 67.13H 7.63 N 5.05 Found: 67.11 7.64 5.07 Example 211 3-[(N-t3-(5,6-Dimethoxy~naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-_1)-methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2-oxo-2H-3-benzazepine Prepared from 3-[(hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2-oxo-2H-3-benzazepine and 2-(3-chloropropoxy)-5,6-dimethoxy-naphthalene analogously to Example 1.
Yield: 52.4% of theory, ~
Melting point: 129-131C ~ -Calculated: C 70.81 H 7.69 N 4.86 Found: 70.66 7.84 4.63 Example 212 2-[(N-(3-(5,6-Dimethoxy-naphthyl-2-oxy~-propyl)-hexahydro-azepin-3-yl~-methyl]-5,6-dimethoxy-1,3-dihydro-isoindole-dihydrochloride Prepared from 2-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-S,6-. .

3~93 dimethoxy-phthalimide and lithium aluminium hydride in tetrahydrofuran/ether analogously to Example 3.
Yield: 48.2% of theory, Melting range: 172-177C
Calc. tx H2O): C 61.43 H 7.41 N 4.47 Cl 11.33 ~ ~
Found: 61.50 7.7:L 4.59 11.45 ~ -Example 213 ',':"'';' " ' ~,',"' 2-[~N-(3-(5,6-Dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro~azepin-3-yl)-methyl]-5,6-dimethoxy-l dihydro-l-oxo-isoindole-hydrochloride Prepared fr~m 2-[(N-(3-(5,6-dimethoxy-naphthyl- ~ - -2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid ~ -analogously to Example 4.
Yield: 36.4% of theory, Melting range: 215-223~C
Calc. (x H2O): C 61.87 H 7.30 N 4.50 Cl 5.70 Found: 62.08 7.15 4.55 5.80 ~''-':~'' Exam~le 214 ~ ~

2-[(N-(3-(Indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]- ~ -5,6-dimethoxy-lr3-dihydro-isoindole-dihydrochloride- '~
monohydrate ;

Prepared from 2-1(N-(3-(indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-5,6-dimethoxy-phthalimide and lithium aluminium hydride in tetrahydrofuran analogously to Example 3. ;
~ield: 87% of theory, Melting point: 262-264C
CalcuLated: C 61.17 H 7.30N 8.23 Cl 13.89 ;~
Found: 61.34 7.267.92 13.90 ~ :.

~L 3 3 ~

Example 215 3-[ (N- (3-(5,6-DimethoxY-naphthyl-2-oxy)-propYl)-hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-dimethyl-2H-3-benzazepine-dihydrochloride Prepared from 3-[(N-(3-(5,6-dimethoxy-naphthyl-2-oxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-dimethyl-2-oxo-2~-3-benzazepine and lithium aluminium hydride/tetrahydrofuran/ether analogously to Example 3.
~ield: 76.9~ of theory, Melting range: 138-144C ;~
Calculated: C 67.64 H 8.01 N 4.64 Cl 11.74 Found: 67.73 8.26 4.4711.50 Example 216 3-[(N-(3-(5,6-Dimethoxy-naphthyl-2-ox~)-propyl)-hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-dimethyl-2-oxo-2H-3-benzazePine-hydrochloride Prepared from 3-[(hexahydro-azepin-3-yl)-methyl]-1,3,4,5-tetrahydro-7,8-dimethyl-2-oxo-2H-3-benzazepine and 2-(3-chloro-propoxy)-5,6-dimethoxy-naphthalene analogously t~ Example 1. ~
Yield: 47.5% of theory, -Melting range: gO-96C
Calc. (x H2O): C 68.15H 7.90N 4.67Cl 5.91 Found: 67.93 7.94 5.056.09 ~ . .

~ ~33~9~3 Example 217 2-[~N-(3-~5,6-Dimethoxy-naphth~1-2-oxy)-Propyl)-piperid-3-yl)-methyl~-6,7-methylenedioxy-1-oxo- ~':~,.. ,::,:
1,2,3,4-tetrahydro-isoquinolinle-hYdroc-hloride Prepared from 2-[(piperid-3-yl)-methyl]-6,7-methylenedioxy~
l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-5,6-dimethoxy-naphthalene analogously to Example 1.
Yield: 22.5~ of theory, Melting range: 93-98C
Calc. (x H2O): C 63.42H 6.69N 4.77 Cl 6.03 -~
Found: 63.59 6.80 4.70 6.28 ExamPle 218 ~
. . :-2-~(N (3-(5,6-DimethoxY-naphthyl-2-oxy)-propy~
pyrrolid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[(pyrrolid-3-yl)-methyl]-6,7-methylene- ~ ;
dioxy-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)-5,6-dimethoxy-naphthalene analogously --to Example 1.
Yield: 22.5% of theory, Melting point: 87-90C
Calc. (x H2O): C 62.87 H 6.50 N 4.88 Cl 6.18 Found: 62.72 6.38 4.93 6.30 Example 219 2-[(~-(3-~5,6-Dimethoxy-naphth~1-2-oxY)-propYl)-piperid-3-yl)-methyl]-6~7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride ~;~

Prepared from 2-[~piperid-3-yl)-methyl]-6,7-dimethyl-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-133~3 -chloropropoxy)-5,6-dimethoxy-naphthalene analogously to Example 1.
~ield: 21.3~ of theory, Melting range: 72-78C
Calc. (x ~2) C 67.30 H 7.59 N 4.90 Cl 6.21 Found: 67.44 7.74 5.06 6.53 Example 220 2-[(N-(3-(5,6-DimethoxY-naphthy~2-oxy)-propYl)~
hexahydro-azepin-3-yl)-methYl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 2-[(hexahydro-azepin-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 2-(3-chloropropoxy)~5,6-dimethoxy-naphthalene analogously to Example 1.
Yield 12~ of theory, !
Melting range: 84-90C
Calc. (x H20): C 67.73 H 7.73 N 4.78 Cl 6.06 Found: 67.64 7.81 4.94 6.20 Example 221 2-[(N-(2-(4-MethoxY-phenyl)-ethyl)-hexahydro-azepin-3-Yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4 tetrahYdro-isoduinoline-hvdrochloride Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-r2-~4-methoxy-phenyl)-ethyl]-3-chloromethyl-hexahydro-azepine analogously to Example 2.
Yield: 46.7% of theory, Melting point: 101-105C
Calculated: C 62.44 H 7.26 N 5.60 Cl 7.50 Found: 62.62 7.27 5.48 7.66 Exam~e 222 ` ''` 1~309~

2-[ (N- (3-(4-Methoxy-phenoxy)-propYl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenediox~ oxo-1,2,3,4-tetrahyaro-isoquinoline-hydrochloride Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine analogously to Example 2.
Yield: 43.8~ of theory, Melting point: 123-126C
Calculated: C 62.23 H 7.16 N 5.37 Cl 7.05 Found: 62.42 7.34 5.30 6.94 : :', ' - "
Example 223 ~;

2-1~N-(3-(4-Methoxy-phenoxy)-propyl)-hexahydro-azepin-3-yl~-methyl~-6~7-dimethyl-1-oxo-1~2~3~4-tetrahydro-isoquinoline-hydrochloride ~
. -Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-13-(4-methoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine analogously to Example 2.
Yield: 42~ of theory, Melting point: 172-173C
Calculated: C 69.04 H 8.07 N 5.75 Cl 7.28 Found: 69.06 8.25 5.57 7.39 Example 224 2-[(N-~3-(4-Methoxy-phenoxy)-propyl)-hexahydro- ~ ;
azepin-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(4-methoxy-phenoxy)-propyl~-3-chloromethyl-hexahydro-azepine analogously to Example 2. ~

.:

3 ~ 3 Yield: 63.3~ of theory, Melting range: 115-120C
Calculated: C 62.58 H 7.67 N 5.2l Cl 6.83 Found: 62.44 7.68 4.91 6.81 Example 225 2-~ (2-~4-Methoxy-phenyl)-etllyl)-hexahYdro-azepin-3-yl)-methYl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(4-methoxy-phenyl)-ethyl]-3-chloromethyl-hexahydro-azepine analogously to Example 2.
Yield: 51.6~ of theory, Melting point: 110-113C
Calculated: C 61.75 H 7.87 N 5.28 Cl 7.25 Found: 61.84 8.02 5.16 7.22 ;

Example 226 -2-[(N-(2-(3,4-Dimethoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methy~_-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hydrochloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[2-(3,4-dimethoxy-phenyl)-ethyl]-3-chloromethyl-hexahydro-azepine analogously to Example 2.
~ield: 45.5% of theory, Melting point: 107-111C
Calculated: C 62.61 H 7.69 N 5.21 Cl 6.60 Found: 62.78 8.00 5.00 6.43 :

Example 227 2-[~N-(2-(3~4-DlmethoxY-pheny~-3ethyl)-hexahydr azepln-3-vl~-methy~J-6,7-dimethvl-1-oxo-1,2,3,4-tetrahydro-l~oquinoline-hYdrochlorlde Prepared from 6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro- -isoquinollne and N-[2-~3,4-dimethoxy-phenyll-ethyl]-3-chloromethyl-hexahydro-azepine analogou~ly to .
Example 2.
Yiel~: 44.8% of theory, Meltlng point: 162-163C
Calculated:C 66.57~ 8.18N 5.54Cl 7.02 Found- 66.67 8.47 5.35 7.11 ' '`~'' ~ ~' "- . .....

'"' ! 1Y

r~
-165- 2716g-147 ExamPle 234 1330~3 ~
2-~(N-(3-(3-MethYl-PhenoxY)-proPyl)-hexahvdro-azepln 3-Yl)-methyll-6,7-methYlenedioxY-l-oxo-l~2~3~4 tetrahydro-isoquinoline-hYdrochloride Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3-methyl-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine analogously -- :
to Example 2. ~ ~

' ' '' ~ ~

~ ~330~3 ~

Yleld: 46.83 of theory, : :
~eltlng po~nt: 159-161~C
Calculated: C 65.37 H 7.31 N 5.64 Cl 7.28 Found: 65.44 7.40 5.397.23 Example 235 2-[~N-~3-(3-Methyl-phenoxy)-ProPyl)-hexahy~ro-az~Pin~
.......
3-Yl?-methY1]-6,7-dlmethoxy-1-oxo-1,2,3~ tetrahYdro- '~ :~
i~oqulnollne-hydrochlorlde ~. :
':
Prepared rom 6,7-dlmethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-~3-methoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine analogoudly to Example 2.
Yield: 55.2~ of th~ory, ;~
Melting point: 107-111C
Calculated:C 65.67H 7.87N 5.47Cl 7.05 ~ :
Found: 65~47 8.00 5.50 6.97 -: ' . ~.,- ;, ~`,'''',' ,'. '`.','".

~:'::, :

f~` ~ 3 3 ~

2-~(N-~3-f3,4-MQthyl~nedloxy-phenoxy)-propyl)-hexshyaeo-azepln-3-yl)-methyl1-6, 7-a lmethYl-l-oxo-t,2,3,4-tetrahYdro-l~oqulnollne-hydrochlorlde Pr~pared ~rom 6,7-dlmethyl-l-oxo-l,2,3,4-tetr~hydro- :
i~oqulnollne ~nd N-~3-~3,4-methylenedloxy-phenoxy)-propyl]-3-ohlorom~thyl-hexahydro-azepin~ analogou~ly :~
to ~xample 2.
Ylelds 40.6~ of theory, Meltlng polnt: 123-126C :
Calaulatedl C 64.78 ~ 7.57 N 5.39 :Cl 6.B3 ~: Foundt 64.~8 7.59 5.29 7.18 :
. . ~, ~, "

- . . ~
~!
" ~ .
. " `'' '' ~, ^

168~ 3 ~ 9~3 Example 237 '' ~, ' ' 2-~(N-(3-(3,4-Dimethoxy-PhenoxY)-propyl)-hexahYdro-azepin-3-yl)-methyl]-6,7-dimethoxv-1-oxo-1,2,3,4-tetrahydro-isoquinoline-hYdroclhloride Prepared from 6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and N-[3-(3,4-dimethoxy-phenoxy)-propyl]-3-chloromethyl-hexahydro-azepine analogously to Example 2.
Yield: 30.6~ of theory, Melting point: 101-105C
Calculated: C 62.61 ~ 7.59 N 5.01 Cl 6.46 Found: 62.56 7.76 4.94 6.39 -~

Example 238 2-[(N-(2-(3,4-Dimethoxy-phenYl)-ethY1~-hexahydro-azepin-3-Yl)-methYl]-5,6-dimethoxY-l-oxo-1,3-dihYdro-isoindole-h~drochloride Prepared from 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid analogously to Example 4.
Yield: 41.8% of theory, Melting point: 150-151C
Calculated: C 61.99 H 7.57 N 5.35 Cl 6.57 Found: 61.89 7.48 5.17 6.52 Example 239 2-~(N-(3-(3-Methyl-phenoxY)-propyl)-hexahydro-azePin-.~ . ~ . ..
3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole-hydrochloride Prepared from 2-[(N-(3-(3-methyl-phenoxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid analogously to Example 4.

` ~ ~ 133~93 Yield: 88.9% of theory, Melting point: 95-100C
Calculated: C 63.95 H 7.75N 5.52Cl 7.25 Found: 64.09 7.645.357.37 Example 240 2-[~N-~3-(4-Methoxy-phenoxy)-propyl?-hexahYdro-azepin-3-yl)-methyl]-5,6-dimethoxy-1-oxo-1,3-dihydro-isoindole-hYdrochloride Prepared from 2-[(N-(3-(4-methoxy-phenoxy)-propyl)- ~ ~
hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-phthalimide `
and zinc/glacial aceti~ acid analogously to Example 4.
Yield: 87.1~ of theory, Melting point: 107-112C
Calculated: C 61.99 H 7.51 N 5.35 Cl 7.02 Found: 62.07 7.375.287.31 Example 241 2-~N-(3-(3,4-Methylenedioxy-phenoxy)-propyl)-hexahyar azepin-3-Yl)-methyl]-5~6-dimethoxy-1-oxo-1,3-dihydro-isoindole-hyd~rochloride `~

Prepared from 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid analogously to Example 4.
Yield: 59~ of theory, Melting point: 104-107C
Calculated: C 60.38 H 6.94 N 5.20 Cl 7.31 Found: 60.40 7.154.957.25 ~ .

133~3 Example 2 4 2 2 - ~ ( N- ( 3-~3,4-Methylenedioxy-phenoxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-l~oxo-1,3-dihydro-isoindole-hydrochloride Prepared from 2-[(N-(3-(3,4-methylenedioxy-phenoxy)-propyl)-hexahydro-azepin-3-yl)-methyl]-5,6-dimethoxy-phthalimide and zinc/glacial acetic acid analogo~sly to Example 4.
Yield: 79.4% of theory, Melting point: 112-116C
Calculated: C 62.23 H 7.15 N 5.37 Cl 7.05 Found: 62.16 7.25 4.96 7.03 Example 243 -3- E (N-(3 (Pyrid-3-yl)-propyl)-hexahydro-aze~in-3-Yl)-methyl]-7~8-dimethoxy-2-oxo-l~3-dihydro-2H
3-benzazePine-dibydrochloride-dihYdrate .. ~-Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2 3-benzazepine and N-[3-(pyrid-3-yl)-propyl]-3-chloromethyl-hexahydro~azepine in dimethylsulphoxide with potassium tert.butoxide analogously to Example 2.
Yield: 86~ of theory, ~ ~
Melting point: 106-10&C ~ ;
Calculated: C 58.05 H 7.40 N 7.52 Cl 12.69 Found: 57.94 7.55 7.75 12.42 Example 244 .: .
3-[(N-(3-(Pyrid-3-yl)-propyl)-hexahYdro-azepin-3-yl)-methYl]-7,8-dimethoxY-2-oxo-1,3l4,5-tetrahYdro-2H-3-benzazepine-dihydrochloride-dibydrate Prepared from 3-[(N-(3-(pyrid-3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-`-~ ` 133~93 2H-3-benzazepine and 5 bar hydrogen in the presence of 10% palladium on charcoal in dimethylformamide at 80C analogously to Example 5.
Yield: 43% of theory, Melting point: 119-121C
Calculated: C 57.85 H 7.73 N 7.49 Cl 12.65 Found: 57.74 7.79 7.23 12.50 Example 245 3-[(N-(3-(Pyrid-3-yl)-ProE~yl)-hexahydro-azepin 3-yl)-methyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride-monohydrate Prepared from 3-[(N-(3-(pyrid-3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benæazepine and lithium aluminium hydride in tetrahydrofuran and diethylether analogously to Example 3. ~ ~-Yield: 82% of theory, ;- ~-~
Melting point: 139-141C
Calculated: C 57.39 H 7.85N 7.43Cl 18.82 ~
Found: 57.42 8.15 7.56 19.04 ~ ~ -Example 246 ~
, .
2-[(N-(Pyrid-3-Yl-methyl)-pyrrolid-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahy~ro-isoquinoline-dihydrochloride-dihYdrate Prepared from 6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-chloromethyl-N-[(pyrid-3-yl)-methyl]-pyrrolidine and dimethylsulphoxide with potassium tert.butoxide analogously to Example 2.
Yield: 46% of theory, Melting pOillt: 91-93C
Calculated: C 53.17H 6.16N 8.85Cl 14.95 Found: 53.31 5.93 8.71 15.01 .` '~:'''- . ,`

`- 133~9~

Example 247 2-[(N-(Pvrid-3-yl-methvl)-pYrrolid-3-yl~-methyl]-6~7-meth~leneaioxy-l~2~3~4-tetrahvdro-isoquinoline rihyarochloride - 1.5 x hydrat.e Prepared from 2-~(N-(pyrid-3-yl-methyl)-pyrrolid~
3-yl~-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in tetrahydrofuran and diethylether analogously to Example 3.
Yield: 67% of theory, Melting point: 178-181C
Calculated: C 51.70 H 6.41 N 8.61 Cl 21.80 Found: 51.63 6.62 8.45 21.07 - ~:
Example 248 3-[(N-(2-(6-Methyl-pyrid-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methv1]-7,8-dimethoxy-2-oxo-1,3-dihydro- ~;
2H-3-benzazepine-dihydrochloride-dihydrate Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and N-[2-(6-methyl-pyrid-2-yl)-ethyl]-3-chloromethyl-hexahydro-azepine in dimethylsulphoxide with pota~sium ter butoxide analosously to Example 2.
Yield: 63% of theory, MeIting point: 134-136C
Calculated:C 58.05H 7.40N 7.52Cl 12.69 Found: 58.15 7.60 7.45 12.45 ~.
Example 249 ~
. , 3-~(N-(2-(6-Methyl-pyrid-2-vl)-ethyl)-pyrrolid-3-yl)-methy~]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine-dihydrochloride x 1.5 hydrate , ~:
:. ' ' ~ ::

` ` L33~3 Prepared from 7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 3-chloromethyl-N-[2-(6-methyl-pyrid-2-yl)-ethyl]-pyrrolidine in dimethylsulphoxide with potassium tert.butoxide analogously to Example 2.
Yield: 61~ of theory, Melting point: 78-80C
Calculated: C 57.58H 6.96N 8.06Cl 13.60 Found: 57.40 7.18 8.24 13. 39 .:, Exam~le 250 3-[(N-~2-~6-Methyl-pYrid-2-yl)-ethyl)-hexahYdro-azePin-3-yl)-methyL]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine-dihydrochloride x 2.5 -hydrate Prepared from 3-[(N-(2-(6-methyl-pyrid-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 5 bar hydrogen ~ -in the presence of palladium/charcoal and dimethyl-formamide analogously to Example 5.
Yield: 34% of theory, Melting point: 112-114C
Calculated: C 56.93 H 7.78 N 7.38 Cl 12.45 Found: 56.83 8.04 7O43 12.26 Example 251 3-r(N-~2-(6-Methyl-pyrid-2-yl~-ethyl)-hexahydro-azePin-3-yl)-methyl]-7,8-dimethoxY-1,3,4,5-tetrahydro-2H-3-benzazepine-trihydrochloride-dihydrate Prepared ~rom 3-[(N-(2-(6-methyl-pyrid-2-yl)-ethyl)- ~-hexahydro-azepin-3-yl)~methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in tetrahydrofuran and diethylether analogously to Example 3.
Yield: 74~ of theory, ~ ~
'-'.' ,: ~' ''.''.'''''''`''''';'.~'' `,-` 133~3 .. ... .

Melting point: 148-150C ~ ;~
Calculated: C 55.61 H 7.95 N 7.20 Cl 18.24 Found: 55.72 8.10 7.03 18.00 Example 252 3-[~N-(2-(6-MethYl-pyrid-2-yl)-ethyl)-pyrrolid~
3-yl) methyl]-7,8-dimethoxY-2-oxo-1,3~4,5-tetrahYdro-2H-3-benzazepine-dihvdrochloride-dihydrate Prepared from 3-r(N-(2-(6-methyl-pyrid-2-yl~-ethyl)-pyrrolid-3-yl)-methyl]-7,8-dimethoxy~2-oxo-1,3-dihydro-2H-3-benzazepine and palladium/charcoal in dimethylformamide at 50C and 6 bar hydrogen pressure analogously to Example 5.
Yield: 28% of theory, -Melting point: 87-90C
Calculated: C 56.38H 7.38N 7.89Cl 13.31 Found: 56.33 7.53 8.09 13.43 Example 253 3-[~N-(2-~6-Meth~l-pyrid-2-yl)-ethyl)-pyrrolid-3-Yl)-methyl]-7~8 dimethoxy-1~3~4~5-tetrahyaro- ~ -2H-3-benzaze~ine-trihydrochloride-dihydrate Prepared from 7 t 8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin~ and N-[2-~6-methyl-pyrid-2-yl)-ethyl]-3-~benzenesulphonyloxymethyl)-pyrrolidine in dimethylformamide and triethylamine analogously to Example 2.
Yield: 42% of theory, Melting point: 225-227C
Calculated: C 54.10 H 7.62N 7.57Cl 19.16 -Found: 54.18 7.557~5119.30 m Example 254 133~3 , . .

2-[(N-(3-(Indol-3-yl)-propyl~-piperid-3-yl~-methyl]
5,6-dimethoxy-1-oxo-1,3-dih~dro-isoindole x 1.5 benzenesul~onate-trihydrate ~ .

Prepared from 2-[(piperid-3-yl)-methyl]-5,6-dimethoxy-l-oxo-1,3-dihydro-isoindole and 3-(3-benzenesulphonyloxy-propyl)-indole in dimethylformamide and triethylamine analogously to Example 1.
Yield: 45% of theory, Melting point: 87-89C
Calculated: C 58.51H 6.54N 5.68 Found: 58.66 6.43 5.34 Example 255 , :' ':
2-[ ~N- (3- ~Indol-3-yl)-pro~l)-piperid-3-yl)-methyl]
6,7-dimethyl 1-oxo-1,2,3,4-tetrahydro-iso~uinoline-benzenesulphonate-dihydrate ., ' Prepared from 2-[(piperid-3-yl)-methyl]-6,7-dimethyl- ~:
l-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(3-benzenesulphonyloxypropyl)-indole in dimethylformamide and triethylamine analogously to Example 1.
Yield: 94% of theory, Melting point: 117-119C
Calculated: C 65.46 H 7.27 N 6.73 Found: 65.51 6.91 6.72 -:

Example 256 -:~:~
,., "
3-[(N-(3-(Indol-3-Yl)-propyl)-pyrrolid-3-yl)-methYl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazepine-hydrochloride-monohydrate~
. :..'`
Prepared from 3-[(N-(3-(indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl~-7,8-dimethoxy-2-oxo-1,3-dihydro-2H-3-benzazepine and 5 bar hydrogen in the presence of palladiumjcharcoal in dimethylformamide at 80C
analogously to Example 5.

3~9~3 - 176 - ~
.
Yield: 58% of theory, - - --Melting point: 128-130C
Calculated: C 65.16 H 7.42 N 8.14 Cl 6.87 Found: 65.12 7.55 8.11 7.06 Example 257 .:
3-[(N-(3-(Indol-3-Yl)-propyl)-hexahydro-azepin-3-Yl)-methyl]-7~8-dimethoxY-2-oxo-1~3~4~5-tetrahYdr 2H-3-benzazepine-monohydrate Prepared from 3-[(hexahydro-azepin-3-yl~-methyl]~
7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benza~epine and 3-(3-benzenesulphonyloxy-propyl)-indole in dimethylformamide and triethylamine analogously to Example 1. -Yield: 49% of theory, -~-~
Melting point: 56-58C
Calculated: C 70.98H 8.14N 8.27 ;
Found: 71.08 8.10 8.16 Example 258 3-[(N-(3-(Indol-3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine-dihy~ochloride-monohydrate Prepared from 3-~(N-(3-(indol 3-yl)-propyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo 1,3,4,5- -tetrahydro-2H-3-benzazepine and lithium aluminium hydride in diethylether and tetrahydrofuran analogously to Example 3.
Yield: 56% of theory, Meîting point: 155-158C
Calculated: C 62.26 H 7.50 N 7.63 Cl 12.88 Found: 62.31 7.82 7.40 12.89 Example 259 ;
~':

~l33~3 - 177 - ~-3-r (N- (3- (Indol-3-yl)-propyl)-pyrrolid-3-yl)-meth 7,8-dimethoxy-1,3,4,5-tetrahYdro-2H-3-benzazePine-dihydrochloride-monohydrate Prepared ~rom 3-[(N-t3-~indol-3-yl)-propyl)-pyrrolid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and lithium aluminium hydride in diethylether and tetrahydrofuran analogously to Example 3.
Yield: 60~ of theory, Melting point: 125-128C
Calculated: C 62.44 H 7.67 N 7.80 Cl 13.16 -Found: 62.35 7.87 7.59 13.67 Example 260 :: -2-[(N-(3-(Indol-3-yl)-propyl)-piperid-3-yl)-methYl]-6,7-dimethvl-1,2,3,4-tetrahydro-isoquinoline-dihydro-chloride-monohydrate Prepared from 2-[(N-(3-(indol-3-yl)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-l~oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in diethylether ~-and tetrahydrofuran analogously to Example 3. ;-Yield: 90% of theory, Melting point: 198-201C ; ;
Calculated: C 66.38 H 8.16 N 8.29 Cl 14.00 Found: 66.29 8.21 8.46 13.82 ;

Example 261 3-[(N-(3-(Indol-3-yl)-propyl)-hexahydro-azepin-3-Yl)-methyl]-7~8-methylenedioxy-2-oxo-l~3~4~5 tetrahydro-2H-3-benzazepine-monohydrate Prepared from 3-[(hexahydro-azepin-3-yl)-methyl~
7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(3-benzenesulphonyloxy-propyl)-indole analogously to Example 1.

~33~9~3 Yield: 61.5% of theory, -Melting point: 62-64C
Calculated: C 70.84H 7.59N 8.55 Found: 70.73 7.59 8.42 ,: .
Example 262 2-[(N-(3-(Indol-3-yl)-propyl)-pyrr-olid-3-yl)-methyl]-6,7-dimethYl-1,2,3,4-tetrahYdro-isoquinoline-dihYdro-chloride-semihYdrate .
Prepared from 2-E(N-(3-(indol-3-yl)-propyl)-pyrrolid-3-yl~-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline and lithium aluminium hydride in ether analogously to Example 3.
Yield: 86~ of theory, Melting point: 143-145C
Calculated: C 67.06 H 7.92 N 8.69 Cl 14.66 Found: 66.92 8.07 8.48 14.87 Example 263 , ' -. - ~ - ' ':
2-[(N-(3-(Indol-3-yl)-propyl)-pyrrol _-3-Yl)-methYl~
6,7-dimethyl-1-oxo--1,2,3,4-tetrahYdro-iso~uinoline-hydrochloride x 1.5 hYdrate Prepared from 2-[(pyrrolid-3-yl)-methyl]-6,7-dimethyl-l-oxo-1,2,3,4-tetrahydro-isoquinoline and 3-(3 benzenesulphonyloxy-propyl)-indole analogously to Example 1.
Yield: 67% of theory, Melting point: 117-120C
Calculated: C 67.69 H 7.78 N 8.77 Cl 7.40 Found: 67.62 7.80 8.72 7,93 .:.

i33~93 -17~- 271~9-147 Exam~le 264 3-[(N-l3-(Indol-3-~l)-Pro~yl)-~rrolid-3-Yl)-methYll-7,8-methylenedioxy-1,3,4,S-tetrahYdro-2H-3-benzazepine-dihvdrochloride 1.5 x hydrate Prepared from 7,8-methylenedioxy-1,3,4,5-tetrahydro-2H-3-benzazepine and 3-(benzenesulphonyloxymethyl)-N-[3-~indol-3-yl)-propyl]-pyrrolidine analogously to Example 2.
Yield:. 75% of theory, ..
Melting point: 191-193C
: Calculated,C 61.01H 7.21N 7.90 Cl 13.34 ~
Found:60.90 7.27 7.85 13.70 ~ :
'. '-,.' ..~:. :-.

~.~ '; -"'' : "~

~ ' ~ ', -` ~33~93 ~xample I
Tablets containing 7.5 m~ of 3-[(N-(2-(naphth-2-yl)-ethyl~-piperid-3-Yl)-methYl]-7,8-dimethoxv-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazePine-hYdrochloride Composition:
1 tablet contains:
Active substance 7.5 mg Corn starch 59.5 mg Lactose 48.0 mg Polyvinylpyrrolidone 4.0 mg Magnesium stearate 1.0 mq ~ -120.0 mg Method of preParation The active substance, corn starch, lactose and polyvinylpyrrolidone are mixed together and moistened with water. The moist mixture is pushed through a screen with a mesh size of 1.5 mm and dried at about 45C. The dry granulate is passed through a 1.0 mm mesh screen and mixed with magnesium stearate.
The final mixture is compressed in a tablet press with dies 7 mm in diameter provided with a dividing notch to form tablets each weighing 120 mg.

Example II
. . . .
Coated tablets containinq 5 mg of 3-[~N-(2-(naphth~
2-yI)-ethyl)-piperid-3-yl)-methyl]-7~8-dimethoxy-2-oxo-1,3,4,S-tetr~ydro-2H-3-benzazeE~ine-hYdrochloride ~ ~ -1 tablet core contains~
Active substance 5.0 mg Corn starch 41.5 mg Lactose 30.0 mg Polyvinylpyrrolidone 3.0 mg Magnesium stearate 0.5 mg 80.0 mg ` i^~ 133~3 Method of Preparation The active substance, corn starch, lactose and polyvinylpyrrolidone are throughly mixed and moistened with water. The moist mass is forced througb a 1 mm screen, dried at about 45C and then the granulate is passed through the same screen. After magnesium stearate has been adaed~ convex tablet cores with r a diameter of 6 mm are compressed in a tablet making machine. The tablet cores thus produced are coated ~-in known manner with a coating consisting essentially of sugar and talc. The fin$shed coated tablets are polished with wax and the weight of the final coated tablet is 130 mg.

Example III
Ampoules containing 5 mg of 3-~(N-(2-(naphth-2-yl)-i~erid-3-Yl)-methYl]-7~8-dimethoxY-2-oxo-l~3~4~5 tetrahydro-2H-3-benzaze~in-2-one-hydrochloride 1 ampoule contains:
Active substance 5.0 mg Sorbitol 50.0 mg Water for injections ad 2.0 ml : - ~....
Method of Preparation . ~.
In a suitable mixing vessel the active substance is dissolved in water for injec~ions and the solution is made isotonic with sorbitol, After being filtered through a diaphragm filter -~
the solution is transferred under a current of N2 into purified and æterilized ampoules and auto-claved for 20 minutes in a jet of steam.
::
Example IV
:

~` ^` 133~93 Suppositories containinq_10 mg of 3-[(N-(2-(naphth- -2 Yl)-ethyl)-piperid-3-Yl)-methyll-7r8-dimethoxy-2-oxo-1,3,4,5-tetrahYdro-2H-3-benzazepine-hydrochloride 1 suppository contains:
Active substance ~ OoO10 g Hard fat te.g. witepsol H 19 and W 45) 1.690 q 1.700 g Method of PreParation The hard fat is melted. At 38C the ground active substance is homogeneously dispersed in the melt.
It is cooled to 35C and poured into slightly chilled suppository moulds.

Example V
DroPs solution containing 10 mg of 3-[(N-(2-(naphth-2-yl)-ethyl)-pi~erid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzaze~ine-h~drochloride -100 ml of solution contain:
Active substance 0.2 g Hydroxyethylcellulose 0.15g Tartaric acid 0.1 g Sorbitol solution with 70%
dry matter 30.0 g ;
Glycerol 10.0 g Benzoic acid 0.15g Dist. water ad 100 ml Method of Preparation The distilled water is heated to 70C. The hydroxyethyl-cellulose, benzoic acid and tartaric acid are dissolved therein with stirring. The mixture is cooled to ambient temperature and the glycerol and sorbitol solution are added with stirring. At ambient temperature ~fRde ~C,fk ::~

, ,, . , , ., ` , . . .

^ 13~993 the active substance is added and stirred until completely dissolved. Th0 syr~p is then evac~ated of any air with stirring.

:.~' , . ~, ..
',' ,'".'," ",'i,'' ..

' ~ ' '' ~ . . ~ ,, : ~',''';', , .
',.~,.'.':

:. .:

'~

Claims (21)

1. A compound of formula I

(I) (wherein A represents a -CH2-, -CH2-CH2- or -CH=CH- group;

B represents a -CH2-, -CH2-CH2- or -CO- group or a -CH2CO- group of which the carbonyl carbon is attached to the nitrogen atom;

E represents a straight-chained C1-3 alkylene group optionally substituted by a C1-3 alkyl group;

G represents straight-chained C1-6 alkylene group optionally substituted by a C1-3 alkyl group or a group -G'-G"- (where G' represents a straight chained C2-5 alkylene group optionally substituted by a C1-3 alkyl group and G" is attached to an aromatic or heteromatic group R and represents an oxa, thia, sulphinyl or sulphonyl group or an imino group optionally substituted by a C1-3 alkyl group);

R1 represents a hydrogen or halogen atom or a trifluoro-methyl, nitro, amino, C1-3 alkylamino, di(C1-3 alkyl)amino, C1-3 alkyl, hydroxy, C1-3 alkoxy or phenyl(C1-3 alkoxy) group and R2 represents a hydrogen or halogen atom or a hydroxy, C1-3 alkoxy, phenyl(C1-3 alkoxy) or C1-3 alkyl group or R1 and R2 together represent a C1-2 alkylenedioxy group m is any one of the integers from 1 to 6 and n is any one of the integers from 0 to 3, and the sum of n and m is 3, 4, 5 or 6; and R represents a ring carbon- or ring nitrogen- attached cyclic group comprising a 5- or 6-membered heteroaromatic ring optionally carrying a fused benzene ring, wherein said heteroaromatic ring contains one oxygen, sulphur or nitrogen atom, two nitrogen atoms or one nitrogen atom and one oxygen or sulphur atom, wherein the carbon structure of said cyclic group optionally is mono- or disubstituted by substituents selected from halogen atoms and C1-3 alkyl, hydroxy, C1-3 alkoxy, phenyl(C1-3 alkoxy), phenyl, dimethoxyphenyl, nitro, amino, acetylamino, carbamoylamino, N-(C1-3 alkyl)-carbamoylamino, hydroxymethyl, mercapto, C1-3 alkylmercapto, C1-3 alkylsulphinyl, C1-3 alkylsulphonyl, C1-3 alkylsulphonyloxy, C1-3 alkylsulphonylamino, (C1-3 alkoxy)carbonylmethoxy, carboxymethoxy and (C1-3 alkoxy)methyl groups or optionally is substituted by a methylenedioxy or ethylenedioxy group, wherein any imino group in said heteroaromatic ring optionally is substituted by a C1-3 alkyl, phenyl(C1-3 alkyl) or phenyl group, wherein where said cyclic group comprises an indolyl group it additionally optionally is substituted by a methylamino, dimethylamino, methoxy, acetoxy, trifluoromethyl, trichloromethyl, carboxy, methoxycarbonyl, ethoxycarbonyl, cyano, cyclohexyl, trimethoxyphenyl, trifluorophenyl, trichlorophenyl, tribromophenyl or dihaloaminophenyl group or by a benzyl, benzyloxy or benzylamino group optionally mono-, di- or trisubstituted in the phenyl ring of the benzyl nucleus by methoxy or methyl groups, or a naphthyl group optionally substituted by a C1-2 alkylenedioxy group or optionally mono- or disubstituted by substituents selected from halogen atoms and C1-3 alkyl, hydroxy, C1-3 alkoxy, C1-3 alkylsulphonyloxy, nitro, amino and C1-3 alkanoylamino groups, or a benzyloxy or 4,5,6,7-tetrahydro-benzo[b]thienyl group, or, if B represents a -CH2- or -CO- group, R may also represent a phenyl group optionally substituted by a C1-2 alkylenedioxy group or by a halogen atom or by a C1-3 alkyl, hydroxy, C1-3 alkoxy, phenyl(C1-3 alkoxy), nitro, amino, C1-3 alkanoylamino, C1-3 alkylsulphonylamino, bis(C1-3 alkylsulphonyl)amino, C1-3 alkylsulphonyloxy, trifluoromethyl, trifluoromethoxy or trifluoromethylsulphonyloxy group, or disubstituted by substituents selected from halogen atoms and C1-3 alkyl and C1-3 alkoxy groups, a tri(C1-3 alkoxy)phenyl group, a tetra(C1-3alkyl)phenyl group or a dihaloaminophenyl group) or an enantiomer, diastereomer, N-oxide or acid addition salt thereof.
2. A compound of formula I as claimed in claim 1, wherein A, B, m and n are as defined in claim 1, E represents a straight-chained C1-3 alkylene group, G represents a straight-chained C1-6 alkylene group or a group -G'-G"- wherein G' represents a straight chained C2-5 alkylene group and G" represents an oxa, methylimino or ethylimino group, R1 represents a methyl or methoxy group and R2 represents a methyl or methoxy group or R1 and R2 together represent a methylenedioxy group, and R represents an optionally methyl-substituted furyl, thienyl, pyridyl, benzo[b]furyl or benzo[b]thienyl group, a benzo[b]thienyl group substituted by a halogen atom or by a methoxy or methanesulphonyloxy group, an indolyl or N-methyl-indolyl group optionally substituted by a hydroxy, methoxy or benzyloxy group, a dimethyl-thienyl or dimethoxy-isoquinolyl group, a naphthyl group optionally mono- or disubstituted by methyl or methoxy groups wherein the substituents may be the same or different, or, if B represents a -CH2- or -CO- group, R may also represent a phenyl group optionally substituted by a methylenedioxy group, a phenyl group mono- or disubstituted by chlorine or bromine atoms or methyl or methoxy groups wherein the substituents may be the same or different, a phenyl group substituted by a hydroxy, benzyloxy, methanesulphonyloxy, trifluoromethanesulphonyloxy, trifluoromethyl, trifluoromethoxy, nitro, amino, acetamido, methanesulphonylamino or bis(methanesulphonyl)-amino group, or a trimethoxyphenyl, tetramethylphenyl or dihaloaminophenyl group, or an enantiomer, diastereomer, N-oxide or acid addition salt thereof.
3. A compound as claimed in claim 2 being a compound of formula Ia (Ia) wherein R1, R2, A, B, E, G, m and n are as defined in claim 2, or an enantiomer, diastereomer, N-oxide or acid addition salt thereof.
4. A compound of formula Ia as claimed in claim 3, wherein A represents a -CH2CH2- group, B represents a -CH2-, -CH2-CH2-, -CO- or -CH2CO-group, E represents a methylene or ethylene group, G represents a straight-chained C2-4 alkylene group or a straight-chained C2-3 alkyleneoxy group, R1 represents a methoxy group and R2 represents a methoxy group or R1 and R2 together represent a methylenedioxy group, m represents any one of the integers from 2 to 4, n represents the integer 1, and R represents a naphth-2-yl, 6-methoxy-naphth-2-yl, 5-methyl-6-methoxy-naphth-2-yl, thien-2-yl, benzo[b]fur-2-yl or benzo[b]thien-3-yl group or, if B represents a -CH2- or -CO- group, a 4-methoxyphenyl or 3,4-dimethoxyphenyl group, or an enantiomer, diastereomer or acid addition salt thereof.
5. A compound as claimed in claim 1 being:

a) 3-[(N-(2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;
b) 3-[(N-(2-(5-methyl-6-methoxy-naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;

c) 3-[2-(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-piperid-2-yl)-ethyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;

d) 2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

e) 2-[(N-(2-(naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

f) 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1,2,3,4-tetrahydro-isoquinoline;

g) 2-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

h) 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7-dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

i) 3-[(N-(4-(thien-2-yl)-butyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;

k) 3-[(N-(2-(benzo[b]fur-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2 oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;

l) 3-[(N-(2-(benzo[b]thien-3-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro -2H-3-benzazepine, m) 2-[(N-(3-(6-methoxy-naphth-2-yl-oxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimlethoxy-1-oxo-1,2,3,4-tetrahydro - isoquinoline ;

n) 2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

o) 3-[(N-(2-(4-methoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;

p) 3-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine;

q) 3-[(N-(2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2-oxo-1,3,4,5-tetrahydro-2H-3-benzazepine ;

r) 2-[(N-(3-(4-methoxy-phenoxy)-propyl)-piperid-3-yl)-methyl]-6,7 dimethyl-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

s) 3-[(N-(4-(thien-2-yl)-butyl)-piperid-3-yl)-methyl]-7,8-dimethoxy-2- oxo -1,3,4,5-tetrahydro-2H-3-benzazepine;

t) 2-[(N-(3-(6-methoxy-naphthyl-2-oxy)-propyl)-pyrrolid-3-yl)-methyl]-6,7-dimethoxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline;

u) 2-[(N-(2-(6-methoxy-naphth-2-yl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-6,7-methylenedioxy-1-oxo-1,2,3,4-tetrahydro-isoquinoline;
v) 3-[(N-(2-(4-methoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-dimethoxy-1-oxo-1,3,4,5-tetrahydro-2H-2-benzazepine;
w) 3-[(N-(2-(3,4-dimethoxy-phenyl)-ethyl)-hexahydro-azepin-3-yl)-methyl]-7,8-methylenedioxy-2-oxo-1,3,4,5-tetrahydro-2H-2-benzazepine; or an enantiomer, diastereomer or acid addition salt thereof.
6. A compound as claimed in claim 1 being 3-[(N-(2-(naphth-2-yl)-ethyl)-piperid-3-yl)-methyl]-
7,8-dimethoxy-1-oxo-1,3,4,5-tetrahydro-2H-2-benzazepine or an enantiomer, diastereomer or acid addition salt thereof.
7. A compound as claimed in claim 1, 2, 3, 4, 5 or 6 being in the form of a physiologically acceptable acid addition salt.
8. A pharmaceutical composition comprising a compound of formula I as claimed in claim 1, 2, 3, 4, 5 or 6 or a physiologically acceptable acid addition salt thereof together with at least one pharmaceutical carrier or excipient.
9. A process for the preparation of compounds as claimed in claim 1, said process comprising at least one of the following steps:
a) reacting a compound of formula II

(II) (wherein R1, R2, A, B, E, m and n are as defined in claim 1 with a compound of formula III
(III) (wherein R is as defined in claim 1 and Z1 represents a nucleophilic leaving group or a hydroxy group and G"' is a group G as defined in claim 1 or Z1 represents an oxygen atom and G"' represents a straight chained C1-6 alkanylylidene group optionally substituted by a C1-3 alkyl group or a group -G""G"- where G" is as defined in claim 1 and G"" represents a straight-chained C2-5 alkanylylidene group optionally substituted by a C1-3 alkyl group) and subsequently, if desired, cleaving off any protecting group used during the reaction to protect reactive groups;

b) reacting a compound of formula IV
(IV) (wherein R1, R2, A and B are as defined in claim 1 with a compound of formula V
(V) (wherein R, E, G, m and n are as defined in claim 1 and Z2 represents a nucleophilic leaving group) and subsequently, if desired, cleaving off any protecting group used during the reaction to protect reactive groups;
c) (to prepare compounds of formula I wherein B
represents a -CH2- or -CH2CH2- group) reducing a compound of formula VI
(VI) (wherein R, R1, R2, E, G, m and n are as defined in claim 1, A' represents a -CH2-, -CH2CH2-, -CH=CH- or -CO- group, and B1 represents a -CO- group or a -CH2CO- group of which the carbonyl carbon is attached to the nitrogen atom) and subsequently, if desired, cleaving off any protecting group used during the reaction to protect reactive groups;
d) (to prepare compounds of formula I wherein A
represents a -CH2- group and B represents a -CO-or -CH2CO- group) reducing a compound of general formula VII
(VII) (wherein R, R1, R2, E, G, m and n are as defined in claim 1 and B2 represents a -CO- group or a -CH2CO- group of which the carbonyl carbon is attached to the nitrogen atom) with nascent hydrogen and subsequently, if desired, cleaving off any protecting group used during the reaction to protect reactive groups;
e) (to prepare compounds of formula I wherein G
is a group G as defined in claim 1, with the exception of the groups containing a sulphur atom or a sulphinyl or sulphonyl group, and wherein A represents a -CH2CH2- group and B
represents a methylene or carbonyl group) hydrogenating a compound of formula VIII
(VIII) (wherein R, R1, R2, B, E, m and n are as defined in claim 1, G1 is a group G as defined in claim 1 with the proviso that it does not represent a group containing a sulphur atom or a sulphinyl or sulphonyl group, and B3 represents a -CH2- or -CO- group) and subsequently, if desired, cleaving off any protecting group used during the reaction to protect reactive groups;
f) reducing a resulting compound of formula I wherein R contains a nitro group to yield a corresponding amino compound of formula I;
g) acylating a resulting compound of formula I wherein R contains an amino group to yield a corresponding alkanoylamino compound of formula I;
h) resolving a resulting compound of formula I into its diastereomers or enantiomers;
and i) converting a compound of formula I into an acid addition salt thereof or a salt of a compound of formula I into the free base.
10. A process as claimed in claim 9, wherein the reaction is carried out in a solvent.
11. A process as claimed in claim 9 or 10, wherein the reaction of step (a) or step (b) is carried out in the presence of an acid binding agent.
12. A process as claimed in claim 9 or 10 wherein, if in the reagent of formula III or V Z1 or Z2 respectively represents a nucleophilic leaving group, the reaction is carried out at temperatures of between 0 and 150°C.
13. A process as claimed in claim 9 or 10, wherein in step (a), if in the reagent of formula III Z1 represents a hydroxy group or an oxygen atom, the reaction is carried out with hydrogen in the presence of a hydrogenation catalyst at temperatures of between 20 and 120°C.
14. A process as claimed in claim 9 or 10, wherein in step (a), if in the reagent of formula III Z1 represents an oxygen atom, the reaction is carried out in the presence of a complex metal hydride at temperatures of between 0 and 50°C.
15. A process as claimed in claim 9 or 10, wherein the reduction of step (c) is carried out with a metal hydride, with diborane or with a complex of borane and a thioether at temperatures of between 0 and 80°C.
16. A process as claimed in either of claims 9 and 10, wherein the reduction of step (d) is carried out with nascent hydrogen at temperatures of between 20 and 150°C.
17. A process as claimed in claim 9 or 10, wherein the reduction of step (e) is carried out with catalytically activated hydrogen at temperatures of between 0 and 70°C.
18. A process as claimed in claim 10, wherein the subsequent cleavage of any protecting groups used is effected hydrolytically or hydrogenolytically.
19. The use of a compound of formula I as defined in claim 1, 2, 3, 4, 5 or 6, or a physiologically acceptable salt thereof, for the treatment of sinus tachycardia or ischaemic heart disease.
20. A method of making a pharmaceutical composition, which method comprises incorporating a compound of formula I as defined in claim 1, 2, 3, 4, 5 or 6, or a physiologically acceptable salt thereof, as active ingredient in the composition.
21. A commercial package containing as an active pharmaceutical ingredient a compound of formula I as defined in claim 1, 2, 3, 4, 5 or 6, or a physiologically acceptable salt thereof, together with instructions for the use thereof for treating sinus tachycardia or ischaemic heart disease.
CA000567464A 1987-05-25 1988-05-20 Cyclic amine derivatives, pharmaceutical compositions containing these compounds and processes for their preparation Expired - Fee Related CA1330993C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873717561 DE3717561A1 (en) 1987-05-25 1987-05-25 INDOL, ISOCHINOLINE AND BENZAZEPINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DEP3717561.0 1987-05-25

Publications (1)

Publication Number Publication Date
CA1330993C true CA1330993C (en) 1994-07-26

Family

ID=6328351

Family Applications (2)

Application Number Title Priority Date Filing Date
CA000567453A Expired - Lifetime CA1287226C (en) 1987-05-25 1988-05-20 Hollow shaft made of a material having a low modulus of elasticity, with drive elements secured thereon by expanding the shaft
CA000567464A Expired - Fee Related CA1330993C (en) 1987-05-25 1988-05-20 Cyclic amine derivatives, pharmaceutical compositions containing these compounds and processes for their preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA000567453A Expired - Lifetime CA1287226C (en) 1987-05-25 1988-05-20 Hollow shaft made of a material having a low modulus of elasticity, with drive elements secured thereon by expanding the shaft

Country Status (21)

Country Link
EP (1) EP0292840B1 (en)
JP (1) JP2634190B2 (en)
KR (1) KR960009432B1 (en)
AT (1) ATE126225T1 (en)
AU (1) AU607765B2 (en)
CA (2) CA1287226C (en)
DD (1) DD284678A5 (en)
DE (2) DE3717561A1 (en)
DK (1) DK282188A (en)
ES (1) ES2076147T3 (en)
FI (1) FI94343C (en)
GR (1) GR3017550T3 (en)
HU (1) HU198201B (en)
IE (1) IE68842B1 (en)
IL (1) IL86477A (en)
IN (1) IN169514B (en)
NO (1) NO171017C (en)
NZ (1) NZ224756A (en)
PT (1) PT87567B (en)
SU (1) SU1561823A3 (en)
ZA (1) ZA883680B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3640641A1 (en) * 1986-11-28 1988-07-14 Thomae Gmbh Dr K NEW HETEROAROMATIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3835291A1 (en) * 1988-04-19 1989-11-02 Bayer Ag 1,3-DISUBSTITUTED PYRROLIDINES
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
EP0351283A1 (en) * 1988-07-12 1990-01-17 Synthelabo 2-[(4-Piperidinyl)methyl]-2,3-dihydro-1H-isoindole and 2,3,4,5-tetrahydro-1H-benzazepine derivatives, their preparation and therapeutical use
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
US4952692A (en) * 1989-04-04 1990-08-28 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
IE903857A1 (en) * 1989-10-27 1991-05-08 Du Pont Merck Pharma (N-Phthalimidoalkyl)Piperidines
CA2069318A1 (en) * 1989-10-27 1991-04-28 Engelbert Ciganek (n-phthalimidoalkyl) piperidines
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
PT1260512E (en) * 2000-02-29 2007-10-10 Mitsubishi Pharma Corp '' NEW CYCLIC AMID DERIVATIVES ''
BR0317483A (en) 2002-12-20 2005-11-16 Glaxo Group Ltd Benzodiazepine derivatives for the treatment of neurological disorders
FR2868776B1 (en) * 2004-04-13 2008-04-18 Servier Lab NOVEL PROCESS FOR THE SYNTHESIS OF 1,3-DIHYDRO-2H-3-BENZAZEPIN-2-ONE DERIVATIVES AND THE APPLICATION TO THE SYNTHESIS OF IVABRADINE AND ITS SALTS OF ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID
JP5031745B2 (en) * 2005-08-12 2012-09-26 アストラゼネカ アクチボラグ Metaindole glutamate receptor potentiating isoindolone
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
EA017648B1 (en) 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
MX2011002042A (en) 2008-09-02 2011-06-20 Ortho Mcneil Janssen Pharm 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors.
RU2512283C2 (en) 2008-11-28 2014-04-10 Янссен Фармасьютикалз, Инк. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
PT2430022E (en) 2009-05-12 2013-12-26 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
NZ596053A (en) 2009-05-12 2013-05-31 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5852666B2 (en) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
JP5852665B2 (en) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor
EP2741735A1 (en) 2011-08-12 2014-06-18 Boehringer Ingelheim Vetmedica GmbH Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6, 7- dihydropyrazolu [5,1-a] pyrazine-4 (5 hands) -on compounds and their use as negative excretory regulators of Miglore 2 receptors.
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
MX373715B (en) 2014-01-21 2020-05-08 Janssen Pharmaceutica Nv COMBINATIONS INCLUDING ORTHOSTERIC AGONISTS OR POSITIVE ALLOSTERIC MODULATORS OF THE METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE.
HRP20191646T1 (en) 2014-01-21 2019-12-13 Janssen Pharmaceutica Nv COMBINATIONS CONTAINING POSITIVE ALOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE
JP6931456B2 (en) * 2017-04-03 2021-09-08 川崎化成工業株式会社 Photopolymerization sensitizer containing 2-haloalkoxy-6-substituted oxynaphthalene compound and 2-haloalkoxy-6-substituted oxynaphthalene compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639718C2 (en) * 1976-09-03 1987-03-05 Dr. Karl Thomae Gmbh, 7950 Biberach 1-[6,7-Dimethoxy-3,4-dihydro-2H-isoquinolin-1-on-2-yl]-3-[N-methyl-N-(2-(3,4-dimethoxy-phenyl)-ethyl)-amino]-propane, its physiologically acceptable acid addition salts and medicaments containing these compounds
DE3119874A1 (en) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "BENZAZEPINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
DE3418271A1 (en) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach NEW BENZAZEPINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3418270A1 (en) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach NEW AMINOTETRAL DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3541811A1 (en) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K NEW CYCLIC AMINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
EP0306375A1 (en) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their use in therapy
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
FR2686339B1 (en) * 1992-01-22 1994-03-11 Adir Cie NOVEL NAPHTHALENIC AMIDES AND SULFONAMIDES, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
IN169514B (en) 1991-11-02
DK282188D0 (en) 1988-05-24
EP0292840A3 (en) 1990-04-11
JP2634190B2 (en) 1997-07-23
SU1561823A3 (en) 1990-04-30
DK282188A (en) 1988-11-26
ES2076147T3 (en) 1995-11-01
EP0292840A2 (en) 1988-11-30
NO171017C (en) 1993-01-13
DE3854280D1 (en) 1995-09-14
NO882258L (en) 1988-11-28
PT87567A (en) 1989-05-31
IL86477A0 (en) 1988-11-15
IE881559L (en) 1988-11-25
FI94343B (en) 1995-05-15
JPS6445381A (en) 1989-02-17
NO882258D0 (en) 1988-05-24
EP0292840B1 (en) 1995-08-09
DD284678A5 (en) 1990-11-21
KR880013924A (en) 1988-12-22
HUT46906A (en) 1988-12-28
KR960009432B1 (en) 1996-07-19
ATE126225T1 (en) 1995-08-15
FI94343C (en) 1995-08-25
IE68842B1 (en) 1996-07-10
HU198201B (en) 1989-08-28
FI882418A0 (en) 1988-05-23
DE3717561A1 (en) 1988-12-08
NO171017B (en) 1992-10-05
AU607765B2 (en) 1991-03-14
GR3017550T3 (en) 1995-12-31
PT87567B (en) 1992-09-30
ZA883680B (en) 1990-01-31
AU1656288A (en) 1988-12-01
FI882418A7 (en) 1988-11-26
CA1287226C (en) 1991-08-06
NZ224756A (en) 1991-02-26
IL86477A (en) 1992-07-15

Similar Documents

Publication Publication Date Title
CA1330993C (en) Cyclic amine derivatives, pharmaceutical compositions containing these compounds and processes for their preparation
US5175157A (en) Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
US4737495A (en) (2H)-3-benzazepin-2-ones, their pharmaceutical compositions and their pharmaceutical uses
RU2012559C1 (en) Derivatives of isoindolone as (3 ar, 7 ar)- or (3 ars, 7 ars)-forms or theirs mixtures or theirs hydrochlorides, which are antagonists of compound p
CA1241326A (en) Aminotetrahydronaphthyline derivates, pharmaceutical compositions containing these compounds and processes for their preparation
AU600995B2 (en) Heteroaromatic amine derivatives
US5116846A (en) N-aralkyl piperidine derivatives as psychotropic drugs
HUP0104364A2 (en) Pyrrolidine derivatives-ccr-3 receptor antagonists
IE912279A1 (en) 1-indolylalkyl-4-(alkoxypyrimidinyl)piperazines
CA1279064C (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols, preparation, and uses
CA1336833C (en) Piperidine derivatives
PL91512B1 (en)
US4604389A (en) Benzazepine derivatives
US5929072A (en) 1H-2,1,3-benzothiadiazine-2,2-dioxide compounds or derivatives thereof
US4871735A (en) Naphthyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
WO1993022310A1 (en) (n-phthalimidoalkyl)piperidines for the treatment of psychoses
FI88299C (en) FRAMEWORK FOR CYCLIC CYCLING OF PHARMACEUTICAL PRODUCTS
DE60305519T2 (en) Sulphonamide derivatives as antipsychotic agents
CA1211107A (en) Benzazepine derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
KR20010072262A (en) Tricyclic Carboxamides
EA001469B1 (en) Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatmentof cns-disorders
DD247898A5 (en) NEW HETEROAROMATIC AMINE DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
WO1999014197A1 (en) Substituted isoquinolines as anticonvulsivants
MXPA01005034A (en) Pyrrolidine derivatives-ccr-3 receptor antagonists
HK1062436A1 (en) Isoquinolinyl carboxamides and their use as anticonvulsants

Legal Events

Date Code Title Description
MKLA Lapsed